--------------------------------------------------------------------------------
PLAN AND AGREEMENT FOR REORGANIZATION
--------------------------------------------------------------------------------
PROMEDCO, INC.
PROMEDCO OF TEMPLE, INC.
AND
KING'S DAUGHTERS CLINICS, P.A.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
SEPTEMBER 13, 1996
--------------------------------------------------------------------------------
(1)
0363293.08
080020-007 10/09/96
-2-
DRAMATIS PERSONAE
Player Office Address Home Address
ProMedCo, Inc.
H. ▇▇▇▇▇ ▇▇▇▇▇ ProMedCo, Inc.
President ▇▇▇ ▇▇▇▇▇▇ ▇▇.
▇▇▇▇▇ ▇▇▇▇ (▇▇▇▇▇▇▇) ▇▇▇-▇▇▇-▇▇▇▇
▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Vice President ▇▇▇-▇▇▇-▇▇▇▇
E-mail: ▇▇▇▇▇▇▇▇▇@▇▇▇.▇▇▇ Fax ▇▇▇-▇▇▇-▇▇▇▇
ProMedCo Counsel
▇▇▇▇ ▇. ▇▇▇▇▇▇▇ Boult, Cummings, ▇▇▇▇▇▇▇ & ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇
615-252-2305 ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Fax ▇▇▇-▇▇▇-▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ 615-297-3149
E-mail: ▇▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇ ▇▇▇-▇▇▇-▇▇▇▇ Car ▇▇▇-▇▇▇-▇▇▇▇
Fax ▇▇▇-▇▇▇-▇▇▇▇ Portable ▇▇▇-▇▇▇-▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇-▇▇▇-▇▇▇▇
E-mail:▇▇▇▇▇▇▇@▇▇▇▇.▇▇▇
King's Daughters Clinics, P.A.
▇▇▇▇▇ ▇▇▇▇▇▇▇▇ King's Daughters Clinics, P.A.
Executive Vice President ▇▇▇▇ ▇.▇. ▇. ▇. ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇
▇▇▇-▇▇▇-▇▇▇▇
Fax ▇▇▇-▇▇▇-▇▇▇▇
KDC Counsel
▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇
E-mail:▇▇▇▇▇▇▇@▇▇▇▇▇.▇▇▇ San Jacinto Center
Suite 1300
▇▇▇▇▇▇ ▇. ▇▇▇▇▇, ▇▇. ▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇.
512-703-5726 ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
▇▇▇-▇▇▇-▇▇▇▇
Fax ▇▇▇-▇▇▇-▇▇▇▇
(1)
0363293.08
080020-007 10/09/96
-i-
TABLE OF CONTENTS
ARTICLE 1 DEFINITIONS........................................................1
Affiliate...........................................................1
Assets ...........................................................1
Assumed Balance Sheet Liabilities...................................2
Consideration.......................................................2
COBRA ...........................................................2
Clinic Facility.....................................................2
Closing ...........................................................2
Closing Date........................................................2
Code ...........................................................2
Contracts...........................................................2
Definitive Closing Statements.......................................3
Distribution Funds..................................................3
Excluded Assets.....................................................3
Excluded Liabilities................................................3
Exhibit Volume......................................................3
Final Closing Statement.............................................3
GAAP ...........................................................3
Initial Portion of Purchase Consideration...........................3
Inventory...........................................................3
IRS ...........................................................3
KDC ...........................................................3
KDC Financial Statements............................................3
KDCP ...........................................................3
Non-Shareholder Physician Employment Agreement......................3
Pension Plan........................................................3
Person ...........................................................3
ProMedCo Financial Statements.......................................4
ProMedCo, Inc.......................................................4
ProMedCo IPO Date...................................................4
ProMedCo IPO Price..................................................4
ProMedCo-Temple.....................................................4
ProMedCo-Temple Distribution........................................4
ProMedCo Stock......................................................4
Second Portion of the Purchase Consideration........................4
Service Agreement...................................................4
Shareholder Physician Employment Agreement..........................4
Temple ...........................................................4
(1)
0363293.08
080020-007 10/09/96
-ii-
Undertaking.........................................................4
ARTICLE 2 SALE AND TRANSFER OF ASSETS: CONSIDERATION; CLOSING.................4
2.1 Sale and Transfer of Assets.....................................4
2.2 Assets Free and Clear; Undertaking..............................4
2.3 Excluded Assets.................................................5
2.4 Consideration for Sale and Transfer.............................5
2.5 Legend..........................................................6
2.6 Excluded Liabilities............................................6
2.7 Closing.........................................................6
2.8 Further Acts and Assurances.....................................7
2.9 Other Transactions at the Closing...............................7
2.10 Purchase Consideration Adjustments.............................7
ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF KDC .............................9
3.1 Organization, Corporate Power and Qualification.................9
3.2 Capitalization of KDC. .......................................10
3.3 Subsidiaries, Affiliates, Affiliated Companies
and Joint Venture..............................................10
3.4 Financial Statements...........................................10
3.5 Absence of Undisclosed Liabilities.............................10
3.6 Absence of Certain Recent Changes..............................11
3.7 Title to Assets................................................12
3.8 Contracts......................................................13
3.9 Burdensome Agreements..........................................14
3.10 Absence of Related Party Transactions.........................15
3.11 Defaults......................................................15
3.12 Inventory.....................................................15
3.13 Equipment.....................................................16
3.14 Receivables...................................................16
3.15 Permits and Licenses..........................................16
3.16 Litigation, etc...............................................16
3.17 Court Orders, Decrees and Laws................................17
3.18 Taxes.........................................................17
3.19 Immigration Act...............................................17
3.20 Program Compliance............................................18
3.21 Environmental Matters.........................................18
3.22 ERISA.........................................................18
3.23 Pension, etc. ................................................19
3.24 Employee Matters..............................................20
(1)
0363293.08
080020-007 10/09/96
-iii-
3.25 Insurance and Bonds...........................................20
3.26 Labor Matters.................................................21
3.27 Healthcare Compliance.........................................21
3.28 Facility Compliance...........................................21
3.29 Improper Payments.............................................22
3.30 Books of Account; Reports.....................................22
3.31 No Finders or Brokers.........................................22
3.32 Distribution of ProMedCo Stock................................22
3.33 Review of Information.........................................22
3.34 Future Value..................................................22
3.35 Restricted Securities.........................................22
3.36 Legend........................................................23
3.37 Authority; Binding Effect.....................................23
3.38 Consents and Approvals of Governmental Authorities............23
3.39 Disclosure....................................................23
ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF PROMEDCO AND PROMEDCO-
TEMPLE..............................................................23
4.1 Organization and Standing of ProMedCo and ProMedCo-Temple......23
4.2 Capitalization of ProMedCo.....................................23
4.3 ProMedCo Stock.................................................24
4.4 Authority; Binding Effect......................................24
4.5 No Finders or Brokers..........................................24
4.6 Consents and Approvals of Governmental Authorities.............24
4.7 Pending Litigation.............................................24
4.8 Program Compliance.............................................25
4.9 No Material Financial Changes..................................25
ARTICLE 5 COVENANTS OF PROMEDCO AND PROMEDCO-TEMPLE ........................25
5.1 Best Efforts to Secure Consents................................25
5.2 Corporate Action...............................................25
5.3 Handling of Documents..........................................25
5.4 Non-Disclosure.................................................25
5.5 Board Visitation Rights........................................26
ARTICLE 6 COVENANTS OF KDC .................................................26
6.1 Access and Information.........................................26
6.2 Conduct of Business............................................27
6.3 Compliance with Agreement......................................27
(1)
0363293.08
080020-007 10/09/96
-iv-
6.4 Best Efforts to Secure Consents................................27
6.5 Unusual Events.................................................27
6.6 Interim Financial Statements...................................27
6.7 Departmental Violations........................................28
6.8 Assessments....................................................28
6.9 Insurance Ratings..............................................28
6.10 Maintain Insurance Coverage...................................28
6.11 Exclusive Dealings............................................28
6.12 Liquidation and Dissolution...................................29
ARTICLE 7 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF KDC ...................29
7.1 Representations and Warranties True............................29
7.2 Opinion of Counsel.............................................29
7.3 Authority......................................................29
7.4 No Obstructive Proceeding......................................29
7.5 Delivery of Certain Certified Documents........................30
7.6 Proceedings and Documents Satisfactory.........................30
7.7 No Agency Proceedings..........................................30
7.8 No Material Adverse Change.....................................30
7.9 Employees......................................................30
7.10 Closing Transactions..........................................30
ARTICLE 8 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF PROMEDCO AND
PROMEDCO-TEMPLE.....................................................31
8.1 Representations and Warranties True............................31
8.2 No Obstructive Proceeding......................................31
8.3 Opinion of KDC Counsel.........................................31
8.4 Pooling Letters................................................31
8.5 Stockholder Agreements.........................................32
8.6 Consents and Approvals.........................................32
8.7 Dissenting Shareholders........................................32
8.8 Proceedings and Documents Satisfactory.........................32
8.9 No Material Adverse Change.....................................32
8.10 Delivery of Certain Documents.................................32
8.11 Closing Transactions..........................................33
ARTICLE 9 TERMINATION......................................................33
9.1 Optional Termination...........................................33
9.2 Notice of Abandonment. ........................................33
(1)
0363293.08
080020-007 10/09/96
-v-
9.3 Mandatory Termination..........................................33
9.4 Termination....................................................33
ARTICLE 10 INDEMNIFICATION ..................................................34
10.1 Grant of Indemnity............................................34
10.2 Representation, Cooperation and Settlement....................35
10.3 Remedies Cumulative...........................................36
ARTICLE 11 MISCELLANEOUS.....................................................36
11.1 Expenses......................................................36
11.2 Employee Transition...........................................37
11.3 Occasional Sale...............................................38
11.4 Non-Assignable Property Interests.............................38
11.5 Cooperation by ProMedCo and ProMedCo-Temple...................39
11.6 Cooperation by KDC............................................39
11.7 Notices. .....................................................39
11.8 Entire Agreement..............................................40
11.9 Alternative Dispute Resolution................................40
11.10 Governing Law................................................40
11.11 Legal Fees and Costs..........................................41
11.12 Time.........................................................41
11.13 Section Headings.............................................41
11.14 Waiver.......................................................41
11.15 Nature and Survival of Representations.......................41
11.16 Exhibits.....................................................41
11.17 Assignment...................................................41
11.18 Binding on Successors and Assigns............................41
11.19 Parties in Interest..........................................42
11.20 Amendments...................................................42
11.21 Drafting Party...............................................42
11.22 Counterparts.................................................42
11.23 Reproduction of Documents....................................42
11.24 Press Releases...............................................43
APPENDIX 2.2 FORM OF UNDERTAKING
APPENDIX 2.3 EXCLUDED ASSETS
APPENDIX 2.9A FORM OF SERVICE AGREEMENT
(1)
0363293.08
080020-007 ▇▇/▇▇/▇▇
-▇▇-
▇▇▇▇▇▇▇▇ 2.9B FORM OF SHAREHOLDER PHYSICIAN EMPLOYMENT AGREEMENT
APPENDIX 2.9C FORM OF NON-SHAREHOLDER PHYSICIAN EMPLOYMENT AGREE
MENT
APPENDIX 2.9E PROPERTIES TO BE LEASED FROM TEMPLE
APPENDIX 7.2 OPINION OF COUNSEL TO PROMEDCO AND PROMEDCO-TEMPLE
APPENDIX 8.3 OPINION OF COUNSEL TO KDC
APPENDIX 8.4 FORM OF STOCKHOLDER AGREEMENT
(1)
0363293.08
080020-007 10/09/96
-1-
PLAN AND AGREEMENT FOR REORGANIZATION
PLAN AND AGREEMENT FOR REORGANIZATION dated as of September 13, 1996,
among King's Daughters Clinics, P.A., a Texas professional association ("KDC"),
ProMedCo, Inc., a Texas corporation ("ProMedCo") and ProMedCo of Temple, Inc., a
Delaware corporation ("ProMedCo- Temple"), a wholly owned subsidiary of
ProMedCo.
RECITAL:
KDC operates a multi-specialty medical practice in Temple, Texas with
satellite locations in Killeen and Belton, Texas and owns the Assets described
in ss. 2.1 below. ProMedCo, through its subsidiaries, including ProMedCo-Temple
is engaged in the business of providing medical practice facilities, nonmedical
personnel and medical practice management and administrative services.
KDC desires to transfer the Assets to ProMedCo-Temple in exchange for
voting shares of ProMedCo in a transaction intended to qualify as a
"reorganization" within the meaning of Section 368(a)(1)(C) of the Code and as
pooling of interests under GAAP. The parties intend that this Agreement shall
serve as the "plan of reorganization" under Section 361(a) of the Code and the
regulations under Section 368 of the Code, with KDC, immediately after the
Closing hereunder, and as an integral part of the transactions contemplated
hereby, distributing the ProMedCo Shares and other consideration received
hereunder to its the shareholders of KDC as part of a plan of liquidation and
dissolution by KDC .
The parties hereby agree as follows:
ARTICLE 1 DEFINITIONS
For the purposes of this Agreement, the following definitions shall
apply:
"AFFILIATE" means with respect to any Party, any entity which controls, is
controlled by, or is under common control with such party all as more
fully set forth in the rules and regulations of the Securities and
Exchange Commission under the Securities Act of 1933, as amended.
"ASSETS" means the following assets pertaining to KDC:
(a) All furnishings, fixtures and equipment owned by KDC wherever
situated;
(b) All of KDC's rights, benefits and interests under all
contracts and agreements related to the operation of the
business of KDC which are to be assumed by ProMedCo- Temple
(collectively, the "Contracts"), including without limitation
certain real estate leases described in Exhibit 3.8 hereof and
the Service Agreement.
(1)
0363293.08
080020-007 10/09/96
-2-
(c) All licenses and intangible rights related to the business of
KDC;
(d) All books, records, documents and other writings used in
connection with the oper ation of KDC's business of which KDC,
its successors, agents or shareholders shall have a continuing
right to make copies of all documents at the expense of the
person making such copies;
(e) All accounts receivable of KDC;
(f) All cash, inventories and prepaid expenses of KDC; and
(g) All other assets, personal or mixed, tangible or intangible,
used in connection with the operation of KDC's business other
than the Excluded Assets.
"ASSUMED BALANCE SHEET LIABILITIES" is defined in ss. 2.4(b).
"CONSIDERATION" means the shares of ProMedCo Stock to be delivered by
ProMedCo-Temple pursuant to clauses (a) and (c) of ss. 2.4.
"COBRA" means Title X of the Consolidated Omnibus Budget Reconciliation Act of
1985, 26 U.S.C. ss. 162 et seq.
"CLINIC FACILITY" means the clinic facilities located at ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇
▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇, and the clinic facilities located at (i)
Neurology & Headache Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K.
▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇, (ii) Dermatology Center of
King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇,
▇▇▇▇▇ ▇▇▇▇▇, (iii) Womens Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H.
K. ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ (iv) Killeen Clinic, ▇▇▇
▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ and (v) Belton Family Practice Clinic, ▇▇▇▇
▇. ▇▇▇▇▇ ▇▇., ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ and (vi) any future clinic facilities
established by ProMedCo-Temple or KDC pursuant to the Service Agreement.
"CLOSING" and "CLOSING DATE" are defined in ss. 2.7.
"CODE" means the Internal Revenue Code of 1986, as amended.
"CONTRACTS" is defined in the definition of "Assets" above.
"CPA FIRM" is defined in ss. 2.10(a).
(1)
0363293.08
080020-007 10/09/96
-3-
"DEFINITIVE CLOSING STATEMENTS" is defined in ss. 2.10.
"DISTRIBUTION FUNDS" shall have the meaning ascribed thereto in the Service
Agreement.
"ERISA" means the Employee Retirement Income Security Act of 1974, as amended.
"EXCLUDED ASSETS" is defined in ss. 2.3.
"EXCLUDED LIABILITIES" is defined in ss. 2.6.
"EXHIBIT VOLUME" means the volume of Exhibits referred to in this Agreement
prepared and delivered by KDC.
"FINAL CLOSING STATEMENT" is defined in ss. 2.10.
"GAAP" means generally accepted accounting principles.
"INITIAL PORTION OF PURCHASE CONSIDERATION" is defined in ss. 2.4.
"INVENTORY" means the inventory of KDC.
"IRS" means the Internal Revenue Service.
"KDC" means King's Daughters Clinics, P.A., a Texas professional association.
"KDC FINANCIAL STATEMENTS" is defined in ss. 3.4.
"KDCP" means Physicians of King's Daughters, P.A., a Texas professional
association formed contemporaneously with the closing of the
transactions contemplated by this Agreement.
"NON-SHAREHOLDER PHYSICIAN EMPLOYMENT AGREEMENT" is defined in ss. 2.9(c).
"PENSION PLAN" and "PENSION PLANS" means any "employee pension benefit plan"
listed in Exhibit 3.22.
"PERSON" means any individual, corporation, partnership, joint venture,
association, joint stock company, trust or unincorporated organization.
(1)
0363293.08
080020-007 10/09/96
-4-
"PROMEDCOFINANCIAL STATEMENTS" means the consolidated balance sheet at June 30,
1996 and the related consolidated statement of operations,
shareholders' equity and cash flow for the year then ended, together
with the audit report thereon of ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & Co., LLP.
"PROMEDCO, INC." means ProMedCo, Inc., a Texas corporation which is the sole
shareholder of ProMedCo-Temple.
"PROMEDCOIPO DATE" means the date on which ProMedCo first sells stock to the
public pursuant to its initial public offering.
"PROMEDCOIPO PRICE" means the price per share at which ProMedCo offers ProMedCo
Stock to the public at its initial public offering.
"PROMEDCO-TEMPLE" means ProMedCo of Temple, Inc., a Delaware corporation, which
is a wholly owned subsidiary of ProMedCo.
"PROMEDCO-TEMPLE DISTRIBUTION" shall have the meaning ascribed thereto in the
Service Agreement.
"PROMEDCO STOCK" is defined in ss. 2.4.
"SECOND PORTION OF THE PURCHASE CONSIDERATION" is defined in ss. 2.4(c).
"SERVICE AGREEMENT" means the Service Agreement effective September 1, 1996
between ProMedCo-Temple and KDCP as referred to in ss. 2.9(a).
"SHAREHOLDER PHYSICIAN EMPLOYMENT AGREEMENT" is defined in ss. 2.9(b).
"TEMPLE" means Temple Medical Building and Leasing Company, LLC.
"UNDERTAKING" is defined in ss. 2.2.
ARTICLE 2 SALE AND TRANSFER OF ASSETS: CONSIDERATION; CLOSING
2.1 SALE AND TRANSFER OF ASSETS. At the Closing, ProMedCo-Temple agrees
to purchase from KDC and KDC agrees to sell to ProMedCo-Temple, the Assets, but
not the Excluded Assets.
2.2 ASSETS FREE AND CLEAR; UNDERTAKING. The Assets shall be sold free and
clear of all liabilities, liens and encumbrances except those liabilities of KDC
expressly assumed or agreed to be
(1)
0363293.08
080020-007 10/09/96
-5-
discharged by ProMedCo-Temple in the Undertaking in the form attached hereto as
Appendix 2.2. (the "Undertaking"). Except as provided in the Undertaking,
ProMedCo-Temple shall not assume any other liability or obligation of KDC fixed
or contingent, disclosed or undisclosed, and KDC agrees to satisfy, when due,
all of its liabilities, indebtedness and obligations not assumed by
ProMedCo-Temple pursuant to this Agreement and the Undertaking; provided,
however, that KDC shall be entitled to contest in good faith any of such
liabilities, indebtedness or obligations by appropriate legal proceedings.
ProMedCo-Temple will pay, perform and discharge in due course in accordance with
their terms all obligations, indebtedness and liabilities of KDC assumed by it
pursuant to the Undertaking; provided, however, that ProMedCo-Temple shall be
entitled to contest in good faith any of such obligations, indebtedness or
liabilities by appropriate legal proceedings.
2.3 EXCLUDED ASSETS. KDC is not selling and ProMedCo-Temple is not
purchasing or assuming obligations with respect to the following (collectively
the "Excluded Assets"):
(a) any real estate owned by KDC;
(b) KDC's corporate and fiscal records and other records that KDC
is required by law to retain in its possession;
(c) prepaid interest related to debt not assumed by ProMedCo-
Temple; and
(d) Any other assets described on Appendix 2.3.
2.4 CONSIDERATION FOR SALE AND TRANSFER. At the Closing, in consideration
for the sale of the Assets to ProMedCo-Temple, the following will occur:
(a) ProMedCo-Temple will deliver to KDC (i) 547,970 shares of the
no par Common Stock of ProMedCo ("ProMedCo Stock"; such
547,970 shares of ProMedCo Stock is referred to as the
"Initial Portion of Purchase Consideration"). The ProMedCo
Stock shall be registered in the name of KDC.
(b) ProMedCo-Temple will execute and deliver to KDC an executed
copy of the Under taking assuming the liabilities of KDC set
forth therein (such liabilities to include, without
limitation, the accounts payable, accrued expenses, accrued
payroll, and other current liabilities determined in
accordance with GAAP (collectively the "Assumed Balance Sheet
Liabilities") and shall specifically exclude any mortgage or
other liabilities related to real estate owned by KDC.
(1)
0363293.08
080020-007 10/09/96
-6-
(c) As soon as the Definitive Closing Statement is prepared in
accordance with ss. 2.10(a), ProMedCo-Temple shall deliver to
KDC an additional 136,993 shares of ProMedCo Stock (the
"Second Portion of the Purchase Consideration") adjusted
pursuant to ss. 2.10.
2.5 LEGEND. The certificates representing ProMedCo Stock issued to KDC
as the result of the transactions contemplated hereby shall bear the following
legend:
"THESE SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED ("THE SECURITIES ACT"), OR ANY
APPLICABLE STATE SECURITIES LAW. THESE SECURITIES HAVE BEEN
ACQUIRED FOR INVESTMENT AND NOT WITH A VIEW TO OR FOR RESALE
IN CONNECTION WITH THE DISTRIBUTION THEREOF. NO DISPOSITION OF
THESE SECURITIES MAY BE MADE IN THE ABSENCE OF (I) AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT; OR
(II) AN OPINION OF COUNSEL ACCEPTABLE TO THE CORPORATION THAT
SUCH DISPOSITION WITHOUT REGISTRATION IS IN COMPLIANCE WITH
THE SECURI TIES ACT."
2.6 EXCLUDED LIABILITIES. Except as provided in the Undertaking, KDC
shall remain liable and responsible for the payment or performance as the case
may be, of all contracts, leases and other obligations of any nature. KDC shall
remain liable and responsible for all suits, claims, indemnities, judgments,
stipulation agreements, mortgages, taxes, contingent liabilities and other
obligations of KDC, including, without limitation, any and all investment tax
credit recapture, depreciation recapture; recapture or prior period adjustments
under its Blue Cross, PCA, Medicare and Medicaid contracts ; all impositions of
income tax and other taxes for all time periods prior to and including the
Closing; all employee wages, salaries and benefits including, without
limitation, retirement payments, COBRA obligations, accrued vacation not assumed
by ProMedCo-Temple, and other accrued employee benefits and rights of KDC's
retirees to participate in KDC's medical plans. The obligations described in
this Section 2.6 are referred to collectively as the "Excluded Liabilities."
2.7 CLOSING. The sale, purchase, and other activities provided for
herein (the "Closing") shall take place on September 18, 1996 (the "Closing
Date"), at the office of KDC in Temple, Texas. In case the Closing does not take
place on the Closing Date, the Closing Date shall be set by mutual agreement
between ProMedCo-Temple and KDC; provided, however, that in no event shall the
Closing take place later than September 30, 1996 unless extended by
ProMedCo-Temple.
(1)
0363293.08
080020-007 10/09/96
-7-
2.8 FURTHER ACTS AND ASSURANCES. KDC shall, at any time and from time
to time at and after the Closing, upon request of ProMedCo-Temple, take any and
all steps reasonably necessary to place ProMedCo-Temple in possession and
operating control of the Assets and the business to be transferred hereunder and
will do, execute, acknowledge and deliver, or will cause to be done, executed,
acknowledged and delivered, all such further acts, deeds, assignments,
transfers, conveyances, powers of attorney and assurances as may be reasonably
required for the transferring and confirming to ProMedCo-Temple or to its
successors or assigns, or for reducing to possession, any or all of the Assets.
2.9 OTHER TRANSACTIONS AT THE CLOSING. In addition to the transaction
set forth above, the following additional transactions shall occur at the
Closing:
(a) KDCP and ProMedCo-Temple shall enter into a Service Agreement
in the form attached hereto as Appendix 2.9A.
(b) KDCP shall enter into employment agreements in the form
attached as Appendix 2.9B hereto (the "Shareholder Physician
Employment Agreements") with each of the shareholders of KDCP
(c) KDC shall enter into employment agreements in the form
attached as Appendix 2.9C hereto (the "Non-Shareholder
Physician Employment Agreement") with each of the
non-shareholder physicians practicing with KDC.
(d) ProMedCo-Temple shall consummate the purchase of certain
equipment from Temple and Temple shall assign its interests
under that certain Master Equipment Lease dated July 25, 199_
between Temple and Bank One Leasing Corporation in exchange
for a payment from ProMedCo-Temple to Temple of $129,516.72.
(e) ProMedCo-Temple shall have entered into lease agreements with
Temple or related entities respecting the properties described
on Appendix 2.9E on terms satisfactory to ProMedCo-Temple and
KDC.
2.10 PURCHASE CONSIDERATION ADJUSTMENTS.
(a) DEFINITIVE CLOSING STATEMENTS. Within 120 days after the Closing or by such
time as is reasonable under the circumstances, ProMedCo-Temple shall
prepare and deliver to KDC a final closing statement ("Final Closing
Statement") of KDC as of the Closing Date. ProMedCo-Temple covenants that
the Final Closing Statement shall be true, complete and accurate and will
present fairly the assets and liabilities items set
(1)
0363293.08
080020-007 10/09/96
-8-
forthin ▇▇.▇▇. 2.1 and 2.2 hereof as at the Closing, calculated in a manner
consistent with the KDC Financial Statements (as defined in ss. 3.4), and
the requirements of this Agreement. KDC and its representatives shall be
provided access to the books and records of ProMedCo-Temple as necessary to
verify the accuracy of such calcula tions. If within 30 business days of
receipt of the Final Closing Statement, KDC fails to deliver to
ProMedCo-Temple written notice specifying any unacceptable entries on the
Final Closing Statements and the reasons therefor, then such Final Closing
Statement shall constitute the Definitive Closing Statements. If KDC timely
and duly delivers such notice within 30 business days of receipt thereof,
the parties shall attempt in good faith to resolve the differences, and if
they are unable to do so, within 20 days thereafter either party may
deliver the Final Closing Statement to a "big six" accounting firm other
than ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & Co., LLC chosen by ProMedCo- Temple (the "CPA
Firm"), who shall have 20 business days to review the Final Closing
Statement and make such adjustments thereto as it deems necessary to ensure
that the Final Closing Statement has been prepared in a manner consistent
with the KDC Financial Statements calculated on a consistent basis and the
requirements of this Agreement and conform to consistently applied
generally accepted accounting principles. The Final Closing Statement as so
adjusted shall constitute the Definitive Closing Statement and shall be
binding on the parties hereto. If the total amount payable by
ProMedCo-Temple pursuant to clause (c) below increases from that shown on
the Final Closing Statement, ProMedCo-Temple shall pay the fees and
expenses of the CPA Firm, otherwise such fees and expenses shall be borne
by KDC. To the extent possible, all elective accounting principles or
policies shall be consistent with KDC's current principles and policies.
(b) LIABILITIES ADJUSTMENT. To the extent that the aggregate amount of current
and long-term liabilities of KDC assumed by ProMedCo-Temple under this
Agreement is different from $2,000,000, the Consideration hereunder shall
be increased or reduced on a dollar for dollar basis at the rate of one
share of ProMedCo Stock for each $14.00, rounded up or down, to the nearest
number of whole shares equal to the difference.
(c) DISTRIBUTION FUNDS ADJUSTMENT. If Distribution Funds for the annualized six
months ended June 30, 1996 (based on the assumption that the Service
Agreement had been in place during such period) are more than $8,670,313 or
less than $8,270,313 the Consideration shall be increased on a dollar for
dollar basis at the rate of one share of ProMedCo Stock for each $14.00,
rounded up or down, to the nearest number of whole shares equal to the
amount by which such Distribution Funds exceed $8,670,313 or decreased on a
dollar for dollar basis at the rate of one share of
(1)
0363293.08
080020-007 10/09/96
-9-
ProMedCo Stock for each $14.00, rounded up or down, to the nearest number of
whole shares equal to the amount by which such Distribution Funds are less
than $8,270,313 .
(d) PHYSICIAN DEFICIENCY ADJUSTMENT. To the extent that fewer than 100% of the
physicians associated with KDC on the date hereof fail to execute
Shareholder Physician Employment Agreements and/or Non-Shareholder
Physician Employment Agreements as contemplated byss.ss.2.9(b) and (c)
hereof, the Consideration shall be reduced at the rate of one share of
ProMedCo Stock for each $14.00, rounded up or down, to the nearest number
of whole shares equal to 50% the annualized Distribu tion Funds for the six
months ended June 30, 1996 attributable to each physician who fails to
enter into such agreement.
(e) IPO ADJUSTMENT. Upon completion of the ProMedCo IPO, the number of shares
issued pursuant toss.2.4(a) and (c), net of any adjustments pursuant to
clauses (a), (b), (c) or (d) of thisss. 2.10, shall be adjusted upwards or
downwards, as the case may be such that the aggregate number of the shares
of ProMedCo Stock issued pursuant to ss. 2.4(a) and (c), net of such
adjustments, when multiplied by the ProMedCo IPO Price equals $12,828,819
plus or minus the dollar amount of such adjustments (the dollar amount of
any such adjustments made in shares of ProMedCo Stock will be $14.00 per
share).
Any reduction in the Consideration resulting from this ss. 2.10 shall be
accomplished by first reducing the Balance of the Consideration by the amounts
provided hereunder, and if such reductions exhaust the Balance of the
Consideration, then KDC shall return, or cause its shareholders to return,
within 10 days after a demand therefor by ProMedCo-Temple, sufficient additional
shares of ProMedCo Stock and cash from the Initial Portion of the Consideration
to fully satisfy the reduction in Consideration.
ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF KDC
KDC hereby represents and warrants to ProMedCo-Temple as follows:
3.1 ORGANIZATION, CORPORATE POWER AND QUALIFICATION. KDC is a
corporation duly orga nized, validly existing and in good standing under the
laws of the State of Texas and has full corporate power and authority and all
authorizations, licenses and permits necessary to own, lease and operate its
properties and assets and to carry on its business as and where it is now being
conducted, to enter into this Agreement, and to consummate the transactions
contemplated hereby. KDC is duly qualified to do business and is in good
standing in each jurisdiction in which the
(1)
0363293.08
080020-007 10/09/96
-10-
character of the properties owned or leased by it or the nature of the business
transacted by it makes such qualification necessary. KDC is qualified to do
business in Texas. No jurisdiction where KDC is not presently qualified as a
foreign corporation has made any assertion that such corporation's business or
ownership of property makes qualification as a foreign corporation in such
jurisdiction necessary. A copy of the Articles of Incorporation and all
amendments thereto as of the date hereof of KDC and a copy of its by-laws, as
amended to the date hereof (both certified by the Secretary of KDC), are
included as Exhibit 3.1A of the Exhibit Volume and are true, accurate and
complete as of the date hereof. KDC is not in default under or in violation of
any provision of its Articles of Incorporation or bylaws.
3.2 CAPITALIZATION OF KDC. The authorized capital stock of KDC consists
of 1,000,000 shares of $1.00 par value common stock, of which as of the date
hereof, 3,100 shares are validly issued and outstanding. Except as disclosed on
Exhibit 3.2 of the Exhibit Volume, there are no voting trusts, proxies, or any
other stock restriction agreements or understandings with respect to the voting
stock of KDC.
3.3 SUBSIDIARIES, AFFILIATES, AFFILIATED COMPANIES AND JOINT VENTURE.
Except as set forth in Exhibit 3.3,KDC has no direct or indirect ownership
interest in, by way of stock ownership or otherwise, any corporation,
association or business enterprise.
3.4 FINANCIAL STATEMENTS. Exhibit 3.4 consists of the following
financial statements of KDC: (i) balance sheet of KDC at December 31, 1995 and
the related statement of operations, stockholders' equity and cash flow for the
years then ended, together with the audit opinion report thereon of ▇▇▇▇▇▇
▇▇▇▇▇▇▇▇ & Co., LLC certified public accountants and (ii) unaudited balance
sheet of KDC at June 30, 1996 and the related statement of operation for the six
months then ended (such financial statements and the related notes being herein
called "KDC Financial Statements").
The KDC Financial Statements are true, complete and accurate, have been
based upon the information contained in the books and records of KDC and present
fairly the assets, liabilities and financial condition of KDC as of the dates
thereof and the results of its operations for the periods then ended, prepared
in conformity with generally accepted accounting principles. The KDC Financial
Statements do not contain any material inaccuracy and do not suffer from any
material omissions.
3.5 ABSENCE OF UNDISCLOSED LIABILITIES. Except as and to the extent
reflected or reserved against in the KDC Financial Statements and except for
commitments and obligations incurred in the ordinary course of business accruing
after December 31, 1995, KDC, as of December 31, 1995, had, or will have at
Closing, no liabilities, claims or obligations (whether accrued, absolute,
contingent, unliquidated or otherwise, whether or not known to KDC or any
directors, officers or employees of
(1)
0363293.08
080020-007 10/09/96
-11-
KDC, whether due to become payable and regardless of when or by whom asserted)
not fully covered by insurance.
3.6 ABSENCE OF CERTAIN RECENT CHANGES. Except as expressly provided in
this Agreement or as set forth on Exhibit 3.6 in alphabetical order
corresponding to the following subsections, since December 31, 1995, and through
the Closing Date, KDC has not been and will not have:
(a) except in the usual and ordinary course of its business,
consistent with past practice, and in an amount which is usual
and normal incurred any indebtedness or other liabili ties
(whether accrued, absolute, contingent or otherwise),
guaranteed any indebted ness or sold any of its assets;
(b) suffered any damage, destruction or loss, whether or not
covered by insurance, in excess of $10,000;
(c) suffered the resignation or other termination of any
management personnel of KDC, or the loss of or other
termination of a business relationship with any material
customers or suppliers of KDC's business;
(d) increased the regular rate of compensation payable by it to
any employee other than normal merit and cost of living
increases granted in the ordinary course of business; or
increased such compensation by bonus, percentage, compensation
service award or similar arrangement theretofore in effect for
the benefit of any of its employees, and no such increase is
required;
(e) established or agreed to establish, amended or terminated any
pension, retirement or welfare plan or arrangement for the
benefit of its employees not theretofore in effect;
(f) suffered any change in its financial condition, assets,
liabilities, operations, prospects or business or suffered any
other event or condition of any character which individual ly
or in the aggregate has or might reasonably have a material
adverse effect on KDC;
(g) experienced any labor organizational efforts, strikes or
complaints other than griev ance procedures in the ordinary
course of business or entered into any collective bar gaining
agreements with any union;
(h) made any single capital expenditure which exceeded $5,000 or
made aggregate capital expenditures which exceeded $10,000;
(1)
0363293.08
080020-007 10/09/96
-12-
(i) except with respect to liens or encumbrances arising by
operation of law, permitted or allowed any of the Assets to be
subjected to any pledge, lien, security interest, en
cumbrance, restriction or charge of any kind;
(j) written down the value of any of the Assets, or written off as
uncollectible any notes or accounts receivable, except for
write-downs and write-offs in the ordinary course of business
and consistent with past practice, none of which are material
or revalued any of the Assets;
(k) paid, discharged or satisfied any claims, liabilities or
obligations (absolute, accrued, contingent or otherwise) other
than in the usual and ordinary course of business;
(l) suffered any extraordinary losses, canceled any debts or
waived any claims or rights of substantial value, whether or
not in the usual and ordinary course of business;
(m) paid, lent or advanced any amount to, or sold, transferred or
leased any properties or assets (real, personal or mixed,
tangible or intangible) to, or entered into any agree ment or
arrangement with, any stockholder of KDC or any of the
officers or directors of KDC or of any "Affiliate" of any of
its officers or directors, except for any immaterial amounts
or for reimbursement of ordinary and reasonable business ex
penses related to the business of KDC and compensation to
officers at rates not ex ceeding the rates of compensation at
;
(n) amended, terminated or otherwise altered (whether by action or
inaction) any contract, agreement or license of significant
value to which KDC is a party, except in the ordinary course
of business;
(o) entered into a material transaction other than in the
ordinary course of business or made any change in any method
of accounting or accounting practice;
(p) canceled, or failed to continue, insurance coverages; or
(q) agreed, whether in writing or otherwise, to take any action
described in this ss. 3.6.
3.7 TITLE TO ASSETS. The Assets consisting of owned personal property
are subject to no liens or encumbrances except the security interests of record
set forth on Exhibit 3.7A of the Exhibit Volume, which Exhibit is a copy of a
Uniform Commercial Code ("UCC") search as of a recent date duly obtained by KDC
and which search shows security interests of record relating to such Assets in
every place where such security interests are filed and includes copies of all
such financing
(1)
0363293.08
080020-007 10/09/96
-13-
statements. KDC agrees to remove all security interests reflected on such UCC
search, if any, prior to the Closing (except those assumed by ProMedCo pursuant
to this Agreement, listed on Exhibit 3.7B, and approved by ProMedCo-Temple in
writing) and to remove any other security interests filed with respect to such
assets between the date of such UCC search and the Closing Date. The bills of
sale and the assignments and other instruments to be executed and delivered by
KDC at the Closing will be valid and binding and enforceable in accordance with
their respective terms, and will effectively vest in ProMedCo-Temple good and
marketable title to all the Assets. If KDC shall fail to remove all such
security interests, ProMedCo-Temple shall have the right to do so and shall have
the right to off-set the cost of doing so against the Consideration payable
under ss. 2.4 hereof.
3.8 CONTRACTS. Exhibit 3.8 of the Exhibit Volume contains a copy of
each contract, lease, agreement and other instrument to which KDC is a party or
is bound which involves an unperformed commitment or obligation (contingent or
otherwise) of more than $10,000 in the aggregate. Except as noted in such
Exhibit, all such contracts, leases and agreements are in full force and effect,
there has been no threatened cancellation thereof, there are no outstanding
disputes thereunder, each is with unrelated third parties and was entered into
on an arms-length basis in the ordinary course of business and all will continue
to be binding in accordance with their terms after consummation of the transac
tions contemplated hereby. There are no contracts, leases, agreements or other
instruments to which KDC is a party or is bound (other than insurance policies)
which, if properly performed, could either singularly or in the aggregate have
an adverse effect on the value of the Assets to ProMedCo-Temple.
Except as described in Exhibit 3.8 or the other Schedules hereto (and
except for purchase contracts and orders for inventory in the ordinary course of
business consistent with past practice), KDC is not, as of the date of this
Agreement, a party to or bound by any:
(a) material agreement or contract not made in the ordinary course
of business;
(b) employee collective bargaining agreement or other contract
with any labor union;
(c) employment agreements or other agreements that contain any
severance or termination pay liabilities or obligations;
(d) covenant not to compete;
(e) lease or similar agreement under which KDC is a lessor or
sublessor of any material real property owned or leased by KDC
or any portion of premises otherwise occupied by KDC;
(1)
0363293.08
080020-007 10/09/96
-14-
(f) (i) lease or similar agreement under which (A) KDC is lessee
of, or holds or uses, any machinery, equipment, vehicle or
other tangible personal property owned by a third party or
(B)KDC is a lessor or sublessor of any tangible personal
property owned by any of its shareholders, (ii) continuing
contract for the future purchase of materials, supplies or
equipment, or (iii) management, service, consulting or other
similar type of contract, in any such case which has a future
liability in excess of $10,000, and which is not terminable by
KDC for a cost of less than $10,000;
(g) license or other agreement relating in whole or in part to,
trademarks (including, but not limited to, any license or
other agreement under which KDC has the right to use any of
the same owned or held by a third party);
(h) agreement or contract under which KDC has borrowed or lent any
money or issued any note, bond, indenture or other evidence of
indebtedness or directly or indirectly guaranteed
indebtedness, liabilities or obligations of others for an
amount in excess of $10,000 (other than (i) endorsements for
the purpose of collection in the ordinary course of business
and (ii) advances to employees of KDC in the ordinary course
of business);
(i) mortgage, pledge, security agreement, deed of trust or other
document granting a lien against the Assets (including liens
upon properties acquired under conditional sales, capital
leases or other title retention or security devices but
excluding operating leases);
(j) other agreement, contract, lease, license, commitment or
instrument to which KDC is a party or by or to which KDC or
any of it assets or businesses are bound or subject, which has
an aggregate future liability in excess of $10,000 and is not
terminable by KDC for a cost of less than $10,000; or
(k) any agreement, contract, understanding or business venture
with any physician, other provider or any other Person which
violates the Medicare/Medicaid Fraud and Abuse amendments or
any regulations thereunder adopted by the U.S. Department of
Health and Human Services.
3.9 BURDENSOME AGREEMENTS. Except as is set forth in Exhibit 3.9 of the
Exhibit Volume, KDC is not a party to, nor are the Assets subject to or bound or
affected by, any provision of any order of any court or other agency of
government or any indenture, agreement or other instrument or commitment which
has a material adverse affect on the operations, earnings, assets, properties,
liabilities, business or prospects of KDC or its condition, financial or
otherwise.
(1)
0363293.08
080020-007 10/09/96
-15-
3.10 ABSENCE OF RELATED PARTY TRANSACTIONS. Except as disclosed on
Exhibit 3.10, neither KDC, nor any officer, director or affiliate of KDC, has
any material direct or indirect financial or economic interest in any competitor
or supplier of KDC. KDC is not a party to any transaction or proposed
transaction, including without limitation the leasing of property, the purchase
or sale of materials or goods (except with respect to KDC's service business) or
the furnishing of its services (except as employees of the KDC), with KDC, or
any Affiliate of KDC, including (without limitation) any family member of a
shareholder of KDC; and KDC has not directly or indirectly entered into any
agreement or commitment which could result in KDC becoming obligated to provide
funds in respect of or to assume any obligation of any such affiliated person or
entity. Except as set forth on Exhibit 3.10, there are no debts owing to KDC by,
or any contractual agreements or understandings between KDC and, any
shareholder, director or officer of KDC, any member of their respective
families, or any affiliate or associate of any of the foregoing individuals, as
the term "affiliate" is defined for purposes of the Securities Act of 1933 and
the rules and regulations thereunder, and none of the foregoing individuals or
any affiliate or associate of them owns any property or rights, tangible or
intangible (other than an equitable interest), used in or related to KDC's
business. KDC is not indebted to any shareholder, officer, director or employee
of KDC, or to any member of their respective families, or to any affiliate or
associate of any of the foregoing individuals, in any amount whatsoever, other
than for payment of salaries and compensation for services actually rendered to
KDC in the ordinary course of their businesses except as disclosed on Exhibit
3.10.
3.11 DEFAULTS. Except as disclosed in Exhibit 3.11, KDC is not in
default under, nor has any event occurred which, with the lapse of time or
action by a third party, could result in a default under any outstanding
indenture, mortgage, contract, instrument or agreement to which KDC is a party
or by which KDC may be bound or under any provision of the Articles of
Incorporation or by-laws of KDC. The execution, delivery and performance of this
Agreement and the consummation of the transactions contemplated by this
Agreement will not violate any provision of, or result in the breach of, or
constitute a default under, any law the violation of which would result in a
significant liability to KDC, or any order, writ, injunction or decree of any
court, governmental agency or arbitration tribunal; constitute a violation of or
a default under, or a conflict with, any term or provision of the Articles of
Incorporation or by-laws of KDC or any contract, commitment, indenture, lease,
instrument or other agreement, or any other restriction of any kind to which KDC
is a party or is bound; or cause, or give any party grounds to cause (with or
without notice, the passage of time or both) the maturity of any liability or
obligation of KDC, to be accelerated, or increase any such liability or
obligation.
3.12 INVENTORY. The Inventory consists of a quality and quantity usable
and saleable in the ordinary course of business and is carried on the balance
sheet included in the KDC Financial Statements at the lower of cost or market,
except for items of obsolete materials and materials of below standard quality,
all of which have been written down in the balance sheet included in the KDC
(1)
0363293.08
080020-007 10/09/96
-16-
Financial Statements to net realizable market value or for which adequate
reserves have been provided in the balance sheet included in the KDC Financial
Statements. The present quantity of the Inventory of KDC is reasonable and
warranted in the present circumstances of the business conducted by KDC. The
only transactions related thereto since have been additions or sales in the
ordinary course of business.
3.13 EQUIPMENT. All Assets consisting of equipment are well maintained
and in good operating condition, except for reasonable wear and tear and except
for items which have been written down in the KDC Financial Statements to a
realizable market value or for which adequate reserves have been provided in the
KDC Financial Statements. The present quantity of all such equipment of KDC is
reasonable and warranted in the present course of the business conducted by KDC
and its subsidiaries. The only transactions related thereto since , have been
additions thereto in the ordinary course of business.
3.14 RECEIVABLES. All notes and accounts receivable of KDC shown on the
KDC balance sheet and all those arising since the balance sheet dates have
arisen in the ordinary course of business.
3.15 PERMITS AND LICENSES. Included as Exhibit 3.15 in the Exhibit
Volume is a schedule of permits and licenses, listing and briefly describing
each permit, license or similar authorization from each governmental authority
issued with respect to the operation or ownership of properties by KDC together
with the designation of the respective expiration dates of each, and also
listing and briefly describing each association in which KDC is a member and
each association or governmental au thority by which KDC is accredited or
otherwise recognized. KDC is not required to obtain any additional permits,
licenses or similar authorizations (including, without limitation, any
additional certificates of need) from any governmental authority for the proper
conduct of its business or to become a member of or accredited by any
association or governmental authority other than those listed on Exhibit 3.15 in
the Exhibit Volume. All of such permits, licenses and authorizations will
continue to be valid and in full force and effect in accordance with their
respective terms after the consummation of the transactions contemplated hereby.
3.16 LITIGATION, ETC. Except as set forth in Exhibit 3.16 of the
Exhibit Volume, there is no litigation, arbitration, governmental claim,
investigation or proceeding pending or, to the best knowledge of KDC, threatened
against KDC at law or in equity, before any court, arbitration tribunal or
governmental agency. No such proceeding set forth in Exhibit 3.16 concerns the
ownership or other rights with respect to the Assets. To the best knowledge of
KDC, there are no facts based on which material claims may be hereafter made
against KDC. Any and all claims arising from incidents on or before the Closing
Date shall be the sole responsibility of KDC and, except as otherwise provided
herein, are specifically excluded from the liabilities to be assumed by
ProMedCo-Temple hereunder. All claims and litigations against KDC are fully
covered by insurance. KDC shall
(1)
0363293.08
080020-007 10/09/96
-17-
unconditionally indemnify and hold ProMedCo-Temple harmless against any loss or
liability including, without limitation, attorney's fees, resulting from any
claims or litigation arising out of incidents relating to KDC which occurred
prior to the Closing Date, to the extent such loss or liability is not covered
by insurance.
3.17 COURT ORDERS, DECREES AND LAWS. There is not outstanding or to the
best of KDC's knowledge, threatened any order, writ, injunction or decree of any
court, governmental agency or arbitration tribunal against or affecting KDC or
the Assets. KDC is in compliance with all applicable federal, state and local
laws, regulations and administrative orders which are material to the business
of KDC and KDC has received no notices of alleged violations thereof. No
governmental authorities are presently conducting proceedings against KDC and to
the best knowledge of KDC, no such investigation or proceeding is pending or
being threatened.
3.18 TAXES. All federal, state and other tax returns of KDC required by
law to be filed have been timely filed, and KDC has paid or provided for all
taxes (including taxes on properties, income, franchises, licenses, sales and
payrolls) which have become due pursuant to such returns or pursuant to any
assessment, except for any taxes and assessments of which the amount,
applicability or validity is currently being contested in good faith by
appropriate proceedings and with respect to which KDC has set aside on its books
adequate reserves. All such tax returns have been prepared in compliance with
all applicable laws and regulations and are true and accurate in all respects.
The amounts set up as provisions for taxes (including provision for deferred
income taxes) on the KDC Financial Statements are sufficient for the payment of
all unpaid federal, state, county and local taxes accrued for or applicable to
all periods (or portions thereof) ending on or before the Closing Date. There
are no tax liens on any of the Assets except those with respect to taxes not yet
due and payable and except for any taxes and assessments of which the amount,
applicability or validity is currently being contested in good faith by
appropriate proceedings and with respect to which KDC has set aside on its books
adequate reserves. There are no pending tax examinations nor has KDC received a
revenue agent's report asserting a tax deficiency. KDC does not expect any
taxing authority to claim or assess any amount of additional taxes against it.
No claim has ever been made by a taxing authority in a jurisdiction where KDC
does not file tax returns that KDC is or may be subject to taxes assessed by
such jurisdiction.
3.19 IMMIGRATION ACT. KDC is in compliance with the terms and
provisions of the Immigration Act in all material respects. For each employee
(as defined in 8 C.F.R. ss.274a.1(f)) of KDC for whom compliance with the
Immigration Act by KDC is required, KDC has obtained and retained a complete and
true copy of each such employee's Form I-9 (Employment Eligibility Verification
Form) and all other records or documents prepared, procured or retained by KDC
pursuant to the Immigration Act. There are no violations or potential violations
of the Immigration Act by KDC. KDC has not been cited, fined, served with a
Notice of Intent to Fine or with a Cease
(1)
0363293.08
080020-007 10/09/96
-18-
and Desist Order, nor, to KDC's knowledge, has any action or administrative
proceeding been initiated or threatened against KDC, by reason of any actual or
alleged failure to comply with the Immigration Act.
3.20 PROGRAM COMPLIANCE. To the best knowledge of KDC, neither KDC nor
any of its shareholders or employees is a party to, or the beneficiary of, any
agreement, contract, understanding or business venture with any provider or
referral source which violates the Medicare/Medicaid Fraud and Abuse amendments
or any regulations thereunder adopted by the U.S. Department of Health and Human
Services or any regulations adopted by any other federal or state agency or
which results in overutilization of health care services by patients.
3.21 ENVIRONMENTAL MATTERS. Except as disclosed on Exhibit 3.21:
(a) There are no outstanding violations or any consent decrees
entered against KDC regarding environmental matters,
including, but not limited to, matters affecting the emission
of air pollutants, the discharge of water pollutants, the
management of hazardous or toxic substances or wastes, or
noise.
(b) There are no claimed, threatened or alleged violations with
respect to any federal, state or local environmental law,
rule, regulation, ordinance, permit, license or authorization,
and there are no present discussions with any federal, state
or local governmental agency concerning any alleged violation
of environmental laws, rules, regulations, ordinances,
permits, licenses or authorizations.
(c) All operations conducted by KDC have been and are in material
compliance with all federal, state and local statutes, rules,
regulations, ordinances, permits, licenses and authorizations
relating to environmental compliance and control.
3.22 ERISA.
(a) Except as listed in Exhibit 3.22 of the Exhibit has no
"employee benefit plans", as such term is defined under
Section 3(3) of the Employee Retirement Income Security Act of
1974, as amended ("ERISA"), or any other plan or similar
arrangement, written or otherwise, which provides any type of
pension or welfare benefit to any of its directors, employees,
or former employees.
(b) With respect to all of the plans listed in Exhibit 3.22,KDC
has delivered to ProMedCo-Temple true and exact copies of (i)
all plan documents embodying the provisions of such plans,
together with all amendments thereto, (ii) all summary plan
(1)
0363293.08
080020-007 10/09/96
-19-
descriptions and summaries of material modifications
pertaining thereto, (iii) copies of the most recent Internal
Revenue Service determination letters, if any, relating to
such plans, (iv) copies of the last three (3) years' Annual
Report (Form 5500 series), as filed with respect to such plans
with the Internal Revenue Service, together with all Schedules
and attachments thereto, including, without limitation, copies
of the plan audits and/or actuarial valuations, (v) copies of
all contract administration agreements between KDC and third
party administrators, (vi) copies of all participant-related
forms currently in use in connection with such plans
including, without limitation, salary reduction agreements and
beneficiary designations and (vii) participant-specific claims
history for any "welfare benefit plan" (within the meaning of
Section 3(1) of ERISA) that has been in existence during any
part of the last three years.
(c) No "prohibited transaction", as such term is defined under
Section 4975(c) of the Code or under Section 406 of ERISA, and
the respective regulations thereunder, has occurred or is
occurring with respect to any "employee benefit plan"
maintained by KDC or with respect to any trustee or
administrator thereof.
3.23 PENSION, ETC.
(a) No "unfunded accrued liability", as such term is defined under Section
3(30) of ERISA, exists with respect to any "employee pension benefit plan"
listed in Exhibit 3.22 (each a "Pension Plan" and collectively the "Pension
Plans").
(b) None of the Pension Plans or any related trusts have been partially or
fully terminated (through the complete cessation of contributions thereto
or otherwise). In addition there has not occurred any "reportable events",
as such term is defined under Section 4043 of ERISA, which could have a
material adverse effect on the condition, financial or otherwise, of KDC.
(c) Neither any of the Pension Plans nor any related trusts have incurred any
"accumu lated funding deficiency", as such term is defined under Section
302(a)(2) of ERISA or Section 412(a) of the Code (whether or not waived),
since the effective date of ERISA. Neither KDC nor any administrator or
fiduciary of any Plan (or agent of any administrator or fiduciary of any
Plan. or agent of any of the foregoing) has engaged in any transaction or
acted or failed to act in a manner which is likely to subject KDC to any
liability for a breach of fiduciary or other duty under ERISA or any other
applicable law.
(1)
0363293.08
080020-007 10/09/96
-20-
(d) With respect to each Pension Plan, there are not in existence any
liabilities other than those liabilities shown on the Annual Reports (Form
5500 series) delivered to ProMedCo-Temple in connection herewith. No
material change with respect to the matters covered by the most recent
Annual Report for each Pension Plan has occurred since the filing date
thereof. The terms and operation of each Pension Plan have complied, and
are in compliance, with the applicable provisions of ERISA and the Code.
All Pension Plans have at all times been and are qualified under Section
401(a) of the Code, except for those Pension Plans set forth in Exhibit
3.23 of the Exhibit ------------ Volume. None of the Pension Plans listed
in Exhibit 3.22 is unfunded. ------------
(e) Other than claims for benefits submitted by participants or beneficiaries
or appeals from denial thereof, there is no litigation legal action, suit,
investigation, claim, counterclaim or proceeding pending or threatened
against of the KDC Plan.
(f) All filings required by ERISA and the Code as to the KDC Plan have been
timely made and all notices and disclosures to participants comply in all
material respects with ERISA or the Code with respect to the KDC Plan. No
amounts, nor any assets, of the KDC Plan are subject to tax as unrelated
business taxable income under Section 511, 519, or 419A of the Code.
(g) Except for not more than $_______ relating to contributions required for
1996, the minimum fair market value of the assets held in the trust or
trusts funding the KDC Plan as of the Closing Date plus the amount of all
contributions, if any, made by KDC subsequent to the Closing Date under the
KDC Plan through the date of complete transfer shall be at least equal to
the accrued benefits of all participants under the KDC Plan on such date.
3.24 EMPLOYEE MATTERS. Included as Exhibit 3.24A of the Exhibit Volume
is a list of all em ployees of KDC together with their current annual rates of
compensation (as of June 30, 1996) and a list of all people who were paid
bonuses in the last twelve months plus the amount thereof. No written employment
agreement to which KDC is a party requires longer than a four-week notice before
termination or agreement to lend, or guarantee any loan, to an employee or an
agreement relating to a bonus, severance pay or similar plan, agreement,
arrangement or understanding. Exhibit 3.24B of the Exhibit Volume is a brief
description of employee benefits of KDC.
3.25 INSURANCE AND BONDS. Exhibit 3.25A contains a description of all
fire, liability and other insurance coverage maintained by KDC currently in
force, including the amounts and losses and risks covered; all such policies are
fully paid as to all premiums heretofore due. Exhibit 3.25C contains a
description of all malpractice liability insurance policies of KDC since January
1, 1994.
(1)
0363293.08
080020-007 10/09/96
-21-
Except as set forth on Exhibit 3.25C, KDC has not had in the last seven years
filed a written application for any insurance coverage which has been denied by
an insurance agency or carrier. Exhibit 3.25C sets forth a list of all claims
for any insured loss in excess of $5,000 per occurrence, filed by KDC during the
three year period immediately preceding the date hereof, including, but not
limited to, workers compensation, general liability and environmental liability.
KDC is not in material default with respect to any provision contained in any
such policy and has not failed to give any notice or present any claim under any
such policy in due and timely fashion.
3.26 LABOR MATTERS. There are no collective bargaining agreements with
any labor union to which KDC is a party or by which KDC is bound, and it is not
currently negotiating with a labor union. No employees of KDC have ever
petitioned for a representation election. KDC is in compli ance with all
applicable laws respecting employment and employment practices, terms and
conditions of employment and wages and hours, and is not engaged in any unfair
labor practice. There is no unfair labor practice complaint against KDC pending
before the National Labor Relations Board. There is no labor strike, dispute,
slowdown or stoppage actually pending or, to its knowledge, threatened against
or affecting KDC. No grievance which might have a material adverse effect on KDC
or the conduct of its business nor any such arbitration proceeding arising out
of or under collective bargaining agreements is pending and no claim therefor
exists. KDC has not experienced any employee strikes during the last three
years. KDC will advise ProMedCo-Temple of any such labor dispute, petition for
representative election or negotiations with any labor union which shall arise
before the Closing Date. Except as may be required by ss.4980B of the Code or
applicable state health care continuation coverage statutes, KDC has no
liability under any plan or arrangement which provides welfare benefits,
including medical and life insurance, to any current or future retiree or
terminated employee.
3.27 HEALTHCARE COMPLIANCE. KDC is participating in or otherwise
authorized to receive reimbursement from or is a party to Medicare, Medicaid,
and other third-party payor programs (collectively "Third Party Payor
Programs"). All necessary certifications and contracts required for
participation in such programs are in full force and effect and have not been
amended or otherwise modified, rescinded, revoked or assigned as of the date
hereof, and to the best of KDC's knowledge, no condition exists or event has
occurred which in itself or with the giving of notice or the lapse of time or
both would result in the suspension, revocation, impairment, forfeiture or
non-renewal of any such Third Party Payor Program. To the best of KDC's
knowledge, KDC is in full compliance with the requirements of all such Third
Party Payor Programs applicable thereto.
3.28 FACILITY COMPLIANCE. The Clinic Facility is duly licensed and is
lawfully operated in accordance with the requirements of all applicable law and
has all necessary authorizations for the use and operation, all of which are in
full force and effect. There are no outstanding notices of deficiencies relating
to KDC issued by any governmental authority or Third Party payor Program
(1)
0363293.08
080020-007 10/09/96
-22-
requiring conformity or compliance with any applicable law or condition for
participation of such governmental authority or Third Party Payor program, and
after reasonable and independent inquiry and due diligence and investigation,
KDC has neither received notice nor has any knowledge or reason to believe that
such necessary authorizations may be revoked or not renewed in the ordinary
course.
3.29 IMPROPER PAYMENTS. Neither KDC nor any officer or employee of KDC
have made any bribes, kickbacks or other improper payments on behalf of KDC or
received any such payments from vendors, suppliers or other persons contracting
with KDC.
3.30 BOOKS OF ACCOUNT; REPORTS. The books of account of KDC in
reasonable detail, accu rately and fairly reflect its transactions and the
disposition of its assets. KDC has filed all reports and returns required by any
law or regulation to be filed by it.
3.31 NO FINDERS OR BROKERS. Neither KDC nor any officer or director of KDC
has engaged any finder or broker in connection with the transactions
contemplated hereunder.
3.32 DISTRIBUTION OF PROMEDCO STOCK. KDC intends to distribute the
ProMedCo Stock to its shareholders all of whom are executing and delivering
Stockholder Agreements contemplated by ss. 8.5 hereof. KDC has no reason to
believe that any of the statements, representations and warranties made forth in
such instruments by its shareholders are not true and correct.
3.33 REVIEW OF INFORMATION. KDC has been afforded access to all
material information referred to in the ProMedCo Financial Statements delivered
to KDC on August 14, 1996 and, in addition thereto, has been afforded the
opportunity to ask questions of, and receive answers from, ProMedCo concerning
the business and properties of ProMedCo and to review any materials relating to
ProMedCo.
3.34 FUTURE VALUE. KDC is not acquiring the ProMedCo Stock based upon
any representation, oral or written, by any Person with respect to the future
value of, or income from, the ProMedCo Stock, but rather upon an independent
examination and judgment as to the prospects of ProMedCo.
3.35 RESTRICTED SECURITIES. KDC recognizes that the ProMedCo Stock have
not been registered under the Securities Act, or the securities laws of any
other jurisdiction, that KDC (as opposed to its shareholders who are parties to
the Stockholder Agreements contemplated by ss. 8.5 hereof) has no right to
require such registration, and that KDC's right to transfer the ProMedCo Stock
is restricted by the Securities Act and applicable state securities laws
(including suitability requirements).
(1)
0363293.08
080020-007 10/09/96
-23-
3.36 LEGEND. KDC understands that certificates representing the
ProMedCo Stock shall bear the legend set forth in ss. 2.5 hereof.
3.37 AUTHORITY; BINDING EFFECT. KDC has full power and authority to
enter into this Agreement and, subject to the convening of a stockholders'
meeting and the approval of stockholders as required by Texas law, to carry out
the transactions contemplated hereby. The Board of Directors of KDC has taken
all action required by law and by KDC's Articles of Incorporation and by-laws,
or otherwise, to authorize the execution and delivery of this Agreement and the
transactions contem plated hereby. The execution, delivery, and performance of
this Agreement constitutes the valid and binding agreement of KDC enforceable in
accordance with its terms.
3.38 CONSENTS AND APPROVALS OF GOVERNMENTAL AUTHORITIES. No
characteristic of KDC or of the nature of its business or operations requires
any consent, approval or authorization of, or declaration, filing or
registration with any governmental or regulatory authority in connection with
the execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby.
3.39 DISCLOSURE. No representations and warranties by KDC in this
Agreement and no statement in this Agreement or any document or certificate
furnished or to be furnished to ProMedCo and ProMedCo-Temple pursuant hereto
contains or will contain any untrue statement or omits or will omit to state a
fact necessary in order to make the statements contained therein not materially
misleading. KDC has disclosed to ProMedCo and ProMedCo-Temple all facts known to
KDC material to the assets, liabilities, business, operation and property of
KDC. There are no facts known to KDC not yet disclosed which would have a
material adverse effect the future operations of KDC.
ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF PROMEDCO AND
PROMEDCO-TEMPLE
ProMedCo and ProMedCo-Temple hereby represent and warrant as follows:
4.1 ORGANIZATION AND STANDING OF PROMEDCO AND PROMEDCO-TEMPLE. ProMedCo
and ProMedCo-Temple are each corporations duly organized, validly existing and
in good standing under the laws of the state of Texas and Delaware,
respectively; each has full corporate power and authority to conduct its
business as now being conducted; and each is duly qualified to do business in
each jurisdiction in which the nature of the property owned or leased or the
nature of the business conducted by it requires such qualification.
4.2 CAPITALIZATION OF PROMEDCO. The authorized capital stock of ProMedCo
consists of 700,000 shares of no par value Series A Convertible Preferred Stock,
20,000,000 shares of no par
(1)
0363293.08
080020-007 10/09/96
-24-
value Common Stock and 2,600,000 shares of no par value Class B Common Stock, of
which as of the date hereof, 500,000 shares of Series A Convertible Preferred
Stock, 2,301,837 shares of Common Stock and 1,226,150 shares of Series B Common
Stock are validly issued and outstanding, fully paid and non-assessable.
4.3 PROMEDCO STOCK. The ProMedCo Stock to be issued in connection with
the transactions contemplated hereby will be duly authorized, validly issued,
fully paid and non-assessable.
4.4 AUTHORITY; BINDING EFFECT. Each of ProMedCo and ProMedCo-Temple has
corporate power to execute and deliver this Agreement and consummate the
transactions contemplated hereby and has taken (or by the Closing Date will have
taken) all action required by law, its Articles of Incorporation, by-laws or
otherwise to authorize such execution and delivery and the consummation of the
transactions contemplated hereby. The execution, delivery, and performance of
this Agreement constitutes the valid and binding agreement of each of ProMedCo
and ProMedCo-Temple enforce able in accordance with its terms (except as the
same may be restricted, limited or delayed by applica ble bankruptcy or other
laws affecting creditors' rights generally and except as to the remedy of spe
cific performance which may not be available under the laws of various
jurisdictions) assuming that this Agreement has been duly authorized, delivered
and executed by KDC and constitutes the valid and binding obligation,
enforceable against KDC in accordance with its terms (except as enforce ability
against KDC may be restricted, limited or delayed to the same extent as referred
to in parenthetical phrase immediately above).
4.5 NO FINDERS OR BROKERS. Neither ProMedCo, ProMedCo-Temple nor any
officer or director of either has engaged any finder or broker in connection
with the transactions contemplated hereunder.
4.6 CONSENTS AND APPROVALS OF GOVERNMENTAL AUTHORITIES. No
characteristic of ProMedCo or ProMedCo-Temple or of the nature of their business
or operations requires any consent, approval or authorization of, or
declaration, filing or registration with any governmental or regulatory
authority in connection with the execution and delivery of this Agreement and
the con summation of the transactions contemplated hereby.
4.7 PENDING LITIGATION. There are no proceedings pending or threatened,
against or affecting ProMedCo in any court or before any governmental authority
or arbitration board or tribunal which involve the possibility of materially and
adversely affecting the properties, business, prospects, profits or condition
(financial or otherwise) of ProMedCo considered as a whole.
(1)
0363293.08
080020-007 10/09/96
-25-
4.8 PROGRAM COMPLIANCE. To the best knowledge of ProMedCo, neither
ProMedCo nor any of its shareholders or employees is a party to, or the
beneficiary of, any agreement, contract, understanding or business venture with
any provider or referral source which violates the Medicare/Medicaid Fraud and
Abuse amendments or any regulations thereunder adopted by the U.S. Department of
Health and Human Services or any regulations adopted by any other federal or
state agency or which results in overutilization of health care services by
patients.
4.9 NO MATERIAL FINANCIAL CHANGES. ProMedCo has not have suffered a
material adverse change in its financial condition from the condition disclosed
in the financial statements disclosed in the ProMedCo Financial Statements.
ARTICLE 5 COVENANTS OF PROMEDCO AND PROMEDCO-TEMPLE
ProMedCo and ProMedCo-Temple hereby covenant and agree as follows:
5.1 BEST EFFORTS TO SECURE CONSENTS. ProMedCo and ProMedCo-Temple shall
use their best efforts to secure before the Closing all necessary consents and
approvals needed to satisfy all the conditions precedent to the obligations of
KDC hereunder.
5.2 CORPORATE ACTION. ProMedCo and ProMedCo-Temple will take all
necessary corporate and other action and use its best efforts to obtain all
consents, approvals and amendments of agreements required of it to carry out the
transactions contemplated by this Agreement and to satisfy the conditions
specified herein.
5.3 HANDLING OF DOCUMENTS. With respect to information provided by KDC
pursuant to this Agreement prior to the Closing, ProMedCo and ProMedCo-Temple
shall keep all such information confidential which is not in the public domain,
except to the extent that such information (i) becomes generally available to
the public other than as a result of a disclosure directly or indirectly by
ProMedCo or ProMedCo-Temple, (ii) was known by ProMedCo or ProMedCo-Temple on a
non- confidential basis prior to disclosure to ProMedCo or ProMedCo-Temple by
KDC pursuant to this Agreement or (iii) becomes available to ProMedCo or
ProMedCo-Temple on a non-confidential basis from a source (other than KDC) which
is entitled to disclose the same, and to exercise the same care in handling such
information as it would exercise with similar information of its own.
5.4 NON-DISCLOSURE. ProMedCo and ProMedCo-Temple will keep confidential
and not disclose to any third party any information relating to the business of
KDC, whether acquired by ProMedCo or ProMedCo-Temple before or after the Closing
Date, which KDC has not made generally available to the public.
(1)
0363293.08
080020-007 10/09/96
-26-
5.5 BOARD VISITATION RIGHTS. Until such time as the physicians employed
by KDCP constitute fewer than 10% of all physicians affiliated with entities
associated with ProMedCo and its affiliates, ProMedCo shall accord the President
of KDCP the right to attend all meetings of the ProMedCo Board of Directors
(including timely notice thereof).
ARTICLE 6 COVENANTS OF KDC
KDC hereby covenants and agrees as follows:
6.1 ACCESS AND INFORMATION. Between the date of this Agreement and the
Effective Date; KDC will: (i) provide to ProMedCo-Temple and its officers,
attorneys, accountants and other representatives, during normal business hours,
or otherwise if ProMedCo-Temple deems reasonably necessary, free and full access
to all of the properties, assets, agreements, commitments, books, records,
accounts, tax returns, and documents of KDC and permit them to make copies
thereof; (ii) furnish ProMedCo-Temple and its representatives with all
information concerning the business, properties and affairs of KDC as
ProMedCo-Temple reasonably requests and certified by the officers, if requested;
(iii) cause the independent public accountants of KDC to make available to
ProMedCo- Temple and its representatives all financial information relating to
KDC requested, including all working papers pertaining to audits and reviews
made heretofore by such auditors; (iv) furnish ProMedCo-Temple true and complete
copies of all financial and operating statements of KDC; (v) permit access to
customers and suppliers for consultation or verification of any information
obtained by ProMedCo-Temple and use their best efforts to cause such customers
and suppliers to cooperate with ProMedCo-Temple in such consultation and in
verifying such information; and (vi) cause their employees, accountants and
attorneys to make disclosure of all material facts known to them affecting the
financial condition and business operations of KDC and to cooperate fully with
any audit, review, investigation or examination made by ProMedCo-Temple and its
representatives, including, without limitation, with respect to:
(a) The books and records of KDC;
(b) The reports of state and federal regulatory examinations;
(c) Leases, contracts and commitments between the KDC and any
other person;
(d) Physical examination of the Clinic Facility; and
(e) Physical examination of the equipment and furnishings within
the Clinic Facility.
(1)
0363293.08
080020-007 10/09/96
-27-
6.2 CONDUCT OF BUSINESS. Between the date hereof and the Effective
Date, except as other wise expressly approved in writing by ProMedCo-Temple, KDC
shall conduct its business only in the ordinary course thereof consistent with
past practice and in such a manner that the representations and warranties
contained in Article 3 of this Agreement shall be true and correct at and as of
the Effective Date (except for changes contemplated, permitted or required by
this Agreement) and so that the conditions to be satisfied by KDC at the Closing
shall have been satisfied. KDC will, consistent with conducting its business in
accordance with reasonable business judgment, preserve the business of the KDC
intact; use its reasonable best efforts to keep available to ProMedCo-Temple the
services of the present employees of the KDC (except those dismissed for cause,
those who voluntarily discontinue their employment and those whose termination
is consented to by ProMedCo- Temple) and preserve for ProMedCo-Temple the
goodwill of the suppliers, patients and others having business relations with
the KDC.
6.3 COMPLIANCE WITH AGREEMENT. KDC shall not undertake any course of
action inconsistent with satisfaction of the conditions applicable to it set
forth in this Agreement, and shall do all such acts and take all such measures
as may be reasonably necessary to comply with the representations, agreements,
conditions and other provisions of this Agreement. KDC shall give
ProMedCo-Temple prompt written notice of any change in any information contained
in the representations and warranties made in Article 3 hereof and on the
Exhibits referred to therein (provided, however, that such notice shall not
limit ProMedCo-Temple's rights under ss. 8.1 hereof) and of any condition or
event which constitutes a default of any covenant or agreement made in Article 6
or in any other section hereof.
6.4 BEST EFFORTS TO SECURE CONSENTS. KDC shall take the necessary
corporate and other action and shall use its reasonable best efforts to secure
before the Closing Date all necessary consents and approvals required to carry
out the transactions contemplated by the Agreement and to satisfy all other
conditions precedent to the obligations of ProMedCo, ProMedCo-Temple and KDC.
6.5 UNUSUAL EVENTS. Until the Closing Date, KDC shall supplement or
amend all relevant Exhibits in the Exhibit Volume with respect to any matter
thereafter arising or discovered which, if existing or known at the date of this
Agreement, would have been required to be set forth or de scribed in such
Exhibits; provided, however, that for the purposes of the rights and obligations
of the parties hereunder, any such supplemental disclosure shall not be deemed
to amend or supplement any Exhibits or to prevent or cure any misrepresentation,
breach of warranty or breach of covenant, unless agreed to in writing by
ProMedCo-Temple.
6.6 INTERIM FINANCIAL STATEMENTS. Within 30 days after the end of each
calendar month subsequent to the date of this Agreement and prior to the Closing
Date, KDC shall deliver to
(1)
0363293.08
080020-007 10/09/96
-28-
ProMedCo-Temple an unaudited balance sheet of KDC as of the end of such calendar
month together with the related statement of operations. All such financial
statements shall fairly present the financial position, results of operations
and changes in financial periods indicated, in accordance with generally
accepted accounting principles consistently applied except that note information
may be omitted in such statements, and that such statements shall be subject to
normal year-end audit adjustments, but only if such adjustments are of a normal,
recurring type and are not material in the aggregate..
6.7 DEPARTMENTAL VIOLATIONS. All notes or notices of violations of law
or municipal ordi nances, orders or requirements noted in or issued by the
departments of buildings, fire, labor, health, or any other state or municipal
department having jurisdiction against or affecting the business, property or
assets of KDC shall be complied with prior to the Closing Date. All such notes
or notices, after the date hereof and prior to the Closing Date, shall be
complied with by KDC prior to the Closing Date. Upon written request, KDC shall
furnish ProMedCo-Temple with an authorization to make the necessary searches for
such notes or notices.
6.8 ASSESSMENTS. If, on the Closing Date, the business, property or
assets of KDC are or will be subject to an assessment or assessments which are
or may become payable in annual install ments, of which the first installment is
then a charge or lien, or has been paid, then for the purposes of this Agreement
all the unpaid installments of any such assessment, including those which are to
become due and payable, shall be paid and discharged by KDC prior to the Closing
Date.
6.9 INSURANCE RATINGS. KDC shall take all action reasonably requested
by ProMedCo- Temple to enable it to succeed to the Workers' Compensation and
Unemployment Insurance ratings, insurance policies, deposits and other interests
of KDC and other ratings for insurance or other purposes established by KDC.
ProMedCo-Temple shall not be obligated to succeed to any such rating, insurance
policy, deposit or other interest, except as it may elect to do so.
6.10 MAINTAIN INSURANCE COVERAGE. From the date hereof until the
Closing, KDC shall maintain and cause to be maintained in full force and effect
the existing insurance on the Assets and the operations of KDC and shall
provide, upon request by ProMedCo-Temple, evidence satisfactory to
ProMedCo-Temple that such insurance continues to be in effect and that all
premiums due have been paid.
6.11 EXCLUSIVE DEALINGS. During the period from the date of this
Agreement to the Closing Date, or until the earlier termination of this
Agreement pursuant to Article 9, KDC shall refrain from taking any actions,
directly or indirectly, to encourage, initiate, or engage in discussions or
negotiations with, or provide any information to, any corporation, partnership,
person, or other entity or group, other than ProMedCo-Temple, concerning the
purchase of KDC or its assets, or any
(1)
0363293.08
080020-007 10/09/96
-29-
merger, joint venture or similar transaction involving KDC and will not enter
into any such transaction.
6.12 LIQUIDATION AND DISSOLUTION. As soon as practicable, and in any
event within one year after the Closing, KDC shall dissolve and distribute all
of its assets, including the ProMedCo Stock received at the Closing and the
right to receive additional shares of ProMedCo Stock after the Closing, to its
shareholders.
ARTICLE 7 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF KDC
All obligations of KDC which are to be discharged under this Agreement
at the Closing are subject to the performance, at or prior to the Closing, of
all covenants and agreements contained herein which are to be performed by
ProMedCo and ProMedCo-Temple at or prior to the Closing and to the fulfillment
at, or prior to, the Closing, of each of the following conditions (unless
expressly waived in writing by KDC at any time at or prior to the Closing):
7.1 REPRESENTATIONS AND WARRANTIES TRUE. All of the representations and
warranties made by ProMedCo and ProMedCo-Temple contained in Article 4 of this
Agreement shall be true as of the date of this Agreement, shall be deemed to
have been made again at and as of the date of Closing, and shall be true at and
as of the date of Closing in all material respects; ProMedCo and ProMedCo-
Temple shall have performed and complied in all material respects with all
covenants and conditions required by this Agreement to be performed or complied
with by then prior to or at the Closing; and KDC shall have been furnished with
a certificate of the President or any Vice President of ProMedCo and of
ProMedCo-Temple, dated the Closing Date, in such officer's capacity, certifying
to the truth of such representations and warranties as of the Closing and to the
fulfillment of such covenants and conditions.
7.2 OPINION OF COUNSEL. KDC shall have been furnished with an opinion
dated the Closing Date of Boult, Cummings, ▇▇▇▇▇▇▇ & ▇▇▇▇▇, PLC, counsel to
ProMedCo and ProMedCo-Temple, in form and substance satisfactory to KDC, to the
effect set forth as Appendix 7.2 attached hereto.
7.3 AUTHORITY. All action required to be taken by or on the part of
ProMedCo and ProMedCo-Temple to authorize the execution, delivery and
performance of this Agreement by ProMedCo and ProMedCo-Temple and the
consummation of the transactions contemplated hereby shall have been duly and
validly taken by the Boards of Directors of ProMedCo and ProMedCo- Temple.
7.4 NO OBSTRUCTIVE PROCEEDING. No action or proceedings shall have been
instituted against, and no order, decree or judgment of any court, agency,
commission or governmental
(1)
0363293.08
080020-007 10/09/96
-30-
authority shall be subsisting against KDC, or the officers or directors of KDC,
which seeks to, or would, render it unlawful as of the Closing to effect the
transactions contemplated hereby in accordance with the terms hereof, and no
such action shall seek damages in a material amount by reason of the
transactions contemplated hereby. Also, no substantive legal objection to the
transactions contemplated by this Agreement shall have been received from or
threatened by any governmental department or agency.
7.5 DELIVERY OF CERTAIN CERTIFIED DOCUMENTS. At the Closing,
ProMedCo-Temple shall deliver to KDC copies of the Articles of Incorporation of
each of ProMedCo-Temple and ProMedCo certified (not more than 30 days prior to
the Closing Date) by the appropriate governmental authorities, copies of
resolutions of the Board of Directors of and ProMedCo-Temple, certified by the
secretary or assistant secretary of ProMedCo-Temple approving and authorizing
the execution and delivery of this Agreement and the consummation of the
transactions contemplated hereby and copies of resolutions of the Board of
Directors of ProMedCo, certified by the secretary or assistant secretary of
ProMedCo approving the issuance of the ProMedCo Stock and guaranty of this
Agreement.
7.6 PROCEEDINGS AND DOCUMENTS SATISFACTORY. All proceedings in
connection with the transactions contemplated hereby and all certificates and
documents delivered to KDC pursuant to this Agreement shall be satisfactory in
form and substance to KDC and its counsel acting reasonably and in good faith.
7.7 NO AGENCY PROCEEDINGS. There shall not be pending or, to the
knowledge of ProMedCo or ProMedCo-Temple, threatened, any claim, suit, action or
other proceeding brought by a governmental agency before any court or
governmental agency, seeking to prohibit or restrain the transactions
contemplated by this Agreement or material damages in connection therewith.
7.8 NO MATERIAL ADVERSE CHANGE. ProMedCo shall not have suffered a
material adverse change in its financial condition, assets, liabilities,
operations, or business prospects represented in the ProMedCo Financial
Statements delivered to KDC.
7.9 EMPLOYEES. All employees of KDC desiring employment with
ProMedCo-Temple shall be so employed at Closing on terms comparable to those of
KDC; provided however, nothing herein shall preclude ProMedCo-Temple from
exercising its rights toward such employee under the Service Agreement.
7.10 CLOSING TRANSACTIONS. All the transactions described in ss. 2.9 shall
have been consummated simultaneously with the Closing.
(1)
0363293.08
080020-007 10/09/96
-31-
ARTICLE 8 CONDITIONS PRECEDENT TO THE OBLIGATIONS OF PROMEDCO AND
PROMEDCO-TEMPLE
All obligations of ProMedCo and ProMedCo-Temple which are to be
discharged under this Agreement at the Closing are subject to the performance,
at or prior to the Closing, of all covenants and agreements contained herein
which are to be performed by KDC at or prior to the Closing and to the
fulfillment at or prior to the Closing of each of the following conditions
(unless expressly waived in writing by ProMedCo and ProMedCo-Temple at any time
at or prior to the Closing):
8.1 REPRESENTATIONS AND WARRANTIES TRUE. All of the representations and
warranties of KDC contained in Article 3 of this Agreement shall be true as of
the date of this Agreement, shall be deemed to have been made again at and as of
the Closing, and shall be true at and as of the date of Closing in all material
respects (without taking into account any disclosures made by KDC to ProMedCo
and ProMedCo-Temple pursuant to ss. 6.5 hereof); KDC shall have performed or
complied in all material respects with all covenants and conditions required by
this Agreement to be performed or complied with by it prior to or at the
Closing; and ProMedCo and ProMedCo-Temple shall be furnished with a certificate
of the President or any Vice President of KDC, dated the Closing Date, in such
person's corporate capacity, certifying to the truth of such representations and
warranties as of the time of the Closing and to the fulfillment of such
covenants and conditions.
8.2 NO OBSTRUCTIVE PROCEEDING. No action or proceedings shall have been
instituted against, and no order, decree or judgment of any court, agency,
commission or governmental authority shall be subsisting against ProMedCo or
ProMedCo-Temple or the officers or directors of ProMedCo or ProMedCo-Temple
which seeks to, or would, render it unlawful as of the Closing to effect the
transactions contemplated hereby in accordance with the terms hereof, and no
such action shall seek damages in a material amount by reason of the transaction
contemplated hereby. Also, no substantive legal objection to the transactions
contemplated by this Agreement shall have been received from or threatened by
any governmental department or agency.
8.3 OPINION OF KDC COUNSEL. KDC shall have delivered to ProMedCo and
ProMedCo- Temple at the Closing an opinion of ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇, counsel to KDC,
dated the Closing Date, in form and substance satisfactory to ProMedCo and
ProMedCo-Temple, to the effect set forth as Appendix 8.3 attached hereto.
8.4 POOLING LETTERS. At or prior to the Closing, ProMedCo shall have
received letters from ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ & Co. LLP in form and substance
satisfactory to ProMedCo to the effect that the transactions contemplated by
this Agreement and the Appendices hereto will constitute a "Pooling of
Interests" under GAAP.
(1)
0363293.08
080020-007 10/09/96
-32-
8.5 STOCKHOLDER AGREEMENTS. Each of the shareholders of KDC shall have
executed and delivered a stockholder agreement in the form attached hereto as
Appendix 8.5 (the "Stockholder Agreements").
8.6 CONSENTS AND APPROVALS. Each of the parties to any agreement or
instrument under which the transactions contemplated hereby would constitute or
result in a default or acceleration of obligations shall have given such consent
as may be necessary to permit the consummation of the transactions contemplated
hereby without constituting or resulting in a default or acceleration under such
agreement or instrument, and any consents required from any public or regulatory
agency or organization having jurisdiction shall have been given. Also,
ProMedCo-Temple shall have received releases, waivers of default and consents to
assignment in form satisfactory to it from all parties to contracts and
agreements to be assumed by ProMedCo-Temple hereunder.
8.7 DISSENTING SHAREHOLDERS. Not more than 10% the stockholders of KDC
shall have become Dissenting Stockholders within the meaning of the Texas
Business Corporation Act, and each non-Dissenting Stockholder shall have entered
into a Shareholder Physician Employment Agreement as contemplated in ss. 2.9
hereof.
8.8 PROCEEDINGS AND DOCUMENTS SATISFACTORY. All proceedings in
connection with the transactions contemplated hereby and all certificates and
documents delivered to ProMedCo-Temple pursuant to this Agreement shall be
satisfactory in form and substance to ProMedCo and ProMedCo- Temple and its
counsel acting reasonably and in good faith.
8.9 NO MATERIAL ADVERSE CHANGE. From the date of this Agreement until
the Closing, the operations of KDC shall have been conducted in the ordinary
course of business consistent with past practice and from the date of the KDC
Financial Statements until the Closing no event shall have occurred or have been
threatened which has or would have a material and adverse affect upon the
financial condition, assets, liabilities, operations, prospects or business of
KDC; and KDC shall have not sustained any loss or damage to their assets,
whether or not insured, or union activity that affects materially and adversely
its ability to conduct its business.
8.10 DELIVERY OF CERTAIN DOCUMENTS. At the Closing, KDC shall have
delivered to ProMedCo-Temple copies of the Articles of Incorporation of KDC
certified (not more than 30 days prior to the Closing Date) by the appropriate
governmental authorities and copies of resolutions of the stockholders of KDC
and of the Board of Directors of KDC, certified by the secretary of KDC,
approving and authorizing the execution and delivery of this Agreement and the
consummation of the transactions contemplated hereby.
(1)
0363293.08
080020-007 10/09/96
-33-
8.11 CLOSING TRANSACTIONS. All the transactions described in ss. 2.9 shall
have been consummated simultaneously with the Closing.
ARTICLE 9 TERMINATION
9.1 OPTIONAL TERMINATION. This Agreement may be terminated and the
transactions contemplated hereby abandoned at any time prior to the Effective
Date, notwithstanding stockholder approval as follows:
(a) By the mutual consent of ProMedCo, ProMedCo-Temple and KDC; or
(b) By KDC, if any of the conditions set forth in Article 7 shall
not have met by September 20, 1996; provided that KDC shall
not be entitled to terminate this Agreement pursuant to this
ss. 9.1(b) if KDC's willful breach of this Agreement has
prevented the consummation of the transactions contemplated
hereby; or
(c) By ProMedCo-Temple, if any of the conditions provided in
Article 8 hereof have not been met by September 20, 1996;
provided that ProMedCo-Temple shall not be enti tled to
terminate this Agreement pursuant to this ss. 9.1(c) if
ProMedCo-Temple's willful breach of this Agreement has
prevented the consummation of the transactions contemplated
hereby.
Notwithstanding anything to the contrary set forth herein, the parties
acknowledge and agree that the Exhibits referred to in Article 3 herein were not
prepared or delivered to ProMedCo and ProMedCo- Temple prior to or
contemporaneously with the execution of this Agreement. By ________, KDC shall
deliver to ProMedCo and ProMedCo-Temple all the Exhibits referred to in Article
3, to be pre pared in accordance with Article 3 of this Agreement, and ProMedCo
and ProMedCo-Temple may, at their discretion, within five days after its receipt
of such Exhibits, terminate this Agreement by notice to KDC if any information
contained in any of such Exhibits or any information obtained by ProMedCo and
ProMedCo-Temple pursuant to ss. 6.3 of this Agreement shall establish that any
rep resentation or warranty of KDC contained in Article 3 of this Agreement or
any information pre viously furnished to ProMedCo and ProMedCo-Temple by KDC
concerning KDC shall not be true and accurate in all material respects as of the
date of the termination notice or in the opinion of ProMedCo and
ProMedCo-Temple, any of such Exhibits shall disclose facts which shall be
materially adverse concerning the financial condition, business or operations of
KDC.
9.2 NOTICE OF ABANDONMENT. In the event of such termination by either
ProMedCo and ProMedCo-Temple or KDC pursuant to ss. 9.1 above, written notice
shall forthwith be given to the other party hereto.
9.3 MANDATORY TERMINATION. If the Closing has not occurred by September 30,
1996, this Agreement shall automatically terminate and no longer be of any force
or effect.
9.4 TERMINATION. In the event this Agreement is terminated as provided
above, ProMedCo and ProMedCo-Temple shall deliver to KDC all documents (and
copies thereof in their possession) concerning KDC and its Affiliates previously
delivered by KDC to ProMedCo and ProMedCo- Temple; and none of the parties nor
any of their respective partners, shareholders, directors, or officers shall
have any liability to the other party for costs, expenses, loss of anticipated
profits, consequential damages, or otherwise, except for any deliberate breach
of any of the provisions of this Agreement.
(1)
0363293.08
080020-007 10/09/96
-34-
ARTICLE 10 INDEMNIFICATION
10.1 GRANT OF INDEMNITY.
(a) KDC agrees to indemnify, defend and hold ProMedCo and ProMedCo-Temple and
their Affiliates, and subsidiaries, and its and their respective employees,
representa tives, officers and agents, harmless from and against any
claims, losses, liability, obligations, lawsuits, deficiencies, damages or
expense of whatever nature, whether known or unknown, accrued, absolute,
contingent or otherwise including (without limitation) interest, penalties,
attorneys' fees, costs of investigation and all amounts paid in defense or
settlement of the foregoing, suffered or incurred by ProMedCo or
ProMedCo-Temple as a result of the occurrence of any of the following: (i)
the Assets were subject to any liabilities or obligations of any kind,
whether accrued, absolute, contingent or otherwise, which are not being
specifically assumed by ProMedCo- Temple hereunder or otherwise consented
to by ProMedCo-Temple, including without limitation, liabilities for
federal, state, local and other applicable taxes of every kind and
description, whether or not said liabilities or obligations are disclosed
in Exhibit 3.4; (ii) KDC did not have title to any of the Assets; (iii) a
breach of any ----------- obligation, representation, warranty, covenant or
agreement made by KDC in this Agreement or any agreement referred to herein
or because any representation or warranty by KDC contained herein, in any
document furnished or required to be furnished pursuant to this Agreement
by KDC to ProMedCo or ProMedCo-Temple or any of their representatives, or
any documents furnished to ProMedCo and ProMedCo-Temple in connection with
the Closing hereunder, shall be false; (iv) any litigation arising out of
or based upon events or operative facts occurring prior to the Closing
Date, in connection with the Assets, whether or not disclosed in Exhibit
3.16; ------------ (v) any employee benefits, including pension or
retirement benefits, and any severance payments to the employees of KDC
which are or may be assessed as a result of the transactions contemplated
by this Agreement, payable to or on behalf of the employees of KDC as of
the Closing Date, or due through the consummation of this Agreement; (vi)
unless otherwise specifically agreed in this Agreement, any and all claims,
including legal, administrative or creditor claims or actions, in
connection with the Assets or their sale or transfer hereunder, if any fact
material to any such claim or cause of action pleaded or stated there
occurred prior to or on the Closing Date; and (vii) costs and expenses
(including reasonable attorneys' fees) incurred by ProMedCo and
ProMedCo-Temple in connection with any demand, action, suit, proceeding,
assessment or judgment incident to any of the foregoing.
(1)
0363293.08
080020-007 10/09/96
-35-
(b) ProMedCo and ProMedCo-Temple agree to indemnify, defend and hold KDC and
its Affiliates, and subsidiaries, and its and their respective employees,
representatives, officers and agents, harmless from and against any claims,
losses, liability, obliga tions, lawsuits, deficiencies, damages or expense
of whatever nature, whether known or unknown, accrued, absolute, contingent
or otherwise including (without limitation) interest, penalties, attorneys'
fees, costs of investigation and all amounts paid in defense or settlement
of the foregoing, suffered or incurred by ProMedCo or ProMedCo-Temple as a
result of the occurrence of any of the following: (i) a breach of any
obligation, representation, warranty, covenant or agreement made by
ProMedCo and ProMedCo-Temple in this Agreement or any agreement referred to
herein or because any representation or warranty by ProMedCo and ProMedCo-
Temple contained herein, in any document furnished or required to be
furnished pursuant to this Agreement by ProMedCo and ProMedCo-Temple to
ProMedCo or ProMedCo-Temple or any of their representatives, or any
documents furnished to KDC in connection with the Closing hereunder, shall
be false; (ii) unless otherwise specifically agreed in this Agreement, any
and all claims, including legal, administra tive or creditor claims or
actions, in connection with the Assets or their sale or transfer hereunder,
if any fact material to any such claim or cause of action pleaded or stated
there occurred after the Closing Date; and (iii) costs and expenses
(including reasonable attorneys' fees) incurred by KDC in connection with
any demand, action, suit, proceeding, assessment or judgment incident to
any of the foregoing.
10.2 REPRESENTATION, COOPERATION AND SETTLEMENT.
(a) Any party entitled to indemnification hereunder (the "Indemnified Party")
shall give prompt notice to the party obligated to indemnify it hereunder
(the "Indemnifying Party") of any claim against Indemnified Party might
give rise to a claim based on the indemnity contained in this Article 10,
stating the nature and basis of the claim and the amount thereof.
(b) In the event any claim, action, suit or proceeding is brought against the
Indemnified Party with respect to which the Indemnifying Party may have
liability under the indemnity contained in this Article 10, the Indemnified
Party shall permit the Indemnifying Party to assume the defense of any such
claim or any litigation resulting from such claim, provided that the
Indemnified Party shall not be required to permit the Indemnifying Party to
assume the defense of any third party claim which if not first paid,
discharged, or otherwise complied with would result in an interruption or
cessation of the conduct of ProMedCo-Temple's business or any material part
thereof. Failure by the Indemnifying Party to notify the Indemnified Party
of its election to
(1)
0363293.08
080020-007 10/09/96
-36-
defend any such claim or action by a third party within thirty (30) days after
notice thereof shall have been given by the Indemnified Party, shall be
deemed a waiver of any such election. If the Indemnifying Party assumes the
defense of such claim or litigation resulting therefrom, the obligations of
the Indemnifying Party hereunder as to such claim shall include taking all
steps reasonably necessary in the defense or settlement of such claim or
litigation resulting in the defense or settlement of such claim or
litigation resulting therefrom, including the retention of counsel
satisfactory to the Indemnified Party, and holding the Indemnified Party
harmless from and against any and all damage resulting from, arising out
of, or incurred with respect to any settlement approved by the Indemnifying
Party or any judgment in connection with such claim or litigation resulting
therefrom. The Indemnifying Party shall not, in the defense of such claim
or litigation, consent to the entry of any judgment (other than a judgment
of dismissal on the merits with costs) except with the written consent of
the Indemnified Party nor enter into any settlement (except with the
written consent of the Indemnified Party) which does not include as an
unconditional term thereof the giving by the claimant or the plaintiff to
the Indemnified Party a release from all liability in respect to such claim
or litigation.
(c) If the Indemnifying Party shall not assume the defense of any such claim by
a third party or litigation resulting therefrom, the Indemnified Party may
defend against such claim or litigation in such manner as it deems
appropriate. the Indemnifying Party shall, in accordance with the
provisions hereof, promptly reimburse the Indemnified Party for the amount
of any settlement reasonably entered into by the Indemnified Party and for
all damage incurred by the Indemnified Party in connection with the defense
against or settlement of such claim or litigation.
10.3 REMEDIES CUMULATIVE. The remedies provided herein shall be
cumulative and shall not preclude ProMedCo and ProMedCo-Temple from asserting
any other rights or seeking any other remedies against KDC to which ProMedCo and
ProMedCo-Temple are entitled by law.
ARTICLE 11 MISCELLANEOUS
11.1 EXPENSES. All expenses of the preparation of this Agreement and of
the transactions contemplated hereby, including, without limitation, counsel
fees, accounting fees, investment adviser's fees and disbursements, shall be
borne by the respective parties incurring such expense, whether or not such
transactions are consummated.
(1)
0363293.08
080020-007 10/09/96
-37-
11.2 EMPLOYEE TRANSITION.
(a) TERMINATION OF AFFECTED EMPLOYEES. Effective at the Closing Date, KDC shall
terminate all Affected Employees who shall be given the option of becoming
employees of ProMedCo-Temple on terms comparable to those in effect
immediately prior to the Closing. "Affected Employees" shall mean
non-medical employees of KDC on the Closing Date.
(b) INSURANCE AND BENEFIT PLANS. KDC shall satisfy, or cause its insurance
carriers to satisfy, all claims for medical, health and hospital benefits,
whether insured or otherwise (including, but not limited to, workers
compensation, life insurance, medical and disability programs), under KDC's
employee benefit plans brought by, or in respect of, Affected Employees and
former employees of the KDC prior to the Closing Date, in accordance with
the terms and conditions of such employee benefit plans or applicable
workers compensation statutes without interruption as a result of the
employment by ProMedCo-Temple of any such employees after the Closing Date.
(c) PAYROLL AND PAYROLL TAXES. KDC shall make a clean cut-off of payroll and
payroll tax reporting with respect to the Affected Employees paying over to
the federal, state and city governments those amounts respectively withheld
or required to be withheld for periods ending prior to the Closing Date.
KDC shall issue, by the date prescribed by IRS Regulations, Forms W-2 for
wages paid to the Closing Date. ProMedCo-Temple shall be responsible for
all payroll and payroll tax obligations accruing on and after the Closing
Date for Affected Employees.
(d) TERMINATION BENEFITS. KDC shall be solely responsible for, and shall pay or
cause to be paid, severance payments and other termination benefits, if any
(not including state unemployment compensation), to Affected Employees who
may become entitled to such benefits by reason of any events. If any action
on the part of KDC prior to the Closing or the purchase by ProMedCo-Temple
of the Assets of KDC pursuant to this Agreement or the transactions
contemplated hereby, shall result in any liability or claim of liability
for severance payments or termination benefits, or any liability,
forfeiture, fine or other obligation by virtue of any state, federal or
local law, such liability or claim of liability shall be the sole
responsibility of KDC, and KDC shall indemnify and hold harmless
ProMedCo-Temple for any losses resulting directly or indirectly from such
liability or claim. ProMedCo-Temple shall be solely responsible for and
shall pay or cause to be paid severance payments and other termination
benefits, if any, to Affected Employees who may become entitled to such
benefits by reason of events occurring after Closing. If any action on the
part of ProMedCo- Temple after Closing shall result in any liability or
claim of liability for severance payments or termination benefits, or any
liability, forfeiture, fine or other obligation
(1)
0363293.08
080020-007 10/09/96
-38-
by virtue of any state, federal or local law, such liability or claim of
liability shall be the sole responsibility of ProMedCo-Temple, and
ProMedCo-Temple shall indemnify and hold harmless KDC for any losses
resulting directly or indirectly from such liability or claim.
(e) EMPLOYEE BENEFIT PLANS. ProMedCo-Temple and KDC shall take, or cause to be
taken, such action as may be necessary or appropriate in order to establish
ProMed Co-Temple as successor sponsor with all rights, assets, duties,
liabilities and obligations as of the Closing Date under, or with respect
to, the King's Daughters Clinics, P.A. Profit Sharing Plan (the "KDC
Plan"). Except for funding KDC's payment of not more than $_______ relating
to itsss.125 Plan contribution in 1996, neither ProMedCo nor ProMedCo-
Temple shall assume any responsibility under any other employee benefit
plan maintained by KDC.
KDC shall provide ProMedCo-Temple either prior to, or as soon as practical
after, the Closing Date, with a list of the Employees who were participants
in or otherwise entitled to benefits under the KDC Plan immediately prior
to the Closing Date, together with a listing of each such Employee's term
of service for eligibility and vesting purposes under the KDC Plan. KDC
shall, as soon as practicable after the Closing Date, provide
ProMedCo-Temple with such additional information as may be reasonably
requested by ProMedCo-Temple and necessary in order for ProMedCo- Temple to
administer effectively the KDC Plan.
Notwithstanding the foregoing, ProMedCo-Temple shall have the right to postpone
the actions contemplated by this Section 11.2 to a date after the Closing Date.
11.3 OCCASIONAL SALE. KDC, ProMedCo and ProMedCo-Temple believe that
the transaction contemplated by this Agreement constitute the sale of an entire
operating unit or a separate division or a separate identifiable segment of a
division in accordance with the Texas Code, and, therefore, the sale of any and
all items of tangible personal property to ProMedCo-Temple pursuant to this
Agreement is exempt from any and all state and local sales and use tax. In the
event the transactions contemplated by this Agreement do not qualify for such
exemption or other applicable exemption and the State of Texas seeks to collect
sale or use tax under the Texas Tax Code, ProMedCo-Temple shall be liable and
responsible for any such tax. KDC shall cooperate with ProMedCo-Temple in
connection with any audit of this transaction regarding the application of the
sales tax law thereto.
11.4 NON-ASSIGNABLE PROPERTY INTERESTS.
(a) To the extent that any lease, contract, permit or other
property interest which would otherwise constitute a part of
the Assets is not capable of being assigned, transferred or
subleased or if such assignment, transfer or sublease or
attempted assignment,
(1)
0363293.08
080020-007 10/09/96
-39-
transfer or sublease would constitute a breach thereof or a
violation of any law, decree, order, regulation or other
governmental edict, neither this Agreement nor the Closing
shall constitute an assignment, transfer or sublease thereof,
or an attempted assignment, transfer or sublease thereof.
(b) To the extent that any lease, contract, permit or other
property interest constituting a part of the Assets is not
capable of being assigned, transferred or subleased, from and
after the Closing Date, and to the extent reasonably possible,
KDC shall make all benefits of such non-assignable interests
available to ProMedCo-Temple at no charge, cost or expense to
ProMedCo-Temple.
11.5 COOPERATION BY PROMEDCO AND PROMEDCO-TEMPLE. In the event KDC is
required to defend against any action, suit or proceeding arising out of a claim
pertaining to the business or operations of KDC, ProMedCo and ProMedCo-Temple
shall provide such assistance and cooperation, including, without limitation,
witnesses and documentary or other evidence as may reasonably be requested by
KDC in connection with its defense. KDC shall reimburse ProMedCo and
ProMedCo-Temple for their reasonable out-of-pocket expenses incurred in
providing such assistance and cooperation.
11.6 COOPERATION BY KDC. In the event ProMedCo or ProMedCo-Temple is
required to defend against any action, suit or proceeding arising out of a claim
pertaining to a liability assumed by ProMedCo-Temple pursuant to this Agreement
relating to the business or operations of KDC, KDC shall provide such assistance
and cooperation, including without limitation, witnesses and documentary or
other evidence, as may reasonably be requested by ProMedCo-Temple in connection
with its defense. ProMedCo-Temple shall reimburse KDC for its reasonable
out-of-pocket expenses incurred in providing such assistance.
11.7 NOTICES. All notices, demands and other communications hereunder
shall be in writing and shall be deemed to have been duly given if delivered in
person or mailed by certified mail or registered mail (postage prepaid) or sent
by reputable overnight courier service (charges prepaid):
To KDC: King's Daughters Clinics, P.A.
▇▇▇▇ ▇.▇. ▇. ▇. ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇
Attention: President
(1)
0363293.08
080020-007 10/09/96
-40-
with a copy to: ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇
Hilgers & ▇▇▇▇▇▇▇, P.C.
▇▇ ▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇-▇▇▇▇
To ProMedCo and
ProMedCo-Temple: ProMedCo, Inc.
▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇ ▇▇▇▇
▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attention: Chief Executive Officer
with a copy to ▇▇▇▇ ▇. ▇▇▇▇▇▇▇
Boult, Cummings, ▇▇▇▇▇▇▇ & ▇▇▇▇▇, PLC
▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
or to such other address as either KDC or ProMedCo may designate by notice to
the other.
11.8 ENTIRE AGREEMENT. This Agreement and the Appendices, Exhibits,
schedules and docu ments delivered pursuant hereto constitute the entire
contract between the parties hereto pertaining to the subject matter hereof and
supersede all prior and contemporaneous agreements, understand ings,
negotiations and discussions, whether written or oral, of the parties, and there
are no representations, warranties or other agreements between the parties in
connection with the subject matter hereof, except as specifically set forth
herein. No supplement, modification or waiver of this Agreement shall be binding
unless executed in writing by the parties to be bound thereby.
11.9 ALTERNATIVE DISPUTE RESOLUTION. Any dispute, disagreement, claim
or controversy arising out of or related to this Agreement (a "Disputed Matter")
may, at the option of either party hereto upon written notice to the other
party, be submitted to non-binding mediation before a mutually acceptable
neutral advisor. To the extent the neutral advisor is compensated, the parties
shall each bear half the cost. Any Disputed Matter that is not resolved through
mediation will be settled by binding arbitration in accordance with the rules of
commercial arbitration of the American Arbitration Association, and judgment
upon the award rendered by the arbitrator(s) may be entered in any court having
jurisdiction thereof. Such arbitration shall occur within ▇▇▇▇ County, Texas,
unless the parties mutually agree to have such proceedings in some other locale.
The arbitrator(s) may in any such proceeding award attorneys' fees and costs to
the prevailing party.
11.10 GOVERNING LAW. THE VALIDITY AND CONSTRUCTION OF THIS AGREE
MENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF TEXAS.
(1)
0363293.08
080020-007 10/09/96
-41-
11.11 LEGAL FEES AND COSTS. In the event either party elects to incur
legal expenses to enforce or interpret any provision of this Agreement, the
prevailing party will be entitled to recover such legal expenses, including,
without limitation, reasonable attorneys' fees, costs and necessary
disbursements, in addition to any other relief to which such party shall be
entitled.
11.12 TIME. Time is of the essence for purposes of each and every provision
of this Agreement.
11.13 SECTION HEADINGS. The Section headings are for reference only and
shall not limit or control the meaning of any provision of this Agreement.
11.14 WAIVER. No delay or omission on the part of any party hereto in
exercising any right hereunder shall operate as a waiver of such right or any
other right under this Agreement.
11.15 NATURE AND SURVIVAL OF REPRESENTATIONS. All statements contained
in any certificate delivered by or on behalf of any of the parties to this
Agreement pursuant hereto in connection with the transactions contemplated
hereby shall be deemed to be representations and warranties made by the
respective parties hereunder. The covenants, representations and warranties made
by the parties each to the other in this Agreement or pursuant hereto shall
survive the transactions contemplated hereby and any investigation made by
ProMedCo or ProMedCo-Temple.
11.16 EXHIBITS. All Exhibits, Appendices, schedules and documents
referred to in or at tached to this Agreement are integral parts of this
Agreement as if fully set forth herein and all statements appearing therein
shall be deemed to be representations. All items disclosed hereunder shall be
deemed disclosed only in connection with the specific representation to which
they are explicitly referenced.
11.17 ASSIGNMENT. No party hereto shall assign this Agreement without
first obtaining the written consent of the other party, except ProMedCo and
ProMedCo-Temple shall have the right to assign this Agreement to an Affiliate or
any institutional lender providing financing to ProMedCo and its subsidiaries.
11.18 BINDING ON SUCCESSORS AND ASSIGNS. Subject to ss. 11.17, this
Agreement shall inure to the benefit of and bind the respective heirs,
administrators, successors and assigns of the parties hereto. Nothing expressed
or referred to in this Agreement is intended or shall be construed to give any
person other than the parties to this Agreement or their respective successors
or permitted assigns any legal or equitable right, remedy or claim under or in
respect of this Agreement or any provision contained herein, it being the
intention of the parties to this Agreement that this Agreement shall be for the
sole and exclusive benefit of such parties or such successors and assigns and
not for the benefit of any other person.
(1)
0363293.08
080020-007 10/09/96
-42-
11.19 PARTIES IN INTEREST. Nothing in this Agreement is intended to
confer any right on any person other than the parties to it and their respective
successors and assigns, nor is anything in this Agreement intended to modify or
discharge the obligation or liability of any third person to any party to this
Agreement, nor shall any provision give any third person any right of
subrogation or action over against any party to this Agreement.
11.20 AMENDMENTS. This Agreement may be amended, but only in writing,
signed by the parties hereto, at any time prior to the Closing, before or after
approval hereof by the stockholders of KDC, with respect to any of the terms
contained herein, but after such stockholder approval, no amendment shall be
made which reduces the consideration per share paid each such stockholder
without the further approval of such stockholders.
11.21 DRAFTING PARTY. The provisions of this Agreement, and the
documents and instruments referred to herein, have been examined, negotiated,
drafted and revised by counsel for each party hereto and no implication shall be
drawn nor made against any party hereto by virtue of the drafting of this
Agreement.
11.22 COUNTERPARTS. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall comprise one and the same instrument.
11.23 REPRODUCTION OF DOCUMENTS. This Agreement and all documents
relating thereto, including without limitation, consents, waivers and
modifications which may hereafter be executed, the Exhibits and documents
delivered at the Closing, and financial statements, certificates and other
information previously or hereafter furnished to ProMedCo-Temple may be
reproduced by ProMedCo-Temple by any photographic, photostatic, microfilm,
microcard, miniature photographic or other similar process and ProMedCo-Temple
may destroy any original documents so reproduced. KDC agrees and stipulates that
any such reproduction shall be admissible in evidence as the original itself in
any judicial or administrative proceeding (whether or not the original is in
existence and whether or not such reproduction was made by ProMedCo-Temple in
the regular course of business) and that any enlargement, facsimile or further
reproduction of such reproduction shall likewise be admissible in evidence.
(1)
0363293.08
080020-007 10/09/96
-43-
11.24 PRESS RELEASES. Except as required by law, KDC shall not make any
press releases or other public announcements relating to this Agreement or the
transactions contemplated hereby without the prior written consent of
ProMedCo-Temple.
IN WITNESS WHEREOF, the parties hereto have duly executed this
Agreement as of the day and year first above written.
PROMEDCO, INC.
By
Its
Name
PROMEDCO OF TEMPLE, INC.
By
Its
Name
KING'S DAUGHTERS CLINICS, P.A.
By
Its
Name
(1)
0363293.08
080020-007 10/09/96
-44-
UNANIMOUS CONSENT OF DIRECTORS
The undersigned constituting all of the directors of King's Daughters
Clinics, P.A., a Texas corporation (the "Company"), hereby unanimously (i)
consent to, and approve, the foregoing Plan and Agreement for Reorganization and
the various Appendices and Exhibits thereto (collectively the "Agreement") and
to the transactions contemplated thereby; (ii) ratify the actions of officers of
the Company in negotiating, executing and delivering the Agreement; (iii)
recommend that the shareholders of the Company authorize the sale of
substantially all of the assets of the Company pursuant to the Agreement and
(iv) contingent upon authorization of such sale by the shareholders of the
Company, authorize the officers of the Company to carry into effect the
transactions contemplated by the Agreement, including the taking of any action
and the delivery of any document reasonably in furtherance thereof.
▇▇▇ ▇▇▇▇, M.D.
▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇., M.D.
▇▇▇▇▇▇ ▇▇▇▇▇▇▇, III, M.D.
▇▇▇▇▇▇▇ ▇▇▇, M.D.
(1)
0363293.08
080020-007 10/09/96
-45-
Shareholder Shareholder's Spouse
UNANIMOUS CONSENT OF SHAREHOLDERS
The undersigned constituting all of the shareholders of King's
Daughters Clinics, P.A., a Texas corporation (the "Company"), hereby unanimously
authorize the sale of substantially all of the assets of the Company pursuant to
the foregoing Plan and Agreement for Reorganization and the various Appendices
and Exhibits thereto.
EFFECTIVE as of the latest date set forth below.
Shareholder Shareholder's Spouse
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇▇, M.D.
Date:
▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
Date:
▇▇▇ ▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇▇, M.D.
Date:
(1)
0363293.08
080020-007 10/09/96
-46-
Shareholder Shareholder's Spouse
▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
Gopal Guttickonda, M.D.
Date:
▇▇▇▇▇▇ ▇▇▇, M.D.
Date:
▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇ ▇▇▇▇▇▇▇, D.O.
Date:
▇▇▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
(1)
0363293.08
080020-007 10/09/96
-47-
Shareholder Shareholder's Spouse
▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇▇, ▇▇., M.D.
Date:
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, D.P.M.
Date:
(1)
0363293.08
080020-007 10/09/96
-48-
Shareholder Shareholder's Spouse
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇., M.D.
Date:
▇▇▇▇▇▇ ▇▇▇▇▇▇▇, III, M.D.
Date:
▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇▇ ▇▇▇, M.D.
Date:
(1)
0363293.08
080020-007 10/09/96
-49-
Shareholder Shareholder's Spouse
▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇ ▇▇▇▇▇▇▇, D.O.
Date:
▇▇▇▇ ▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
Date:
▇▇▇▇▇ ▇▇▇▇, M.D.
Date:
0363293.08
080020-007 10/09/96
-54-
LIST OF APPENDICES
NUMBER DESCRIPTION
2.2 Form of Undertaking
2.3 List of Excluded Assets
2.9A Service Agreement
2.9B Form of Shareholder Physician Employment Agreement
2.9C Form of Non-Shareholder Physician Employment Agreement
2.9E Properties to be leased from Temple
7.2 Form of opinion of ProMedCo-Temple's counsel to be delivered at
the Closing
8.3 Form of opinion of KDC's counsel to be delivered at the Closing
8.5 Form of Stockholder Agreement
(1)
0363293.08
080020-007 10/09/96
-55-
LIST OF EXHIBITS
NUMBER DESCRIPTION
3.1A List of States in which KDC is qualified to do business
3.1B Copies of KDC's Articles of Incorporation and Bylaws
3.2 KDC Voting Agreements
3.3 Subsidiaries of KDC
3.4 KDC Financial Statements
3.6 Exceptions to Absence of Recent Changes Representation
3.7A Recent UCC report on KDC's Assets
3.7B Security Interests to be Assumed by ProMedCo-Temple
3.8 Contracts
3.9 List of Burdensome Agreements
3.10 Related party transactions
3.11 Exceptions to No Default Representation
3.15 Permits and licenses
3.16 Litigation
3.21 Environmental Matters
3.22 List of Employee Benefit Plans
3.23 List of Employee Benefit Plans not qualified underss.401(a)
of the Internal Revenue Code
3.24A List of highly compensated employees
3.24B Description of Employee Benefits
3.25A List of Insurance coverages and bonds
3.25B Description denials of coverage
3.25C Claims History
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 2.2
FORM OF UNDERTAKING
UNDERTAKING
Undertaking dated as of September 18, 1996 ("Undertaking") by ProMedCo of
Temple, Inc., a Delaware corporation ("ProMedCo-Temple"), in favor of King's
Daughters Clinics, P.A. ("KDC").
RECITAL:
By a Plan and Agreement for Reorganization dated as of September 13,
1996 (the "Acquisition Agreement") between KDC and ProMedCo-Temple, KDC agreed
to sell, convey, transfer and deliver to ProMedCo-Temple at the Closing under
the Agreement, certain assets (the "Assets") of Target in consideration for the
payment by ProMedCo-Temple to KDC of the purchase price of the Assets and
delivery by ProMedCo-Temple to KDC of an undertaking of the character described
below. For the purpose of consummating such Closing, KDC has delivered to
ProMedCo- Temple various instruments and has taken other actions to effect such
sale, conveyance, transfer and delivery, and ProMedCo-Temple has delivered to
KDC the documents required by the Agreement to be so delivered at the Closing.
To complete the action required of ProMedCo-Temple by the Agreement as full
consideration for such sale, conveyance, transfer and delivery, ProMedCo-Temple
hereby undertakes and agrees as follows:
12. ProMedCo-Temple hereby assumes and agrees to pay, perform and
discharge the liabilities and obligations of KDC relating to the Assets
described in Schedule 1 hereto, except for liabilities or obligations arising
out of any breach of any such obligations by KDC.
13. ProMedCo-Temple assumes and agrees to discharge only the
obligations of KDC set forth in Section 1 above, and no others. Without limiting
the generality of the foregoing, ProMedCo- Temple specifically does not assume
any of the following obligations or liabilities of the KDC:
(a) any other liabilities reflected in the KDC Financial Statements;
(1)
0363293.08
080020-007 10/09/96
-2-
(b) any litigation or other claims involving incidents or courses
of conduct prior to the date hereof including, without
limitation, any litigation described in Exhibit 3.16 to the
Agreement;
(c) any unfunded liability existing on the date hereof under any
pension plan of KDC.
14. This Undertaking shall inure to the benefit of KDC, its successors
and assigns. The terms defined in the Agreement, unless otherwise defined herein
or unless the context otherwise requires, shall have the same defined meanings
herein. The sole purpose hereof is to relieve KDC of certain obligations and not
to create third party beneficiary rights. Therefore, this Agreement may be
modified by a writing signed by the KDC and ProMedCo-Temple without the consent
of any third party.
15. This Undertaking, particularly Section 1 hereof, is not intended to
and does not waive, compromise or in any other manner lessen the rights of
ProMedCo-Temple under the Agreement relating to the representations and
warranties of KDC and its obligations thereunder to indemnify ProMedCo-Temple
thereunder against various liabilities.
16. Capitalized terms not otherwise defined in this Undertaking shall
have the meanings ascribed thereto in the Acquisition Agreement.
IN WITNESS WHEREOF, ProMedCo-Temple has caused this Undertaking to be
signed in several counterparts (each of which shall constitute an original
hereof) by its duly authorized officer as of the date first above written.
PROMEDCO OF TEMPLE, INC.
By
Its
Name
(1)
0363293.08
080020-007 10/09/96
-3-
GUARANTY
ProMedCo, Inc., a Texas corporation ("ProMedCo") which is the sole
shareholder of ProMedCo of Temple, Inc., a Delaware corporation
("ProMedCo-Temple"), hereby guarantees the performance of ProMedCo-Temple under
the above Undertaking.
PROMEDCO, INC.
By
Its
Name
(1)
0363293.08
080020-007 10/09/96
-4-
SCHEDULE 1
TO UNDERTAKING
1. The Assumed Balance Sheet Liabilities as defined in ss. 2.4(b) of the
Acquisition Agreement.
2. The contracts and equipment leases of KDC listed in Exhibit 3.8 to the
Acquisition Agreement.
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 2.3
EXCLUDED ASSETS
The ownership interests in the Affiliates of KDC listed in Exhibit 3.3
of the Exhibit Volume.
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 2.9A
FORM OF SERVICE AGREEMENT
--------------------------------------------------------------------------------
SERVICE AGREEMENT
--------------------------------------------------------------------------------
PROMEDCO OF TEMPLE, INC.
AND
PHYSICIANS OF KING'S DAUGHTERS, P.A.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
EFFECTIVE SEPTEMBER 1, 1996
--------------------------------------------------------------------------------
(1)
0363293.08
080020-007 10/09/96
-i-
TABLE OF CONTENTS
1. RESPONSIBILITIES OF THE PARTIES.................................1
1.1 General Responsibilities of the Parties...............1
1.2 KDCP's Matters........................................1
1.3 Patient Referrals.....................................1
2. POLICY COUNCIL..................................................1
2.1 Formation and Operation of the Policy Council.........1
2.2 Duties and Responsibilities of the Policy Council.....2
3. OBLIGATIONS OF PROMEDCO-TEMPLE..................................3
3.1 Management and Administration.........................4
3.2 Administrator.........................................8
3.3 Expansion of Clinic...................................8
3.4 Events Excusing Performance...........................8
3.5 Compliance With Applicable Laws.......................8
3.6 Capital Needs.........................................8
4. OBLIGATIONS OF KDCP.............................................8
4.1 Professional Services.................................8
4.2 Employment Of Physician Employees.....................9
4.3 Non-Clinic Expenses...................................9
4.4 Medical Practice......................................9
4.5 Professional Insurance Eligibility....................9
4.6 Employment Of Non-Physician Employees.................9
4.7 Events Excusing Performance...........................9
4.8 Compliance With Applicable Laws......................10
4.9 Restrictions on Use of Clinic Facility...............10
4.10 KDCP Employee Benefit Plans.........................10
4.11 Physician Powers of Attorney........................11
4.12 Spokesperson........................................11
5. RECORDS........................................................11
5.1 Patient Records......................................11
5.2 Other Records........................................11
5.3 Access to Records....................................11
6. FACILITIES TO BE PROVIDED BY PROMEDCO-TEMPLE...................11
6.1 Facilities...........................................11
(1)
0363293.08
080020-007 10/09/96
-ii-
6.2 Use of Facilities....................................12
7. FINANCIAL ARRANGEMENTS.........................................12
7.1 Payments to KDCP and ProMedCo-Temple..........................12
7.2 Distribution.........................................12
7.3 Clinic Expenses......................................12
7.4 Accounts Receivables.................................12
8. INSURANCE AND INDEMNITY........................................13
8.1 Insurance to Be Maintained by ProMedCo-Temple........13
8.2 Insurance to be Maintained by KDCP...................13
8.3 Tail Insurance Coverage..............................13
8.4 Additional Insured...................................14
8.5 Indemnification......................................14
9. RESTRICTIVE COVENANTS AND LIQUIDATED DAMAGES..................14
9.1 Restrictive Covenants by KDCP........................14
9.2 Restrictive Covenants By Medical Professionals.......14
9.3 Physician Shareholder and Physician
Employee Liquidated Damages..........................15
9.4 Enforcement..........................................16
9.5 Termination of Restrictive Covenants.................16
10. TERM..........................................................16
10.1 Term and Renewal....................................16
10.2 Termination by KDCP.................................17
10.3 Termination by ProMedCo-Temple......................18
10.4 Actions After Termination...........................18
11. DEFINITIONS...................................................20
11.1 Adjustments ........................................20
11.2 Clinic .............................................20
11.3 Clinic Expenses ....................................20
11.4 Clinic Expenses shall not include...................22
11.5 Clinic Facility ....................................22
11.6 Distribution Funds .................................23
11.7 Effective Date .....................................23
11.9 KDCP Employees .....................................23
11.10 Medical Professional ..............................23
(1)
0363293.08
080020-007 10/09/96
-iii-
11.11 Net Clinic Revenues ...............................23
11.12 Opening Balance Sheet .............................23
11.13 Physician Employees ...............................23
11.14 Physician Extenders ...............................23
11.15 Physician Shareholders ............................23
11.16 Plan and Agreement for Reorganization .............24
11.17 ProMedCo...........................................24
11.18 ProMedCo IPO Date..................................24
11.19 ProMedCo IPO Price.................................24
11.20 ProMedCo-Temple Distribution ......................24
11.21 Risk Pool Surpluses ...............................24
11.22 Technical Employees ...............................24
12. GENERAL PROVISIONS............................................24
12.1 Independent Contractor..............................24
12.2 Other Contractual Arrangement.......................25
12.3 Proprietary Property................................26
12.4 Cooperation.........................................26
12.5 Licenses, Permits and Certificates..................26
12.6 Compliance with Rules, Regulations and Laws.........26
12.7 Generally Accepted Accounting Principles (GAAP).....27
12.8 Notices.............................................27
12.9 Attorneys' Fees.....................................27
12.10 Severability.......................................27
12.11 Arbitration........................................27
12.12 Construction of Agreement..........................27
12.13 Assignment and Delegation..........................28
12.14 Confidentiality....................................28
12.15 Waiver.............................................28
12.16 Headings...........................................28
12.17 No Third Party Beneficiaries.......................28
12.18 Time is of the Essence.............................28
12.19 Modifications of Agreement for
Prospective Legal Events...........................28
12.20 No Right of Off-Set................................29
12.21 Whole Agreement....................................29
(1)
0363293.08
080020-007 10/09/96
-1-
SERVICE AGREEMENT
Service Agreement ("Agreement") dated September 18, 1996, between
ProMedCo of Temple, Inc., a Delaware corporation ("ProMedCo-Temple"), and
Physicians of King's Daughters, P.A., a Texas professional association ("KDCP").
RECITALS:
Subject to the terms and conditions hereof, KDCP desires to engage
ProMedCo-Temple to provide to KDCP management services, facilities, personnel,
equipment and supplies necessary to operate the Clinic (as defined herein) and
ProMedCo-Temple desires to accept such engagement.
The parties agree as follows:
1. RESPONSIBILITIES OF THE PARTIES
1.1 GENERAL RESPONSIBILITIES OF THE PARTIES. ProMedCo-Temple shall
provide KDCP with offices, facilities, equipment, supplies, non-professional
support personnel, and management and financial advisory services.
ProMedCo-Temple shall neither exercise control over nor interfere with the
physician-patient relationship, which shall be maintained strictly between the
physicians of KDCP and their patients.
1.2 KDCP'S MATTERS. KDCP shall maintain sole discretion and authority
over the financial matters relative to its corporate existence. It shall set
compensation levels for KDCP Employees. KDCP will also be responsible for all
other matters pertaining to the operation of KDCP.
1.3 PATIENT REFERRALS. The parties agree that the benefits to KDCP do
not require, are not payment for, and are not in any way contingent upon the
admission, referral or any other arrangement for the provision of any item or
service offered by ProMedCo-Temple to any of KDCP's patients in any facility or
laboratory controlled, managed or operated by ProMedCo-Temple.
2. POLICY COUNCIL
2.1 FORMATION AND OPERATION OF THE POLICY COUNCIL. A Policy Council
will be established which shall be responsible for the major policies which will
serve as the basis for operations of the Clinic. The Policy Council shall
consist of six members. ProMedCo-Temple shall designate, at its sole discretion,
three members of the Policy Council. Members of the Policy Council designated by
ProMedCo-Temple and/or KDCP shall be entitled to attend and vote by proxy at any
meetings of the Policy Council so long as at least one such representative is
present in person. KDCP at its sole discretion shall designate three members.
Except as may otherwise be provided, the act of a majority of the six members of
the Policy Council shall be the act of the Policy Council.
(1)
0363293.08
080020-007 10/09/96
-2-
2.2 DUTIES AND RESPONSIBILITIES OF THE POLICY COUNCIL. During the term
of this Agreement, the Policy Council shall have the following duties and
responsibilities.
(a) ANNUAL BUDGETS. All annual capital and operating budgets prepared by
ProMedCo- Temple, as set forth in Section 3 and employing ProMedCo-Temple's
financial expertise, shall be subject to the review and approval of the
Policy Council, provided; however, ProMedCo-Temple shall have final
approval of any capital expenditure required by ProMedCo-Temple.
(b) ADMINISTRATOR. The selection and retention of the Administrator pursuant to
Section 3.1 shall be subject to the reasonable approval of the Policy
Council. If KDCP is dissatisfied with the services provided by the
Administrator, KDCP shall refer the matter to the Policy Council.
ProMedCo-Temple and Policy Council shall in good faith determine whether
the performance of the Administrator could be brought to acceptable levels
through counsel and assistance, or whether the Administrator should be
terminated. ProMedCo-Temple shall have the ultimate authority to terminate
the Administrator.
(c) ADVERTISING. All advertising, marketing, and public relations shall be
subject to the prior review and approval of the Policy Council, in
compliance with applicable laws and regulations governing professional
advertising and in accordance with the standards and medical ethics of the
American Medical Association and the Texas Medical Association.
(d) ANCILLARY SERVICES. The Policy Council shall approve Clinic provided
ancillary services based upon the pricing, access to and quality of such
services.
(e) CAPITAL IMPROVEMENTS AND EXPANSION. The Policy Council shall determine the
priority for any renovation, expansion plans and major equipment
expenditures with respect to the Clinic based upon economic feasibility,
physician support, productivity and market conditions. Any capital
expenditure in excess of $20,000 shall require the approval of the Policy
Council; all others may be made by ProMedCo-Temple at its discretion in the
exercise of prudent business judgement..
(f) EXCEPTIONS TO INCLUSION IN THE NET REVENUE CALCULATION. The exclusion of
any revenue from Net Clinic Revenues, whether now or in the future, shall
be subject to the approval of the Policy Council.
(g) GRIEVANCE ISSUES. Subject to the provisions of Section 1.2 of this
Agreement, the Policy Council shall consider and make final decisions
regarding grievances pertaining
(1)
0363293.08
080020-007 10/09/96
-3-
to matters not specifically addressed in this Agreement as referred to it
by KDCP's Board or ProMedCo-Temple.
(h) PATIENT FEES. In consultation with KDCP and ProMedCo-Temple, the Policy
Council shall review and adopt the fee schedule for all physician and
ancillary services rendered by the Clinic.
(i) PHYSICIAN HIRING. The Policy Council, with information and analysis
provided by ProMedCo-Temple, shall determine the number and type of
physicians required for the efficient operation of the Clinic and KDCP
shall determine the individual physicians to be hired to fill such
positions. The approval of ProMedCo-Temple shall be required for any
variations to the restrictive covenants in any physician employ ment
contract.
(j) PROVIDER AND PAYOR RELATIONSHIPS. The Policy Council shall make the
decisions regarding the establishment and maintenance of relationships with
institutional health care providers and payors. The Policy Council shall be
responsible for approving the allocation of capitation risk pools between
the professional and institutional components of these pools to the extent
applicable under a payor agreement. ProMedCo-Temple and KDCP may choose to
use actuarial data from a nationally recognized actuarial firm as agreed to
by both parties, for the purposes of allocating capitation funds, for those
professional services provided directly by KDCP.
(k) STRATEGIC PLANNING. The Policy Council, with the assistance of
ProMedCo-Temple, shall develop long-term strategic planning objectives.
3. OBLIGATIONS OF PROMEDCO-TEMPLE
During the term of this Agreement, ProMedCo-Temple shall provide or
arrange for the services set forth in this Section 3, the cost of all of which
shall be included in Clinic Expenses. ProMedCo-Temple is hereby expressly
authorized to perform its services in whatever manner it deems reasonably
appropriate, in accordance with policies approved by the Policy Council, and
including without limitation, performance of some functions at locations other
than the Clinic Facility. KDCP will not act in a manner which would prevent
ProMedCo-Temple from efficiently managing the Clinic Facility operations in a
businesslike manner. KDCP, through KDCP Employees, will provide all medical
services. ProMedCo-Temple will have no authority, directly or indirectly, to
perform, and will not perform, any medical function. ProMedCo-Temple may,
however, advise KDCP as to the relationship between its performance of medical
functions and the overall administrative and business functioning of the Clinic.
(1)
0363293.08
080020-007 10/09/96
-4-
3.1 MANAGEMENT AND ADMINISTRATION. During the term of this Agreement,
KDCP hereby appoints ProMedCo-Temple as the sole and exclusive manager and
administrator of all non-medical functions and services related to KDCP's
services at the Clinic. KDCP shall perform all medical services, and
ProMedCo-Temple shall have no authority, directly or indirectly, to perform, and
will not perform, any medical function. Without limiting the generality of the
foregoing, ProMedCo- Temple shall provide the following administrative,
management and marketing services as may be required in conjunction with KDCP's
services at the Clinic. ProMedCo-Temple shall hire and supervise an
Administrator, subject to the reasonable approval of the Policy Council, to
manage and administer all of the day-to-day business functions of
ProMedCo-Temple, including without limitation:
3.1.1 ANNUAL BUDGETS. Financial planning and preparation of
annual budgets. Annually and at least 30 days prior to the commencement
of each fiscal year, ProMedCo- Temple shall prepare and deliver to KDCP
capital and operating budgets reflecting in reasonable detail
anticipated revenues and expenses, sources and uses of capital to
maintain and enhance KDCP's medical practice and Clinic services.
3.1.2 FINANCIAL STATEMENTS. ProMedCo-Temple shall prepare
monthly and fiscal year unaudited financial statements containing a
balance sheet and a statement of income for Clinic operations, which
shall be delivered to KDCP within thirty (30) days after the close of
each calendar month. The fiscal year statement shall be reviewed by a
certified public accountant as selected by ProMedCo-Temple in
connection with the audit of the financial statements of ProMedCo. If
KDCP desires an audit in addition to the audit provided by
ProMedCo-Temple, such an audit would be at KDCP's expense.
3.1.3 NON-PROFESSIONAL PERSONNEL. ProMedCo-Temple will provide
all personnel reasonably necessary for the conduct of Clinic operations
with the exception of Physician Extenders and Technical Employees.
ProMedCo-Temple shall determine and cause to be paid the salaries,
fringe benefits and any sums for income taxes, unemployment insurance,
social security taxes or any other withholding amounts required by
applicable law or governmental authority, of all such personnel. Such
personnel shall be under the direction, supervision and control of
ProMedCo-Temple, with those personnel performing patient care services
subject to the professional supervision of KDCP. If KDCP is
dissatisfied with the services of any person, KDCP shall consult with
ProMedCo-Temple. ProMedCo-Temple shall in good faith determine whether
the performance of that employee could be brought to acceptable levels
through counsel and assistance, or whether such employee should be
terminated. All of ProMedCo-Temple's obligations regarding staff shall
be governed by the overriding principle and goal of providing high
quality medical care. At ProMedCo-Temple's option some or all of the
non-physician personnel may be carried on the books of KDCP as
(1)
0363293.08
080020-007 10/09/96
-5-
KDCP's employees in which event the costs associated with such
employees will be a Clinic Expense.
3.1.4 QUALITY ASSURANCE. ProMedCo-Temple will assist KDCP in
fulfilling its obligation to its patients to maintain high quality
medical and professional services, including patient satisfaction
programs, employee education, outcomes analysis, clinical protocol
development and to implement a risk management program.
3.1.5 FACILITIES AND EQUIPMENT. ProMedCo-Temple will ensure
the proper cleanliness of the premises, maintenance and cleanliness of
the equipment, furniture and furnishings located on the premises.
3.1.6 INVENTORY CONTROL AND PURCHASING SUPPLIES.
ProMedCo-Temple shall order and purchase inventory and supplies, and
such other ordinary, necessary or appropriate materials which
ProMedCo-Temple shall deem to be necessary in the operation of the
Clinic, to deliver quality Clinic services in a cost effective manner.
3.1.7 MANAGED CARE CONTRACTING. ProMedCo-Temple will be
responsible for marketing, negotiation, and administering all managed
care contracts, subject to the provisions of Section 2.2(j); provided,
however, no contract or arrangement regarding the provision of clinical
services shall be entered into without KDCP's consent.
3.1.8 BILLING AND COLLECTIONS. ProMedCo-Temple shall ▇▇▇▇
patients and collect all fees for services performed inside or outside
the Clinic Facility or arrange for such billing and collection. KDCP
hereby appoints ProMedCo-Temple, for the term hereof, to be its true
and lawful attorney-in-fact for the following purposes (i) to ▇▇▇▇
patients in KDCP's name and on its behalf, (ii) to collect accounts
receivable resulting from such billing in KDCP's name and on its
behalf, (iii) to receive payments from Blue Cross and Blue Shield,
Medicare, Medicaid, payments from health plans, and all other third
party payors; (iv) to receive the cash proceeds of any accounts
receivable; (v) to take possession of and endorse in the name of KDCP
(and/or in the name of an individual physician, such payment intended
for purpose of payment of a physician's ▇▇▇▇) any notes, checks, money
orders, insurance payments and other instruments received in payment of
accounts receivable; and (vi) in accordance with policies adopted by
the Policy Council, to initiate legal proceedings in the name of KDCP
to collect any accounts and monies owed to the Clinic, to enforce the
rights of KDCP as creditors under any contract or in connection with
the rendering of any service, and to contest adjustments and denials by
governmental agencies (or its fiscal intermediaries) as third-party
payors. All adjustments made for uncollectible accounts, professional
courtesies and other activities that do not generate a collectible fee
shall be done in a reasonable and consistent manner acceptable to
ProMedCo-Temple's independent certified public accountants.
(1)
▇▇▇▇▇▇▇.08
080020-007 10/09/96
-6-
3.1.9 DEPOSIT OF NET CLINIC REVENUES. During the term of this
Agreement, all Net Clinic Revenues collected resulting from the
operations of the Clinic shall be deposited directly into a bank
account of which KDCP shall be the owner ("Account"). ProMedCo- Temple
and KDCP shall maintain their accounting records in such a way as to
clearly segregate Net Clinic Revenues from other funds of
ProMedCo-Temple or KDCP. KDCP hereby appoints ProMedCo-Temple as its
true and lawful attorney-in-fact to deposit in the Account all revenues
collected. KDCP covenants, and shall cause all KDCP Employees to
covenant, to forward any payments received with respect to Net Clinic
Revenues for services provided by KDCP and KDCP Employees to
ProMedCo-Temple for deposit. ProMedCo- Temple shall have the right to
withdraw funds from the Account and all owners of the Account shall
execute a revocable standing transfer order ("Transfer Order") under
which the bank maintaining the Account shall periodically transfer the
entire balance of the Account to a separate bank account owned solely
by ProMedCo-Temple ("ProMedCo-Temple Account"). KDCP and
ProMedCo-Temple hereby agree to execute from time to time such
documents and instructions as shall be required by the bank maintaining
the Account and mutually agreed upon to effectuate the foregoing
provisions and to extend or amend such documents and instructions. Any
action by KDCP that interferes with the operation of this Section,
including, but not limited to, any failure to deposit or allow
ProMedCo-Temple to deposit any Net Clinic Revenues into the Account,
any withdrawal of any funds from the Account not authorized by the
express terms of this Agreement, or any revocation of or attempt to
revoke the Transfer Order (otherwise than upon expiration or
termination of this Agreement), will constitute a breach of this
Agreement and will entitle ProMedCo-Temple, in addition to any other
remedies that it may have at law or in equity, to seek a court ordered
assignment of the following rights:
(a) To collect accounts receivable resulting from the
provision of services to patients of KDCP and the
KDCP Employees;
(b) To receive payments from patients, third party payor
plans, insurance companies, Medicare, Medicaid and
all other payors with respect to services rendered by
KDCP and its KDCP Employees;
(c) To take possession of and endorse any notes, checks,
money orders, insurance payments and any other
instruments received as payment of such accounts
receivable; and
(d) To collect all revenues of the Clinic.
(1)
0363293.08
080020-007 10/09/96
-7-
3.1.10 MANAGEMENT INFORMATION SYSTEMS/COMPUTER SYSTEMS.
ProMedCo-Temple shall supervise and provide information systems that
are necessary and appropriate for the operation of the Clinic.
3.1.11 LEGAL AND ACCOUNTING SERVICES. ProMedCo-Temple shall
arrange for or render to KDCP such business and financial management
consultation and advice as may be reasonably required or requested by
KDCP and directly related to the operations of the Clinic.
ProMedCo-Temple shall not be responsible for rendering any legal or tax
advice or services or personal financial services to KDCP or any
employee or agent of KDCP.
3.1.12 NEGOTIATION AND PAYMENT OF PREMIUMS FOR ALL INSURANCE
PRODUCTS HELD BY KDCP. ProMedCo-Temple shall negotiate for and cause
premiums to be paid with respect to the insurance provided for in
Section 8. Premiums and deductibles with respect to such policies shall
be a Clinic Expense.
3.1.13 PHYSICIAN RECRUITING. ProMedCo-Temple shall assist KDCP
in recruiting additional physicians, carrying out such administrative
functions as may be appropriate such as advertising for and identifying
potential candidates, checking credentials, and arranging interviews;
provided, however, KDCP shall interview and make the ultimate decision
as to the suitability of any physician to become associated with the
Clinic. All physicians recruited by ProMedCo-Temple and accepted by
KDCP shall be the sole employees of KDCP to the extent such physicians
are hired as employees. Any expenses incurred in the recruitment of
physicians, including, but not limited to, employment agency fees,
relocation and interviewing expenses shall be Clinic Expenses approved
by the Policy Council.
3.1.14 SUPERVISION OF ANCILLARY SERVICES. ProMedCo-Temple
shall operate and supervise such ancillary services as approved by the
Policy Council.
3.1.15 STRATEGIC PLANNING ASSISTANCE. ProMedCo-Temple
shall assist with and implement the strategic plan as approved by the
Policy Council.
3.1.16 ADVERTISING AND PUBLIC RELATIONS. From time to time
ProMedCo-Temple shall recommend to the Policy Council various
advertising and public relations initiatives which shall not be
implemented without Policy Council approval.
3.1.17 FILES AND RECORDS. ProMedCo-Temple shall supervise and
maintain custody of all files and records relating to the operation of
the Clinic, including but not limited to accounting, billing, patient
medical records, and collection records. Patient medical records shall
at all times be and remain the property of KDCP and shall be located at
Clinic facilities so that they are readily accessible for patient care.
The management of all files and records
(1)
0363293.08
080020-007 10/09/96
-8-
shall comply with applicable state and federal statutes.
ProMedCo-Temple shall use its reasonable efforts to preserve the
confidentiality of patients' medical records and use information
contained in such records only for the limited purpose necessary to
perform the services set forth herein, provided, however, in no event
shall a breach of said confidentiality be deemed a default under this
Agreement.
3.2 ADMINISTRATOR. The selection and retention of the Administrator,
subject to the provisions of Section 2.2(b).
3.3 EXPANSION OF CLINIC. ProMedCo-Temple will pursue various programs
to increase revenue and profitability including assisting KDCP in adding
additional office based procedures, ancillary services and adding additional
satellite office(s) as determined by the Policy Council to be beneficial to the
Clinic. ProMedCo-Temple will also assist in recruiting new physicians and
developing relationships and affiliations with other physicians, hospitals,
networks, HMOs, etc. To assist in the continued growth and development of the
Clinic within a 30 mile radius of Temple, Texas, ProMedCo-Temple may acquire
other physician practices for incorporation into KDCP. KDCP will cooperate with
ProMedCo-Temple in such expansion efforts and use its reasonable efforts to
assist ProMedCo-Temple with respect thereto. Without limiting the generality of
the foregoing, neither party not enter into any agreements with respect to any
such matter without the prior approval of the Policy Council.
3.4 EVENTS EXCUSING PERFORMANCE. ProMedCo-Temple shall not be liable to
KDCP for failure to perform any of the services required herein in the event of
strikes, lock-outs, calamities, acts of God, unavailability of supplies, or
other events over which ProMedCo-Temple has no control for so long as such
events continue, and for a reasonable amount of time thereafter.
3.5 COMPLIANCE WITH APPLICABLE LAWS. ProMedCo-Temple shall comply with all
applicable federal, state and local laws, regulations and restrictions in the
conduct of its obligations under this Agreement.
3.6 CAPITAL NEEDS. ProMedCo-Temple shall be responsible for the capital
necessary to maintain, expand and grow KDCP, subject to the approval of the
Policy Committee.
4. OBLIGATIONS OF KDCP
4.1 PROFESSIONAL SERVICES. KDCP shall provide professional services to
patients in compliance at all times with ethical standards, laws and regulations
applying to the medical profession. KDCP shall also ensure that each physician
associated with KDCP is licensed by the State of Texas. In the event that any
disciplinary actions or medical malpractice actions are initiated against any
such physician, KDCP shall immediately inform the Administrator of such action
and the
(1)
0363293.08
080020-007 10/09/96
-9-
underlying facts and circumstances. KDCP shall carry out a program to monitor
the quality of medical care practiced, with ProMedCo-Temple's assistance. KDCP
will cooperate with ProMedCo- Temple in taking steps to resolve any utilization
review or quality assurance issues which may arise in connection with the
Clinic.
4.2 EMPLOYMENT OF PHYSICIAN EMPLOYEES. KDCP shall have complete control
of and responsibility for the hiring, compensation, supervision, evaluation and
termination of its Physician Shareholders and Physician Employees, although at
the request of KDCP, ProMedCo-Temple shall consult with KDCP regarding such
matters. KDCP shall enforce formal employee agreements from each of its
Physician Shareholders and Physician Employees, hired or contracted,
substantially in the form attached to the Plan and Agreement for Reorganization
as Appendix 2.9B-2.
4.3 NON-CLINIC EXPENSES. KDCP shall be solely responsible for the
payment of all costs and expenses incurred in connection with KDCP operations
which are not Clinic Expenses, including, but not limited to, accounting and
other professional services fees, salaries and benefits, retirement plan
contributions, health, disability and life insurance premiums, payroll taxes,
membership in professional associations, continuing medical education, licensing
and board certification fees for its Physician Employees and Physician Extenders
and automobile and cellular telephone expenses of KDCP Physician Employees and
Physician Extenders.
4.4 MEDICAL PRACTICE. KDCP shall use and occupy the Clinic Facility
exclusively for the practice of medicine, and shall comply with all applicable
local rules, ordinances and all standards of medical care. It is expressly
acknowledged by the parties that the medical practice or practices conducted at
the Clinic Facility shall be conducted solely by physicians associated with
KDCP, and no other physician or medical practitioner shall be permitted to use
or occupy the Clinic Facility without the prior written consent of the Policy
Council.
4.5 PROFESSIONAL INSURANCE ELIGIBILITY. KDCP shall cooperate in the
obtaining and retaining of professional liability insurance by assuring that its
Physician Shareholders and Physician Employees are insurable, and participating
in an ongoing risk management program.
4.6 EMPLOYMENT OF NON-PHYSICIAN EMPLOYEES. There will be certain
Technical Employees that perform technical functions for KDCP. These Technical
Employees will remain in the employ of KDCP. As provided in Section 3.1.3,
ProMedCo-Temple will provide payroll and administrative services for such
Technical Employees which shall be a Clinic Expense.
4.7 EVENTS EXCUSING PERFORMANCE. KDCP shall not be liable to
ProMedCo-Temple for failure to perform any of the services required herein in
the event of strikes, lock-outs, calamities, acts of God, unavailability of
supplies, or other events over which KDCP has no control for so long as such
events continue, and for a reasonable amount of time thereafter.
(1)
0363293.08
080020-007 10/09/96
-10-
4.8 COMPLIANCE WITH APPLICABLE LAWS. KDCP shall comply with all applicable
federal, state and local laws, regulations and restrictions in the conduct of
its obligations under this Agreement.
4.9 RESTRICTIONS ON USE OF CLINIC FACILITY. KDCP shall at all times
during the term of this Agreement comply with the policy of ProMedCo-Temple
stated in Section 6.2 herein.
4.10 KDCP EMPLOYEE BENEFIT PLANS.
(a) As of the Effective Date of this Agreement, KDCP has in effect the employee
welfare benefit plans (as such term is defined in Section 3(1) of the
Employee Retirement Income Security Act of 1974, as amended ("ERISA")) and
the employee pension benefit plans (as such term is defined in Section 3(2)
of ERISA), as set forth in Exhibit 3.22 to the Plan and Agreement for
Reorgani zation.
(b) KDCP shall not enter into any new "employee benefit plan" (as defined in
Section 3(3) of ERISA) without the express written consent of ProMedCo-
Temple. Except as otherwise required by law, KDCP shall not materially
amend, freeze, terminate or merge any employee welfare or employee benefit
plan without the express written consent of ProMedCo-Temple unless such
action is contemplated by the Plan and Agreement for Reorganization. KDCP
agrees to make such changes to any employee welfare or employee benefit
plan, including the freeze, termination, or merger of such plan, as may be
approved by ProMedCo-Temple.
(c) Expenses incurred in connection with any KDCP Plan or other employee
benefit plan maintained by KDCP, including without limitation the compensa
tion of counsel, accountants, corporate trustees and other agents shall not
be included in Clinic Expenses.
(d) The contribution and administration expenses for Medical Professionals
shall be an expense of KDCP. ProMedCo-Temple shall make contributions or
payments with respect to any KDCP Plan, as a Clinic Expense, on behalf of
eligible Technical Employees or other non-Medical Professionals employed by
KDCP at ProMedCo-Temple's request pursuant to ss. 3.1.3.
(e) ProMedCo-Temple shall have the sole and exclusive authority to adopt,
amend, or terminate any employee benefit plan for the benefit of its employ
ees. ProMedCo-Temple shall have the sole and exclusive authority to appoint
the trustee, custodian, and administrator of any such plan.
4.11 PHYSICIAN POWERS OF ATTORNEY. KDCP shall require all KDCP
Employees to execute and deliver to ProMedCo-Temple powers of attorney,
satisfactory in form and substance to ProMedCo-Temple and KDCP, appointing
ProMedCo-Temple as attorney-in-fact for each for the purposes set forth in
Sections 3.1.8 and 3.1.9, which powers of attorney shall immediately terminate
upon termination of this Agreement.
4.12 SPOKESPERSON. KDCP shall serve as spokesperson for ProMedCo-Temple
and ProMedCo in Clinic, ProMedCo-Temple and ProMedCo development activities. The
parties agree that such Physician Shareholders as the Policy Council shall
appoint, shall serve in this capacity on behalf of KDCP.
5. RECORDS
5.1 PATIENT RECORDS. Upon termination of this Agreement, KDCP shall
retain all patient medical records maintained by KDCP or ProMedCo-Temple in the
name of KDCP. KDCP shall, at its option, be entitled to retain copies of
financial and accounting records relating to all services performed by KDCP.
5.2 OTHER RECORDS. All records relating in any way to the operation of the
Clinic which are not the property of KDCP under the provisions of Section 5.1
above, shall at all times be the property of ProMedCo-Temple.
5.3 ACCESS TO RECORDS. During the term of this Agreement, and
thereafter, KDCP or its designee shall upon 24 hours notice have reasonable
access during normal business hours to KDCP's and ProMedCo-Temple's financial
records, including, but not limited to, records of collections, expenses and
disbursements as kept by ProMedCo-Temple in performing ProMedCo-Temple's
obligations under this Agreement, and KDCP may copy any or all such records.
6. FACILITIES TO BE PROVIDED BY PROMEDCO-TEMPLE
6.1 FACILITIES. ProMedCo-Temple hereby agrees to provide or arrange as
a Clinic Expense the offices and facilities for Clinic operations, including but
not limited to, the Clinic Facility and all costs of repairs, maintenance and
improvements, utility (telephone, electric, gas, water) expenses, normal
janitorial services, related real or personal property lease cost payments and
expenses, taxes and insurance, refuse disposal and all other costs and expenses
reasonably incurred in conducting operations in the Clinic Facility during the
term of this Agreement.
(1)
0363293.08
080020-007 10/09/96
-11-
6.2 USE OF FACILITIES. Voluntary abortions will not be performed in
facilities that are owned or leased by ProMedCo-Temple or any of its affiliates
in whole or in part. ProMedCo-Temple and KDCP agree that KDCP, as an independent
contractor, is a separate organization that retains the authority to direct the
medical, professional, and ethical aspects of its medical practice. If a
Physician Shareholder or a Physician Employee performs abortion procedures in
any facility, ProMedCo- Temple shall not receive any ProMedCo-Temple
Distribution from the revenue generated from such procedures.
7. FINANCIAL ARRANGEMENTS
7.1 PAYMENTS TO KDCP AND PROMEDCO-TEMPLE. KDCP and ProMedCo-Temple
agree that the compensation set forth herein is being paid to ProMedCo-Temple in
consideration of a substantial commitment made by ProMedCo-Temple hereunder and
that such fees are fair and reasonable. As payment for its services rendered to
KDCP, each month ProMedCo-Temple shall be paid the amount of all Clinic Expenses
and the ProMedCo-Temple Distribution. All Net Clinic Revenues after deduction of
Clinic Expenses, and the ProMedCo-Temple Distribution, shall be referred to as
the "KDCP Distribution." In the event ProMedCo or ProMedCo-Temple shall be
obligated pursuant to the Plan and Agreement for Reorganization or other
documents related thereto to make payments to any of the Physician Employees of
KDCP and shall have failed to make such payments, the amount of such payments
not made shall be added to the KDCP Distribution until paid in full.
7.2 DISTRIBUTION. The amounts to be paid to ProMedCo-Temple under this
Section 7.2 shall be payable monthly. ProMedCo-Temple shall pay to KDCP, in
accordance with the provisions of Section 7.4, the KDCP Distribution amounts on
or about the 15th day of such following month. Some amounts may need to be
estimated, with adjustments made as necessary the following month. Any audit
adjustments would be made after completion of the fiscal year audit.
7.3 CLINIC EXPENSES. Commencing on the Effective Date, ProMedCo-Temple
shall pay all Clinic Expenses as they fall due (including without limitation the
expenses of any Non-Physician Personnel carried on the books of KDCP at the
requirement of ProMedCo-Temple), provided, however, that ProMedCo-Temple may, in
the name of and on behalf of KDCP, contest in good faith any claimed Clinic
Expenses as to which there is any dispute regarding the nature, existence or
validity of such claimed Clinic Expenses. ProMedCo-Temple hereby agrees to
indemnify and hold KDCP harmless from and against any liability, loss, damages,
claims, causes of action and reasonable expenses of KDCP resulting from the
contest of any Clinic Expenses.
7.4 ACCOUNTS RECEIVABLES. Except for the first month of this Agreement,
on approximately the 15th day of each month, ProMedCo-Temple shall purchase the
accounts receivable of KDCP arising during the previous month, by payment of
cash, or other readily available funds into an
(1)
0363293.08
080020-007 10/09/96
-12-
account of KDCP. The consideration for the purchase shall be an amount equal to
the KDCP Distribution for such previous month. Although it is the intention of
the parties that ProMedCo- Temple purchase and thereby become owner of the
accounts receivable of KDCP, in case such purchase shall be ineffective for any
reason, KDCP, as of the Effective Date of this Agreement, grants and shall cause
each KDCP Employee to grant to ProMedCo-Temple a first priority lien on and
security interest in and to any and all interest of KDCP and such KDCP Employees
in any accounts receivable generated by the medical practice of KDCP and the
KDCP Employees or otherwise generated through the operations of the Clinic, and
all proceeds with respect thereto, to secure the payment to ProMedCo-Temple of
all such accounts receivable, and this Agreement shall be deemed to be a
security agreement to the extent necessary to give effect to the foregoing. In
addition, KDCP shall cooperate with ProMedCo-Temple and execute and deliver, and
cause each KDCP Employee to execute and deliver, all necessary documents in
connection with the pledge of such accounts receivable to ProMedCo-Temple or at
ProMedCo-Temple's option, its lenders. All collections in respect of such
accounts receivable shall be deposited in a bank account at a bank designated by
ProMedCo-Temple. To the extent KDCP or any KDCP Employee comes into possession
of any payments in respect of such accounts receivable, KDCP or such KDCP
Employee shall direct such payments to ProMedCo-Temple for deposit in bank
accounts designated by ProMedCo-Temple.
8. INSURANCE AND INDEMNITY
8.1 INSURANCE TO BE MAINTAINED BY PROMEDCO-TEMPLE. Throughout the term
of this Agreement, ProMedCo-Temple will use reasonable efforts to provide and
maintain, as a Clinic Expense, comprehensive professional liability insurance
for all professional employees of ProMedCo- Temple and KDCP with limits for KDCP
Medical Professionals required by ss. 8.2 as reasonably determined by
ProMedCo-Temple in its national program, comprehensive general liability
insurance and property insurance covering the Clinic Facility and operations.
8.2 INSURANCE TO BE MAINTAINED BY KDCP. Unless otherwise determined by
the Policy Council, throughout the term of this Agreement, KDCP shall maintain
comprehensive professional liability insurance with limits of not less than
$1,000,000 per claim and with aggregate policy limits of not less than
$1,000,000 per physician with limits for specialists of not less than $3,000,000
per physician with a separate limit for KDCP. KDCP shall be responsible for all
liabilities (including without limitation deductibles and excess liabilities)
not paid within the limits of such policies. ProMedCo-Temple shall have the
option of providing such professional liability insurance through an alternative
program, provided such program meets the requirements of the Insurance Commis
sioner of the State of Texas and is approved by the Policy Council.
8.3 TAIL INSURANCE COVERAGE. KDCP will cause each individual physician
associated with the Clinic to enter into an agreement with KDCP that upon
termination of such physician's relationship with KDCP, for any reason, tail
insurance coverage will be purchased by the individual
(1)
0363293.08
080020-007 10/09/96
-13-
physician. Such provisions shall be contained in employment agreements,
restrictive covenant agreements or other agreements entered into by KDCP and the
individual physicians, and KDCP hereby covenants with ProMedCo-Temple to enforce
such provisions relating to the tail insurance coverage or to provide such
coverage at the expense of KDCP.
8.4 ADDITIONAL INSURED. KDCP and ProMedCo-Temple agree to use their
reasonable efforts to have each other named as an additional insured on the
other's respective professional liability insurance programs at
ProMedCo-Temple's expense.
8.5 INDEMNIFICATION. KDCP shall indemnify, hold harmless and defend
ProMedCo-Temple, its officers, directors and employees, from and against any and
all liability, loss, damage, claim, causes of action, and expenses (including
reasonable attorneys' fees), to the extent not covered by insurance, caused or
asserted to have been caused, directly or indirectly, by or as a result of the
performance of medical services or any other acts or omissions by KDCP and/or
its shareholders, agents, employees and/or subcontractors (other than
ProMedCo-Temple) during the term hereof, including any claim against
ProMedCo-Temple by a KDCP Employee, which claim arises out of such KDCP
Employees' employment relationship with KDCP or as a result of services
performed by such KDCP Employee, and which claim would typically be covered by
worker's compensation. ProMedCo-Temple shall indemnify, hold harmless and defend
KDCP, its officers, directors and employees, from and against any and all
liability, loss, damage, claim, causes of action, and expenses (including
reasonable attorneys' fees), to the extent not covered by insurance, caused or
asserted to have been caused, directly or indirectly, by or as a result of the
performance of any intentional acts, negligent acts or omissions by
ProMedCo-Temple and/or its shareholders, agents, employees and/or subcontractors
(other than KDCP) during the term of this Agreement.
9. RESTRICTIVE COVENANTS AND LIQUIDATED DAMAGES
The parties recognize that the services to be provided by
ProMedCo-Temple shall be feasible only if KDCP operates an active medical
practice to which the physicians associated with KDCP devote their full time and
attention. To that end:
9.1 RESTRICTIVE COVENANTS BY KDCP. During the term of this Agreement,
KDCP shall not, without the prior written consent of ProMedCo-Temple, establish,
operate or provide physician services at any medical office, clinic or other
health care facility providing services substantially similar to those provided
by KDCP pursuant to this Agreement anywhere within a radius of 30 miles of the
Clinic Facility, or within a radius of 30 miles of any current or future medical
office, clinic or other health care facility from which KDCP provides medical
services.
(1)
0363293.08
080020-007 10/09/96
-14-
9.2 RESTRICTIVE COVENANTS BY MEDICAL PROFESSIONALS. KDCP shall:
(a) Current Medical Professionals. Enforce employment agreements, in a form
satisfactory to ProMedCo-Temple, with its current Medical Professionals;
and
(b) Future Medical Professionals. Obtain and enforce formal employment
agreements from each of its future Medical Professionals in the form
attached to the Plan and Agreement for Reorganization;
pursuant to which each of the Medical Professionals agrees that unless (i) KDCP
is in default under the employment agreement or (ii) the employment of the
Medical Professional is terminated without cause, during the term of such
Medical Professional's employment agreement, and for a period of two years after
any termination of employment with KDCP, such Medical Professional will not
establish, operate or provide physician services at any medical office, clinic
or outpatient and/or ambulatory treatment or diagnostic facility providing
services substantially similar to those provided by KDCP pursuant to this
Agreement within a radius of 30 miles of the Clinic Facility or within a radius
of 30 miles of any current or future medical office, clinic or other health care
facility from which KDCP provides medical services and that ProMedCo-Temple
shall have third-party rights to enforce such agreements.
9.3 PHYSICIAN SHAREHOLDER AND PHYSICIAN EMPLOYEE LIQUIDATED DAMAGES.
(a) RELEASE FROM RESTRICTIVE COVENANTS. The restrictive covenants described in
Section 9.2 of this Agreement will provide that the Physician Shareholders
and Physician Employees (existing or future) may be released from such
restrictive covenants by paying Liquidated Damages in the amount of one
times such physician's income related to the Clinic, as reported to the
Internal Revenue Service for the previous 12 months.
(b) LIQUIDATED DAMAGES IN CERTAIN EVENTS. In addition, if a Physician
Shareholder or Physician Employee received any ProMedCo-Temple
consideration pursuant to the Plan and Agreement for Reorganization, and
said Physician Shareholder or Physician Employee terminates his or her
employment agreement with KDCP for any reason (other than death, Retirement
or Total Disability as defined in the employment agreement between such
Physician Shareholder and KDCP) prior to the fifth anniversary of the
Closing under the Plan and Agreement for Reorganization, or is terminated
with or without cause by KDCP prior to the fifth anniversary of the Closing
under the Plan and Agreement for Reorganization, then KDCP (or if the
Physician Shareholder or Physician Employee has received any of the
consideration paid to KDCP by ProMedCo-Temple under the Plan and Agreement
for Reorganiza tion, said Physician Shareholder or Physician Employee)
shall pay KDCP $300,000 in liquidated damages which amount may be paid in
cash, in ProMedCo Stock valued at $14.00, as adjusted to reflect stock
splits, stock dividends, reverse stock splits or other similar changes in
capitalization, or a combination thereof; provided however, in the event
fewer than 10% of the Physician Employees employed by KDCP as of the date
of this Agreement shall have been terminated without cause, at the time a
Physician Employee is terminated without cause, the liquidated damages
provision shall not be applicable. KDCP shall retain such payments in a
separate fund (the "Recruitment Fund") to be used first to defray all costs
incurred by KDCP or ProMedCo-Temple in the enforcement of the employment
agreement for that departing physician and second for recruiting,
relocating and funding the compensa tion for a replacement physician for
that departing physician and/or additional physicians.
9.4 ENFORCEMENT. ProMedCo-Temple and KDCP acknowledge and agree that
since a remedy at law for any breach or attempted breach of the provisions of
this Section 9 shall be inadequate, either party shall be entitled to specific
performance and injunctive or other equitable relief in case of any such breach
or attempted breach, in addition to whatever other remedies may exist by law.
All parties hereto also waive any requirement for the securing or posting of any
bond in connection with the obtaining of any such injunctive or other equitable
relief. If any provision of Section 9 relating to territory or time described
therein shall be declared by a court of competent jurisdiction to exceed the
maximum time period, scope of activity, restricted or geographical area such
court deems reasonable and enforceable under applicable law, the time period,
scope of activity, restricted and/or area of restriction deemed to be reasonable
and enforceable by the court shall thereafter be the time period, scope of
activity, restricted and/or area of restriction applicable to the restrictive
covenant provisions in this Section 9. The invalidity of non-enforceability of
this Section 9 in any respect shall not affect the validity of enforceability of
the remainder of this Section 9 or of any other provisions of this Agreement
unless the invalid or non-enforceable provisions materially affect the benefits
either party would otherwise be entitled to receive under this Section 9 or any
other provision of this Agreement.
9.5 TERMINATION OF RESTRICTIVE COVENANTS. Notwithstanding anything to
the contrary contained herein, if this Agreement is terminated pursuant to
Section 10.2 herein, the employment agreement term contained in this Section 9
shall be null and void and of no force or effect.
(1)
0363293.08
080020-007 10/09/96
-15-
10. TERM RENEWAL; TERMINATION;
10.1 TERM AND RENEWAL. The term of this Agreement shall commence on the
Effective Date hereof and shall continue for 40 years, after which it shall
automatically renew for five-year terms unless either party provides the other
party with at least 12 months but not more than 13 months written notice prior
to any renewal date.
10.2 TERMINATION BY KDCP. KDCP may terminate this Agreement as
follows:
(i) In the event of the filing of a petition in voluntary bankruptcy or an
assign ment for the benefit of creditors by ProMedCo-Temple, or upon other
action taken or suffered, voluntarily or involuntarily, under any federal
or state law for the benefit of debtors by ProMedCo-Temple, except for the
filing of a petition in involuntary bankruptcy against ProMedCo-Temple
which is dismissed within 30 days thereafter, KDCP may give notice of the
immediate termination of this Agreement.
(ii) In the event ProMedCo-Temple shall materially default in the performance of
any duty or obligation imposed upon it by this Agreement or any agreement
between ProMedCo-Temple or ProMedCo with KDC and such default shall
continue for a period of 90 days after written notice thereof has been
given to ProMedCo-Temple by KDCP; or ProMedCo-Temple shall fail to remit
the payments due as provided in Section 7.2 hereof or under other
agreements between ProMedCo-Temple or ProMedCo and KDC and such failure to
remit shall continue for a period of 30 days after written notice thereof,
KDCP may terminate this Agreement. Termination of this Agreement pursuant
to this Section 10.2(ii) by KDCP shall require the affirmative vote of 75%
of the Physician Shareholders.
(iii)In the event the ProMedCo IPO Date shall not have occurred by September
30, 2001 and ProMedCo shall not have satisfied demands from all sharehold
ers of KDCP holding ProMedCo Stock who have made demand therefor (the
"Demanding Stockholders") to repurchase such stock at a purchase price
determined by the method described in this clause (iii); this right of
termina tion shall expire 30 days after the value of the ProMedCo Stock is
determined pursuant to the following procedures or ProMedCo fails to timely
comply with such procedures: (A) Within 45 days of ProMedCo's receipt of
repurchase demands pursuant to this clause (iii) from the Demanding
Stockholders who hold a majority in interest of the ProMedCo stock held by
the Demanding Stockholders, ProMedCo shall submit to the Demanding
(1)
0363293.08
080020-007 10/09/96
-16-
Stockholders an appraisal (the "ProMedCo Appraisal") of the value its stock as
of September 30, 2001 on a per share basis (the "ProMedCo Stock Value")
made by a reputable appraiser; if the ProMedCo Appraisal is acceptable to
Demanding Stockholders holding a majority of the ProMedCo stock held by the
Demanding Stockholders, the ProMedCo Stock Value shall be as set forth in
the ProMedCo Appraisal; (B) if the Demanding Stockholders holding a
majority of the ProMedCo stock held by Demanding Stockholders, notify
ProMedCo within 14 days of receipt of the ProMedCo Appraisal that they
disagree with the ProMedCo Stock Value set forth therein, the Demanding
Stockholders shall have 30 days to submit to ProMedCo an appraisal (the
"Demanding Stockholder Appraisal") of ProMedCo Stock Value made by a
reputable appraiser selected by the Demanding Stockholders; if the Demand
ing Stockholder Appraisal is acceptable to ProMedCo, the ProMedCo Stock
Value shall be as set forth in the Demanding Stockholder Appraisal; if the
Demanding Stockholder Appraisal is not delivered to ProMedCo within 44 days
of the date the ProMedCo Appraisal is delivered to the Demanding
Stockhholders, ProMedCo Stock Value shall be as set forth in the ProMedCo
Appraisal; (C) if ProMedCo notifies the Demanding Stockholders within 14
days of its receipt of the Demanding Stockholder Appraisal that the Demand
ing Stockholder Appraisal is not acceptable, the appraisers who conducted
the ProMedCo Appraisal and the Demanding Stockholder Appraisal shall select
a third, independent appraiser who, within 30 days, shall appraise the
ProMedCo Stock to determine the ProMedCo Stock Value, and such appraisal
shall be binding on the parties.
10.3 TERMINATION BY PROMEDCO-TEMPLE. ProMedCo-Temple may terminate
this Agreement as follows:
(i) In the event of the filing of a petition in voluntary
bankruptcy or an assign ment for the benefit of
creditors by KDCP, or upon other action taken or
suffered, voluntarily or involuntarily, under any
federal or state law for the benefit of debtors by
KDCP, except for the filing of a petition in
involuntary bankruptcy against KDCP which is
dismissed within 30 days thereafter, ProMedCo-Temple
may give notice of the immediate termination of this
Agreement.
(ii) In the event KDCP shall materially default in the
performance of any duty or obligation imposed upon it
by this Agreement or in the event a majority of the
Physicians Shareholders shall materially default in
the performance of any duty or obligation imposed
upon them by this Agreement or by their employment
(1)
0363293.08
080020-007 10/09/96
-17-
agreements with KDCP, and such default shall continue
for a period of 90 days after written notice thereof
has been given to KDCP and such Physician
Shareholders by ProMedCo-Temple, ProMedCo-Temple may
terminate this Agreement.
10.4 ACTIONS AFTER TERMINATION. In the event that this Agreement shall
be terminated, the KDCP Distribution and the ProMedCo-Temple Distribution shall
be paid through the effective date of termination. In addition, the various
rights and remedies herein granted to the aggrieved party shall be cumulative
and in addition to any others such party may be entitled to by law. The exercise
of one or more rights or remedies shall not impair the right of the aggrieved
party to exercise any other right or remedy, at law. Upon termination of this
Agreement, KDCP shall:
10.4.1 ASSET REPURCHASE. Purchase from ProMedCo-Temple at book
value the intangible assets set forth on the Opening Balance Sheet, as
adjusted through the last day of the month most recently ended prior to
the date of such termination in accordance with GAAP to reflect
amortization or depreciation of the intangible assets, which
amortization shall be for a period not in excess of 40 years.
10.4.2 REAL ESTATE. Purchase from ProMedCo-Temple all real
estate, if any, associated with the Clinic and owned by ProMedCo-Temple
at the then book value thereof.
10.4.3 IMPROVEMENTS. Purchase all improvements, additions or
leasehold improvements which have been made by ProMedCo-Temple as
reflected on ProMedCo- Temple's books as of the last day of this
Agreement and which relate solely to the performance of its obligations
under this Agreement or the properties subleased by ProMedCo-Temple, if
any.
10.4.4 DEBTS. Assume or otherwise discharge all ordinary and
necessary debt, contracts, payables and leases which are obligations of
ProMedCo-Temple and which relate principally to the performance of its
obligations under this Agreement or the properties subleased by
ProMedCo-Temple, if any.
10.4.5 EQUIPMENT; INVENTORIES; ACCOUNTS RECEIVABLE; ETC.
Purchase from ProMedCo-Temple at book value as reflected on ProMedCo-
Temple's books as of the last day of this Agreement:
(i) EQUIPMENT. All of the equipment acquired by
ProMedCo-Temple pursuant to the Plan and Agreement
for Reorganization, including all replacements and
additions thereto made by ProMedCo-Temple with the
approval of the Policy Council pursuant to the
performance of its obligations under this Agreement;
(1)
0363293.08
080020-007 10/09/96
-18-
(ii) INVENTORY. All stock, including inventory and
supplies, tangibles and intangibles of ProMedCo-
Temple relating to KDCP operations;
(iii) ACCOUNTS RECEIVABLE. All uncollected accounts
receivable theretofore purchased by ProMedCo-Temple
pursuant to Section 7.4 hereof at the book
value thereof on ProMedCo-Temple's books; and
(iv) OTHER ASSETS. All other assets of ProMedCo-Temple
relating to the operations of KDCP.
10.4.6 CLOSING OF REPURCHASE. KDCP shall pay cash for the
repurchased assets or may use shares of ProMedCo no par common stock
valued at 75% of the ProMedCo IPO Price, adjusted to reflect stock
splits and the like, or if the ProMedCo IPO Date shall not have
occurred, valued at $14.00 per share. The amount of the purchase price
shall be reduced by the amount of debt and liabilities of
ProMedCo-Temple assumed by KDCP and shall be reduced by any payment
ProMedCo-Temple has failed to make under this Agreement. KDCP and any
physician associated with KDCP shall execute such documents as may be
required to assume the liabilities set forth in Section 10.4.4 and to
remove ProMedCo-Temple from any liability with respect to such
repurchased Stocks and with respect to any property leased or subleased
by ProMedCo-Temple. The closing date for the repurchase shall be
determined by KDCP, but shall in no event occur later than 180 days
from the date of the notice of termination. The termination of this
Agreement shall become effective upon the closing of the sale of the
assets and KDCP shall be released from the Restrictive Covenants
provided for in Section 9 on the closing date. From and after any
termination, each party shall provide the other party with reasonable
access to books and records then owned by it to permit such requesting
party to satisfy reporting and contractual obligations which may be
required of it.
11. DEFINITIONS
For the purposes of this Agreement, the following definitions shall
apply:
11.1 ADJUSTMENTS shall mean any adjustments to KDCP's gross ▇▇▇▇▇▇▇▇
for uncollectible accounts, discounts, PCA, Medicare and Medicaid disallowances,
workers' compensation discount, employee/dependent health care benefit programs,
professional courtesies, and other activities that do not generate a collectible
fee. Any adjustments shall be based on a reasonable historical basis or a
reasonable prospective basis should a new payor agreement apply and shall be
periodically modified during the year to reflect he annual adjustments. Final
Adjustments and any resulting payments owed by one party to the other shall be
made within 30 days after completion of the fiscal year audit.
(1)
0363293.08
080020-007 10/09/96
-19-
11.2 CLINIC shall mean the medical care services, including, but not
limited to the practice of medicine, and all related healthcare services
provided by KDCP and the KDCP Employees, utilizing the management services of
ProMedCo-Temple and the Clinic Facility, regardless of the location where such
services are rendered.
11.3 CLINIC EXPENSES shall mean the amount of all expenses incurred in
the operation of the Clinic including, without limitation:
(i) Salaries, benefits (including contributions under any ProMedCo benefit
plan), and other direct costs of all employees of ProMedCo-Temple and
Technical Employees attributable to KDCP;
(ii) Direct costs, including benefits, of all employees or consultants of
ProMedCo or affiliates of ProMedCo-Temple who, with approval of the Policy
Council, provides services at or in connection with KDCP required for
improved performance, such as work management, purchasing, information
systems, charge and coding analysis, managed care sales, negotiating and
contracting, financial analysis, and business office consultation;
provided, however, only that portion of such employee's or consultant's
costs without ▇▇▇▇-up by ProMedCo that is allocable to Clinic will be a
Clinic Expense;
(iii)Obligations of ProMedCo-Temple or ProMedCo under leases or subleases
related to Clinic operations;
(iv) Interest Expense on indebtedness incurred by ProMedCo-Temple or ProMedCo to
finance or refinance any of its obligations hereunder or services provided
hereunder, irrespective of whether such funds are provided by ProMedCo or
borrowed from outside sources with funds provided by ProMedCo; funds
borrowed from outside sources will be charged at the rate charged by the
lender and funds borrowed from ProMedCo will be charged at a floating rate
equal to the then current blended borrowing rate of ProMedCo.
(v) Personal property and intangible taxes assessed against ProMedCo-Temple's
assets used in connection with the operation of Clinic commencing on the
date of this Agreement;
(vi) All insurance expenses for insurance maintained by ProMedCo-Temple pursuant
to ss. 8.1 for ProMedCo's operations and for the KDCP Employees,
(1)
0363293.08
080020-007 10/09/96
-20-
as well as any deductibles and non-insured expenses relating to claims covered
by such insurance.
(vii)Other expenses incurred by ProMedCo-Temple in carrying out its obligations
under this Agreement, including, but not limited to, recruitment expenses
for new Physician Employees and legal and accounting expenses necessary for
the operations and expansion of KDCP; however, legal and accounting
expenses required by KDCP for its corporate needs not requested by ProMedCo
or ProMedCo-Temple shall be excluded.
(viii) Amortization of intangible asset value resulting from the employment of,
merger with, or other acquisition of, additional physicians in the KDCP
service area approved by the Policy Council.
(ix) Pagers for Physician Employees.
11.4 CLINIC EXPENSES SHALL NOT INCLUDE:
(i) Corporate overhead charges or any other expenses of ProMedCo or any
corporation affiliated with ProMedCo other than the kind of items listed
above;
(ii) Any federal or state income taxes;
(iii)Any expenses which are expressly designated herein as expenses or
responsibilities of KDCP and/or KDCP Employees other than Technical
Employees;
(iv) Any amortization or depreciation expense resulting from the amortization or
depreciation expenses incurred as shown on ProMedCo's financial state
ments, in connection with the acquisition and execution of the Plan and
Agreement for Reorganization and the execution of this Agreement or any
depreciation expenses associated with acquisition of physicians as set
forth in ss. 11.3(viii) hereof;
(v) Any on-going expenses relating to the obligations listed in Exhibit A to
this Agreement assumed by ProMedCo-Temple pursuant to the Plan and
Agreement for Reorganization.
(1)
0363293.08
080020-007 10/09/96
-21-
(vi) Any debt service or interest expense on indebtedness incurred by ProMedCo-
Temple or ProMedCo to finance the consideration paid under the Plan and
Agreement for Reorganization;
(vii)Any liabilities, judgments or settlements assessed against KDCP or
Physician Shareholders in excess of any insurance policy limits.
11.5 CLINIC FACILITY shall mean the clinic facilities located at ▇▇▇▇ ▇.▇.
H. K. ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇, and the clinic facilities located at (i)
Neurology & Headache Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇
▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇, (ii) Dermatology Center of King's
Daughters Clinics, ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇,
(iii) Womens Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇ ▇▇▇▇,
▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ (iv) Killeen Clinic, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇
▇▇▇▇▇ and (v) Belton Family Practice Clinic, ▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇., ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇
and (vi) any substitute facility or additional facility location, whether within
or without ▇▇▇▇▇▇▇, Lampasas, Burnet, Williamson, Milam or Falls Counties, Texas
as approved by the Policy Council.
11.6 DISTRIBUTION FUNDS shall mean those amounts remaining after Clinic
Expenses have been deducted from Net Clinic Revenue.
11.7 EFFECTIVE DATE shall mean 12:01 a.m. on September 1, 1996.
11.8 KDCP CAPITATION shall mean any capitation payments received by
KDCP from any HMO or other managed care payor for health care services provided
by KDCP.
11.9 KDCP EMPLOYEES shall mean all Medical Professionals and Technical
Employees employed by KDCP at the relevant dates.
11.18 RETIREMENT means total permanent withdrawal from the practice of
medicine to pursue activities not related in any way to the provision of health
care services.
11.10 MEDICAL PROFESSIONAL shall mean Physician Shareholders, Physician
Employees and Physician Extenders.
11.11 NET CLINIC REVENUES shall mean KDCP's gross ▇▇▇▇▇▇▇▇, including
Risk Pool Surpluses, ancillaries and any other revenues that have historically
been recorded by KDCP, less Adjustments.
11.12 OPENING BALANCE SHEET shall mean the balance sheet of
ProMedCo-Temple as of the Effective Date (as defined in the Plan and Agreement
for Reorganization), prepared in accordance with GAAP (except for the absence of
certain note information), and substantially in the form of the attached Exhibit
B subject to adjustments in the Consideration (as defined in the Plan and
Agreement for Reorganization).
(1)
0363293.08
080020-007 10/09/96
-22-
11.13 PHYSICIAN EMPLOYEES shall mean any physician employed by KDCP and
providing medical services to patients on behalf of KDCP, who are not Physician
Shareholders.
11.14 PHYSICIAN EXTENDERS shall mean all non-physician professional
employees who provide direct patient care for which a billed charge is
generated.
11.15 PHYSICIAN SHAREHOLDERS shall mean any physician who is a
shareholder of KDCP, both as of the date of this Agreement (which said Physician
Shareholders are parties to this Agreement) and at any future point in time.
11.16 PLAN AND AGREEMENT FOR REORGANIZATION shall mean the Plan and
Agreement for Reorganization dated as of September 13, 1996 between King's
Daughters Clinics, P.A., a Texas corporation ("KDC") the shareholders of which
are the same as KDCP, ProMedCo and ProMedCo- Temple.
11.17 PROMEDCO shall mean ProMedCo, Inc., a Texas corporation which is
sole shareholder of ProMedCo-Temple.
11.18 PROMEDCO IPO DATE shall mean the date on which ProMedCo first
sells stock to the public pursuant to its initial public offering.
11.19 PROMEDCO IPO PRICE shall mean the price per share at which
ProMedCo offers ProMedCo Stock to the public at its initial public offering.
11.20 PROMEDCO-TEMPLE DISTRIBUTION shall mean 15% of Distribution
Funds.
11.21 RISK POOL SURPLUSES shall mean all hospital incentive funds,
specialists incentive funds, and funds from shared risk pools under any
risk-sharing arrangements. Risk Pool Surpluses shall be calculated by
aggregating all risk pools applicable, including making any deductions for pools
that are in a deficit position.
11.22 TECHNICAL EMPLOYEES shall mean technicians who provide services
in the diagnostic areas of KDCP's practice, such as employees of the Clinic
laboratory, radiology technicians and cardiology technicians. All Technical
Employees shall be KDCP employees.
12. GENERAL PROVISIONS
12.1 INDEPENDENT CONTRACTOR. It is acknowledged and agreed that KDCP and
ProMedCo- Temple are at all times acting and performing hereunder as independent
contractors. ProMedCo- Temple shall neither have nor exercise any control or
direction over the methods by which KDCP or
(1)
0363293.08
080020-007 10/09/96
-23-
the KDCP Employees practice medicine. The sole function of ProMedCo-Temple
hereunder is to provide all management services in a competent, efficient and
satisfactory manner. ProMedCo- Temple shall not, by entering into and performing
its obligations under this Agreement, become liable for any of the existing
obligations, liabilities or debts of KDCP unless otherwise specifically provided
for under the terms of this Agreement. ProMedCo-Temple will in its management
role have only an obligation to exercise reasonable care in the performance of
the management services. Neither party shall have any liability whatsoever for
damages suffered on account of the willful misconduct or negligence of any
employee, agent or independent contractor of the other party. Each party shall
be solely responsible for compliance with all state and federal laws pertaining
to employment taxes, income withholding, unemployment compensation contributions
and other employment related statutes regarding their respective employees,
agents and servants.
12.2 OTHER CONTRACTUAL ARRANGEMENT.
(a) The parties acknowledge and agree that they have been advised and consent
to the fact that ProMedCo-Temple, or its affiliates (i) may have, prior to
the date of this Agreement, discussed proposals with respect to, or (ii)
may, from time to time hereafter, enter into agreements with one or more
KDCP Employees to provide consulting, medical direction, advisory or
similar services relating to activities of ProMedCo-Temple or its
affiliates in clinical areas. The parties agree that such agreements, if
any, shall be entered into at the sole discretion of the parties thereto
and subject to such terms and conditions to which such parties may agree,
and any compensation payable to or by ProMedCo-Temple, on the one hand, and
such KDCP Employees, on the other hand, shall not constitute Net Clinic
Revenues, or KDCP Compensation, and shall otherwise not be subject to the
provisions of this Agreement.
(b) Each current Physician Shareholder, by his execution of this Agreement as
provided on the signature page hereof, agrees that neither the negotiation
nor the entry into any agreement or arrangement of a type described in
Section 12.2(a) above shall constitute a breach of any fiduciary or other
duty owned by any KDCP Employee to another, or by ProMedCo-Temple, to KDCP
or any Physician Shareholder. Accordingly, KDCP and each Physician
Shareholder hereby waive any right to disclosure of the negotiations,
proposals or terms of any such agreement, arrangement or right to
participate in and/or share revenues derived from any such agreement or
arrangement with any KDCP Employee, and hereby forever release and
discharge KDCP, the Physician Shareholders, ProMedCo-Temple, and their
respective representatives (including, but not limited to, their respective
attorneys, accountants, affiliates, shareholders, officer, directors,
employees and agents) from any and all actions, claims, charges, suits,
damages and liabilities of any kind whatsoever arising from or by reason of
the participation of any KDCP Employee in any agreement or
(1)
0363293.08
080020-007 10/09/96
-24-
arrangement with ProMedCo-Temple, or their affiliates of a type described in
Section 12.2(a) above or from or by reason of the failure of
ProMedCo-Temple, any KDCP Employee or their respective representatives to
disclose the negotiation, existence or terms of any such agreement or
arrangement. In keeping with the private nature of these matters, the
Physician Shareholders further agree that such negotiations, proposals or
terms of agreement are to be kept confidential between a KDCP Employee on
the one hand, and ProMedCo-Temple, on the other hand, and shall not be
disclosed by them or their representatives, except as required by
applicable law.
12.3 PROPRIETARY PROPERTY.
12.3.1 Each party agrees that the other party's proprietary
property shall not be possessed, used or disclosed otherwise than may
be necessary for the performance of this Agreement. Each party
acknowledges that its violation of this Agreement would cause the other
party irreparable harm, and may (without limiting the other party's
remedies for such breach) be enjoined at the instance of the other
party. Each party agrees that upon termination of this Agreement for
any reason, absent the prior written consent of the other party, it
shall have no right to and shall cease all use of the other party's
proprietary property, and shall return all such proprietary property of
the other party in its possession to the other party.
12.3.2 ProMedCo-Temple shall be the sole owner and holder of
all right, title and interest, to all intellectual property furnished
by it under this Agreement, including, but not limited to the trade
name "ProMedCo," all computer software, copyright, services ▇▇▇▇ and
trademark right to any material or documents acquired, prepared,
purchased or furnished by ProMedCo-Temple pursuant to this Agreement.
KDCP shall have no right, title or interest in or to such material and
shall not, in any manner, distribute or use the same without the prior
written authorization of ProMedCo-Temple, provided, however, that the
foregoing shall not restrict KDCP from distributing managed care
information brochures and materials without the prior written approval
of ProMedCo-Temple provided no Proprietary Property of ProMedCo-Temple
is contained therein. Notwithstanding the preceding, however,
ProMedCo-Temple agrees that KDCP shall be entitled to use on a
nonexclusive and nontransferable basis for the term of this Agreement
the name "KDCP Family Practice" as may be necessary or appropriate in
the performance of KDCP's services and obligations hereunder.
12.4 COOPERATION. Each of the parties shall cooperate fully with the
other in connection with the performance of their respective duties and
obligations under this Agreement.
(1)
0363293.08
080020-007 10/09/96
-25-
12.5 LICENSES, PERMITS AND CERTIFICATES. ProMedCo-Temple and KDCP shall
each obtain and maintain in effect, during the term of this Agreement, all
licenses, permits and certificates required by law which are applicable to their
respective performance pursuant to this Agreement.
12.6 COMPLIANCE WITH RULES, REGULATIONS AND LAWS. ProMedCo-Temple and
KDCP shall comply with all federal and state laws and regulations in performance
of their duties and obligations hereunder. Neither party, nor their employees or
agents, shall take any action that would jeopardize the other party's
participation, if applicable, in any federal or state health program including
Medicare and Medicaid. ProMedCo-Temple and KDCP shall take particular care to
ensure that no employee or agent of either party takes any action intended to
violate Section 1128B of the Social Security Act with respect to soliciting,
receiving, offering or paying any remuneration (including any kickback, bribe,
or rebate) directly or indirectly, overtly or covertly, in cash or in kind in
return for referring an individual to a person for the furnishing or arranging
for the furnishing of any item or service for which payment may be made in whole
or in part under Title XVIII or XIX of the Social Security Act, or for
purchasing, leasing, ordering, or arranging for or recommending purchasing,
leasing, or ordering any good, facility, service, or item for which payment may
be made in whole or in part under Title XVIII or XIX of the Social Security Act.
12.7 GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP). All financial
statements and calculations contemplated by this Agreement will be prepared or
made in accordance with generally accepted accounting principles consistently
applied unless the parties agree otherwise in writing.
12.8 NOTICES. Any notices required or permitted to be given hereunder
by either party to the other may be given by personal delivery in writing or by
registered or certified mail, postage prepaid, with return receipt requested.
Notices shall be addressed to the parties at the addresses appearing on the
signature page of the Agreement, but each party may change such party's address
by written notice given in accordance with this Section. Notices delivered
personally will be deemed communicated as of actual receipt; mailed notices will
be deemed communicated as of three days after mailing.
12.9 ATTORNEYS' FEES. ProMedCo-Temple and KDCP agree that the
prevailing party in any legal dispute among the parties hereto shall be entitled
to payment of its attorneys' fees by the other party.
12.10 SEVERABILITY. If any provision of this Agreement is held by a
court of competent jurisdiction or applicable state or federal law and their
implementing regulations to be invalid, void or unenforceable, the remaining
provisions will nevertheless continue in full force and effect.
12.11 ARBITRATION. Any controversy or claim arising out of or relating to
this Agreement or the breach thereof will be settled by binding arbitration in
accordance with the rules of commercial
(1)
0363293.08
080020-007 10/09/96
-26-
arbitration of the American Arbitration Association, and judgment upon the award
rendered by the arbitrator(s) may be entered in any court having jurisdiction
thereof. Such arbitration shall occur within ▇▇▇▇ County, Texas, unless the
parties mutually agree to have such proceedings in some other locale. The
arbitrator(s) may in any such proceeding award attorneys' fees and costs to the
prevailing party.
12.12 CONSTRUCTION OF AGREEMENT. This Agreement shall be governed by
and construed in accordance with the laws of the State of Texas. The parties
agree that the terms and provisions of this Agreement embody their mutual
interest and agreement and that they are not to be construed more liberally in
favor of, nor more strictly against, any party hereto.
12.13 ASSIGNMENT AND DELEGATION. ProMedCo-Temple shall have the right
to assign its rights hereunder to any person, firm or corporation controlling,
controlled by or under common control with ProMedCo-Temple and to any lending
institution, for security purposes or as collateral, from which ProMedCo-Temple
or ProMedCo obtains financing for itself and as agent. Except as set forth
above, neither ProMedCo-Temple nor KDCP shall have the right to assign their
respective rights and obligations hereunder without the written consent of the
other party. KDCP may not delegate any of KDCP's duties hereunder, except as
expressly contemplated herein; however, ProMedCo-Temple may delegate some or all
of ProMedCo-Temple' s duties hereunder to the extent it concludes, in its sole
discretion, that such delegation is in the mutual interest of the parties
hereto.
12.14 CONFIDENTIALITY. The terms of this Agreement and in particular
the provisions regarding compensation, are confidential and shall not be
disclosed except as necessary to the performance of this Agreement or as
required by law.
12.15 WAIVER. The waiver of any provision, or of the breach of any
provision of this Agreement must be set forth specifically in writing and signed
by the waiving party. Any such waiver shall not operate or be deemed to be a
waiver of any prior or future breach of such provision or of any other
provision.
12.16 HEADINGS. The subject headings of the articles and sections of
this Agreement are included for purposes of convenience only and shall not
affect the construction or interpretation of any of its provisions.
12.17 NO THIRD PARTY BENEFICIARIES. Nothing in this Agreement, express
or implied, is intended or shall be construed to confer upon any person, firm or
corporation other than the parties hereto and their respective successors or
assigns, any remedy or claim under or by reason of this Agreement or any term,
covenant or condition hereof, as third party beneficiaries or otherwise, and all
of the terms, covenants and conditions hereof shall be for the sole and
exclusive benefit of the parties hereto and their successors and assigns.
(1)
0363293.08
080020-007 10/09/96
-27-
12.18 TIME IS OF THE ESSENCE. Time is hereby expressly declared to be of
the essence in this Agreement.
12.19 MODIFICATIONS OF AGREEMENT FOR PROSPECTIVE LEGAL EVENTS. In the
event any state or federal laws or regulations, now existing or enacted or
promulgated after the effective date of this Agreement, are interpreted by
judicial decision, a regulatory agency or legal counsel for both parties in such
a manner as to indicate that the structure of this Agreement may be in violation
of such laws or regulations, or in the event the Texas State Board of Medical
Examiners or other authority with legal jurisdiction shall, solely by virtue of
this Agreement, initiate an action to revoke, suspend, or restrict the license
of any physician retained by KDCP to practice medicine in the State of Texas,
KDCP and ProMedCo-Temple shall amend this Agreement as necessary. To the maximum
extent possible, any such amendment shall preserve the underlying economic and
financial arrangements between KDCP and ProMedCo-Temple. In the event it is not
possible to amend this Agreement to preserve in all material respects the
underlying economic and financial arrangements between KDCP and ProMedCo-Temple,
this Agreement may be terminated by written notice by either party within 90
days from date of such interpretation or action, termination to be effective no
sooner than the earlier of 180 days from the date notice of termination is given
or the latest possible date specified for such termination in any regulatory
order or notice. Termination pursuant to this Section 12.19 by KDCP shall
require the affirmative vote of a majority of Physician Shareholders.
12.20 NO RIGHT OF OFF-SET. Notwithstanding any provision of this
Agreement to the contrary, neither ProMedCo-Temple nor ProMedCo shall have any
right of off-set with respect to payments to be made to such Physician Employee
hereunder arising out of obligations of such Physician Employees under the Plan
and Agreement for Reorganization and related agreements.
12.21 WHOLE AGREEMENT; MODIFICATION. A contract in which the amount
involved exceeds $50,000 in value is not enforceable unless the Agreement is in
writing and signed by the party to be bound or by that party's authorized
representative. The rights and obligations of the parties hereto shall be
determined solely from written agreements. Documents and instruments, and any
prior oral agreements between the parties are superseded by and merged into such
writings. This Agreement (As amended in writing from time to time), the
exhibits, and the schedules delivered pursuant hereto
(1)
0363293.08
080020-007 10/09/96
-28-
represent the final agreement between the parties hereto and may not be
contradicted by evidence of prior, contemporaneous, or subsequent oral
agreements by the parties. There are no unwritten oral agreements between the
parties.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as
of the date and year first above written.
PROMEDCO OF TEMPLE, INC.
By:
Name:
Title:
Address: ▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇ ▇▇▇▇
▇▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
PHYSICIANS OF KING'S DAUGHTERS, P.A.
By:
Name:
Title:
Address: ▇▇▇▇ ▇.▇. ▇. ▇. ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇
(1)
0363293.08
080020-007 10/09/96
-29-
Acknowledgment and Agreement by Physician Shareholders
to abide by the terms of the Service Agreement
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇, M.D.
▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
▇▇▇ ▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇, M.D.
▇▇▇▇ ▇▇▇▇▇▇, M.D.
Gopal Guttickonda, M.D.
▇▇▇▇▇▇ ▇▇▇, M.D.
▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇ ▇▇▇▇▇▇▇, D.O.
▇▇▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇, ▇▇., M.D.
(1)
0363293.08
080020-007 10/09/96
-▇▇-
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇.▇.▇.
▇▇▇▇▇▇▇ ▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇., M.D.
▇▇▇▇▇▇ ▇▇▇▇▇▇▇, III, M.D.
▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇▇ ▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
▇▇▇▇ ▇▇▇▇▇▇▇, D.O.
(1)
0363293.08
080020-007 10/09/96
-31-
▇▇▇▇ ▇▇▇▇▇▇, M.D.
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇, M.D.
▇▇▇▇▇ ▇▇▇▇, M.D.
(1)
0363293.08
080020-007 10/09/96
-32-
GUARANTY
ProMedCo, Inc., a Texas corporation which is the sole shareholder of
ProMedCo of Temple, Inc., a Delaware corporation ("ProMedCo-Temple"), hereby
guarantees the performance of ProMedCo-Temple under the above Service Agreement.
PROMEDCO, INC.
By
Its
Name
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 2.9B-1
FORM OF SHAREHOLDER PHYSICIAN EMPLOYMENT AGREEMENT
[To be drafted by ▇▇. ▇▇▇▇▇▇▇]
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 2.9B-2
FORM OF NON-SHAREHOLDER PHYSICIAN EMPLOYMENT AGREEMENT
[To be drafted by ▇▇. ▇▇▇▇▇▇▇]
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 2.9D
PROPERTIES TO BE LEASED BY PROMEDCO-TEMPLE FROM TEMPLE
AND RELATED ENTITIES
(i) ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ (from Temple)
(ii) Neurology & Headache Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K.
▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ (from Temple Medical Center)
(iii)Dermatology Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇
▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ (from Temple Medical Center)
(iv) Womens Center of King's Daughters Clinics, ▇▇▇▇ ▇.▇. H. K. ▇▇▇▇▇▇ ▇▇▇▇,
▇▇▇▇▇ ▇▇▇, ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇ (from Temple Medical Center)
(v) Killeen Clinic, ▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (from Temple)
(vi) Belton Family Practice Clinic, ▇▇▇▇ ▇. ▇▇▇▇▇ ▇▇., ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (from
Temple)
(1)
0363293.08
080020-007 10/09/96
-2-
APPENDIX 7.2
OPINION OF COUNSEL TO PROMEDCO AND PROMEDCO-TEMPLE
The Closing opinion of Boult, Cummings, ▇▇▇▇▇▇▇ & ▇▇▇▇▇, PLC, special
counsel to ProMedCo and ProMedCo-Temple which is called for by ss. 7.2 of the
Agreement, shall be dated the Closing Date and shall be to the following effect:
[Letterhead of Boult, Cummings, ▇▇▇▇▇▇▇ & ▇▇▇▇▇, PLC]1
[Closing Date]
King's Daughters Clinics, P.A.
[Address]
Ladies and Gentlemen:
We have acted as counsel to ProMedCo of Temple, Inc., a Delaware
corporation ("ProMedCo-Temple"), and ProMedCo, Inc., a Texas corporation
("ProMedCo") in connection with the preparation of the Plan and Agreement for
Reorganization dated as of September 13, 1996 (the "Acquisition Agreement"), and
the Undertaking, between ProMedCo-Temple and King's Daughters Clinics, P.A.
("KDC") and the guaranty at the foot of the Undertaking executed by ProMedCo
(the "ProMedCo Guaranties") and have participated on behalf of ProMedCo-Temple
and ProMedCo in connection with the purchase by ProMedCo-Temple of certain
assets from KDC. The Acquisition Agreement and Undertaking are collectively
referred to herein as the "Acquisition Documents". This Opinion Letter is
provided to you at the request of ProMedCo-Temple pursuant to
--------
1Draft only; subject to internal firm review.
(1)
0363293.08
080020-007 10/09/96
-3-
Section 7.2 of the Acquisition Agreement. Except as otherwise indicated herein,
capitalized terms used in this Opinion Letter are defined as set forth in the
Acquisition Agreement or the Accord (see below).
This Opinion Letter is governed by, and shall be interpreted in
accordance with, the Legal Opinion Accord (the "Accord") of the ABA Section of
Business Law (1991). As a consequence, it is subject to a number of
qualifications, exceptions, definitions, limitations on coverage and other
limitations, all as more particularly described in the Accord, and this Opinion
Letter should be read in conjunction therewith. The attorneys in this firm are
licensed to practice law in the State of Tennessee and consequently the law
covered by the opinions expressed herein is limited to the Federal Law of the
United States, the corporate law of the States of Texas and Delaware and in
reliance on public documents issued by the States of Texas and Delaware and
certificates of officers of ProMedCo and ProMedCo-Temple.
We have relied upon factual representations made by ProMedCo- Temple in
Article 3 of the Acquisition Agreement.
Based upon the foregoing and subject to the foregoing, we are of the
opinion that:
1. The Acquisition Documents are enforceable against
ProMedCo-Temple.
2. The ProMedCo Guaranties are enforceable against ProMedCo.
3. The ProMedCo Stock has been duly authorized, validly
issued and is non-assessable.
4. Execution and delivery by ProMedCo-Temple of, and performance of its
agreements in, the Acquisition Documents and the execution and delivery by
ProMedCo of, and performance of its agreements in, ProMedCo Guaranties, do not
(i) violate the Constituent Documents, (ii) breach, or result in a default
under, any existing obligation of ProMedCo-Temple or ProMedCo under contracts
dealing with money borrowed by either such corporation
(1)
0363293.08
080020-007 10/09/96
-4-
known to us, or (iii) breach or otherwise violate any existing obligation of
ProMedCo-Temple or ProMedCo under Court Orders identified in Article 4 of the
Acquisition Agreement and the Schedules pertaining thereto.
5. Execution and delivery by ProMedCo-Temple and ProMedCo of, and
performance by each such corporation of its agreements in, the Acquisition
Documents and ProMedCo Guaranties, as the case may be, do not violate applicable
provisions of statutory law or regulation.
The General Qualifications apply to the opinions set forth above.
This Opinion Letter may be relied upon by you only in connection with
the transaction and may not be used or relied upon by you or any other person
for any purpose whatsoever, except to the extent authorized in the Accord,
without in each instance, our prior written consent.
Very truly yours,
BOULT, CUMMINGS, ▇▇▇▇▇▇▇ & ▇▇▇▇▇, PLC
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 8.3
OPINION OF COUNSEL TO KDC
The Closing opinion of Messrs. ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇, counsel to KDC, Temple
and KDCP which is called for by ss. 8.3 of the Agreement, shall be dated the
Closing Date and shall be to the effect that:
1. KDC is a corporation, duly organized, validly existing and in good
standing under the laws of the State of Texas, with full corporate power to
carry on its business as it is then being conducted, and to enter into this
Agreement and to carry out the transactions contemplated hereby; and KDC is duly
qualified and in good standing in each other jurisdiction in which the character
of the properties owned by it or the nature of the activities conducted by it
make such qualification necessary, except in a jurisdiction or jurisdictions in
which failure to qualify will not adversely affect each such entity's ability to
derive income from, or enforce its right in, any property located therein and,
considering all such jurisdictions, will not have any material adverse effect,
in the aggregate, on KDC.
2. The authorized capital stock of KDC consists of 1,000,000 shares of
common stock, $1.00 par value, of which 3,100 shares were issued and outstanding
as of the record date for determining the stockholders of KDC entitled to vote
at the meeting of KDC stockholders called to vote upon the sale of assets
contemplated by the Plan and Agreement for Reorganization.
3. The execution, delivery and performance of the Plan and Agreement
for Reorganization and the Service Agreement have been duly authorized and
approved by all requisite action of KDC's Board of Directors and stockholders,
and neither the execution, delivery, nor performance of the Plan and Agreement
for Reorganization by KDC violates any provision of its Articles of
Incorporation or by-laws, or the provisions of any indenture, agreement or other
instrument
(1)
0363293.08
080020-007 10/09/96
-2-
to which KDC is a party, and the Plan and Agreement for Reorganiza tion has been
duly authorized, executed and delivered by KDC and constitute the valid and
binding obligation of KDC, enforceable against KDC in accordance with its terms
(except as enforceability may be restricted, limited, or delayed by bankruptcy,
insolvency, moratorium or similar laws affecting or relating to the enforcement
of creditors' rights in general and except as the enforceability of any
provision of the Plan and Agreement for Reorganization is subject to general
principles of equity, regardless of whether enforceability is considered in a
proceeding at law or in equity).
4. All other actions and proceedings required by law or the Plan and
Agreement for Reorganization to be taken by KDC at or prior to the Closing
hereunder in connection with this Agreement and the transactions provided for
herein have been duly and validly taken.
5. Except as disclosed in Exhibit 3.16, such counsel does not know of
any litigation, administrative, arbitration, other proceeding, or governmental,
regulatory or accrediting agency investigation, pending or threatened against,
or relating to, KDC or its subsidiaries or the properties or business thereof or
the transactions contemplated by this Agreement.
6. Except as referred to in this Agreement or as stated in such
opinion, none of the indentures, agreements or other instru ments specified
pursuant to clause (c) above creates any mortgages, pledges, liens, charges, or
other encumbrances upon any of the real or personal property of KDC or its
subsidiaries.
7. KDC has complete and unrestricted power and the unquali fied right
to sell, assign, transfer and deliver the Assets to ProMedCo-Temple, and upon
consummation of the transfer, ProMedCo- Temple will have valid, good and
marketable title to the Assets.
8. No facts have come to the attention of such counsel which would lead
it to believe that any representation or warranty of KDC contained in the Plan
and Agreement for Reorganization or any Exhibit thereto is incorrect.
(1)
0363293.08
080020-007 10/09/96
-3-
9. The execution, delivery and performance of the Service Agreement by
KDCP has been duly authorized and approved by all requisite action of KDCP's
Board of Directors and stockholders, and neither the execution, delivery, nor
performance of the Service Agreement by KDCP violates any provision of its
Articles of Incorporation or by-laws, or the provisions of any indenture,
agreement or other instrument to which KDCP is a party, and Service Agreement
has each been duly authorized, executed and delivered by KDCP and constitutes
the valid and binding obligations of KDCP, enforceable against KDCP in
accordance with its terms (except as enforceability may be restricted, limited,
or delayed by bankrupt cy, insolvency, moratorium or similar laws affecting or
relating to the enforcement of creditors' rights in general and except as the
enforceability of any provision of Service Agreement is subject to general
principles of equity, regardless of whether enforceability is considered in a
proceeding at law or in equity).
10. The relationships created by the Service Agreement and the
Employment Agreements will not result in the unauthorized practice of medicine
by ProMedCo-Temple.
11. The UCC-1 financing statements in connection with the sale of
Accounts Receivable by KDCP to ProMedCo-Temple have been filed in all places
necessary to create a security interest in such Accounts Receivable in favor of
ProMedCo-Temple.
12. The Employment Agreements have been duly executed and delivered by
the Employee parties thereto and each Employment Agreement constitutes the valid
and binding obligation of such Employee enforceable against such Employee in
accordance with its terms (except as enforceability may be restricted, limited,
or delayed by bankruptcy, insolvency, moratorium or similar laws affecting or
relating to the enforcement of creditors' rights in general and except as the
enforceability of any provision of such Employment Agreement is subject to
general principles of equity, regardless of whether enforceability is considered
in a proceeding at law or in equity).
13. The execution, delivery and performance of the ▇▇▇▇ of
Sale and Assignment by Temple relating to the assets it is
(1)
0363293.08
080020-007 10/09/96
-4-
conveying to ProMedCo-Temple has been duly authorized and approved by all
requisite action of Temple's Board of Directors and stockholders, and neither
the execution, delivery, nor performance of such ▇▇▇▇ of Sale by Temple violates
any provision of its Articles of Organization or the provisions of any
indenture, agreement or other instrument to which Temple is a party, and such
▇▇▇▇ of Sale has each been duly authorized, executed and delivered by Temple and
constitutes the valid and binding obligations of Temple, enforceable against
Temple in accordance with its terms (except as enforceability may be restricted,
limited, or delayed by bankruptcy, insolvency, moratorium or similar laws
affecting or relating to the enforcement of creditors' rights in general and
except as the enforceability of any provision of such ▇▇▇▇ of sale is subject to
general principles of equity, regardless of whether enforceability is considered
in a proceeding at law or in equity).
14. Such other legal matters as ProMedCo-Temple may reason
ably request.
Such opinion may state that such counsel has relied, as to matters of
fact, upon certificates of officers of KDC(unless they have reason to believe
that such certificate or certificates are inaccurate), as to matters governed by
the laws of any jurisdiction other than Texas upon the opinion of local counsel
satisfactory to and ProMedCo-Temple and as to matters of incorporation, good
standing, accreditation, and the existence or status of licenses,
authorizations, approvals or related matters upon certificates from the agency
or entity having jurisdiction over such matters; provided, however, that a copy
of all such certificates and opinions shall have been furnished to
ProMedCo-Temple prior to Closing or be attached to such counsel's opinion.
(1)
0363293.08
080020-007 10/09/96
-1-
APPENDIX 8.5
FORM OF STOCK AGREEMENT
PROMEDCO, INC.
STOCK AGREEMENT
STOCK AGREEMENT (the "Agreement") is made as of this __th day of
September, 1996 between ______________________________ ("Stockholder") and
PROMEDCO, INC., a Texas corporation, ("ProMedCo").
RECITALS:
Stockholder is a shareholder of King's Daughters Clinics, P.A., a Texas
Professional Association ("KDC") with has entered into a Plan and Agreement for
Reorganization dated as of September 13, 1996 (the "Plan and Agreement for
Reorganization") with ProMedCo of Temple, Inc., a Delaware corporation
("ProMedCo-Temple which is a wholly owned subsidiary of ProMedCo. Pursuant to
the Plan and Agreement for Reorganization, KDC has transferred, and ProMedCo-
Temple has acquired, certain assets, and as a condition of which Stockholder has
received or will receive as part of the liquidation distribution from KDC shares
of ProMedCo common stock (such shares, as adjusted in accordance with the terms
of the Plan and Agreement for Reorganization, herein referred to as the
"Shares").
Stockholder and ProMedCo desire to restrict the transfer of the Shares
according to the terms and conditions hereafter stated. All capitalized terms
used in this Agreement not otherwise defined herein shall have the meanings as
assigned to them in the Plan and Agreement for Reorganization.
The parties agree as follows:
(1)
0363293.08
080020-007 10/09/96
-2-
ARTICLE 1
REPRESENTATIONS AND ACKNOWLEDGMENTS BY STOCKHOLDER
1.1. Experience in Business and Financial Matters. Stockholder
represents and warrants that Stockholder has such knowledge and experience in
business and financial matters, or competent professional advice concerning
ProMedCo, that Stockholder is capable of evaluating the merits and risks of
owning the Shares.
1.2. Information regarding ProMedCo. Stockholder acknowledges that
Stockholder has had and continues to have the opportunity to obtain from
ProMedCo any additional information, to the extent possessed or obtainable
without unreasonable effort and expense, necessary to evaluate the merits and
risks of owning the Shares and Stockholder has concluded, based on the
information presented to Stockholder, Stockholder's own understanding of
investments of this nature and of this investment in particular, and the advice
of such consultants as Stockholder has deemed appropriate, that Stockholder
wishes to own the Shares.
1.3. Unregistered Stock. Stockholder acknowledges that the Shares being
acquired have not been registered under the Securities Act of 1933, or under the
Blue Sky or other securities laws of certain states, and, therefore, that
Stockholder must bear the economic risk of the investment for an indefinite
period of time, as the Shares cannot be sold or offered for sale unless the
Shares are subsequently so registered or an exemption from registration is
available. Stockholder also understands that there is no market for the resale
of the Shares and that there is no certainty that a market will develop.
1.4. Securities Legend. Stockholder understands that any document
evidencing the Shares will bear a restrictive legend in substantially the
following form:
THESE SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933,
AS AMENDED ("THE SECURITIES ACT"), OR ANY APPLICA BLE STATE SECURITIES
LAW. THESE SECURITIES HAVE BEEN AC QUIRED FOR INVESTMENT AND NOT WITH A
VIEW TO OR FOR RESALE IN CONNECTION WITH THE DISTRIBUTION THEREOF. NO
DISPOSITION OF THESE SECURITIES MAY BE MADE IN THE ABSENCE OF (i) AN
EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT; OR (ii) AN
OPINION OF COUNSEL ACCEPTABLE TO THE CORPORATION THAT SUCH DISPOSITION
WITHOUT REGISTRATION IS IN COMPLIANCE WITH THE SECURITIES ACT.
(1)
0363293.08
080020-007 10/09/96
-3-
Stockholder also understands that the records of ProMedCo will indicate
the restrictions on transferability and sale noted above in this Section 1.4 and
stop transfer instructions have been or will be placed with respect to the
Shares so as to restrict the transfer thereof. Stockholder agrees not to dispose
of any of the Shares unless ProMedCo receives a satisfactory opinion of counsel
that the Shares can be transferred without violation of the registration
requirements of the Securities Act and the rules and regulations of the
Securities and Exchange Commission, and any applicable state securities laws or
regulations, or ProMedCo receives evidence satisfactory to it that the Shares
have been validly registered under the Securities Act and any applicable state
securities laws. Stockholder understands that the Shares may be transferred only
in accordance with Article 2 of this Agreement. Stockholder also understands
that any document evidencing the Shares will bear a restrictive legend
prohibiting transfer other than in accordance with this Agreement.
1.5. Investment Intent. Stockholder is acquiring the Shares solely for
investment for his or her own account; Stockholder has no present agreement,
understanding, intent or arrangement to subdivide, sell, assign or transfer any
part or all of his Shares, or any interest therein, to any other person.
Stockholder has sufficient and adequate means to provide for his or her current
needs and personal contingencies and has no need for liquidity with respect to
an investment in ProMedCo.
1.6. ProMedCo's Limited Operating History. Stockholder is aware of and
understands that ProMedCo has been in operation for approximately one year, and
has a limited financial or operating history and that the Shares are speculative
investments which involve a risk of loss by him of his investment. Stockholder
understands ProMedCo's future operations are subject to many significant risks.
1.7. No Representations Regarding Future Profits. Stockholder has not
relied on any representation by any person, whether such representation was made
directly or indirectly, regarding the amount, percentage or type of profit or
loss to be realized, if any, from an investment in the Shares. Stockholder
further acknowledges that the prior experience of ProMedCo or any other person
is not in any way a prediction of the results which Stockholder may obtain as a
result of his investment in the Shares.
ARTICLE 2
TRANSFER RESTRICTION
2.1 Prohibited Transfers. Except as expressly permitted in this
Agreement, Stockholder shall not, for a period of 48 months from the date of
this Agreement (the "Restricted Period") sell, transfer, assign, pledge,
hypothecate, encumber or in any way alienate any of the Shares owned by
Stockholder, or any right or interest therein, whether voluntarily or by
operation of law, without the
(1)
0363293.08
080020-007 10/09/96
-4-
prior written consent of ProMedCo. Any purported transfer by Stockholder in
violation of any provision of this Agreement shall be void and ineffectual and
shall not operate to transfer any interest or title to the purported transferee.
2.2 Permitted Transfers. Notwithstanding the restrictions on transfer of
the Shares contained in this Article, the following transfers may be effected
without the consent of ProMedCo:
(a) Upon the death of Stockholder, pursuant to the laws of descent
and distribution or a properly probated Last Will and
Testament; provided, however, that in the event of a transfer
pursuant to this clause (a), the Shares shall continue to be
subject to the provisions of this Agreement;
(b) A transfer by the Stockholder, by gift or otherwise, to a
member of the Stockholder's Immediate Family (as hereafter
defined) or to a trust solely for the benefit of one or more
members of the Stockholder's Immediate Family; provided,
however, that any Shares so transferred shall continue to be
subject to the provisions of this Agreement. The term
"Immediate Family" shall mean a Stockholder's spouse,
ancestors and lineal descendants;
(c) A sale or transfer to ProMedCo; and
(d) Any sale of Shares in a public offering pursuant to a
registration statement filed by ProMedCo with the Securities
and Exchange Commission.
2.3 Additional Prohibited Transfers. At no time, whether during the
Restricted Period or thereafter, shall the Stockholder sell any part of the
Shares owned by the Stockholder to a person firm or corporation deemed to be a
competitor of ProMedCo as determined by a majority vote of the ProMedCo board of
directors. Notwithstanding the preceding, however, the prohibitions of this
Section 2.3 shall terminate upon the completion of an IPO by ProMedCo.
2.4 Lock-up Agreement. Stockholder hereby agrees that in connection
with an underwritten, firm commitment public offering pursuant to an effective
registration under the Act covering the offer and sale by ProMedCo of its
securities ("Qualified Public Offering"), upon the request of the principal
underwriter managing the Qualified Public Offering, Stockholder shall not sell,
make any short sale of, loan, grant an option for the purchase of, or otherwise
dispose of any shares owned by Stockholder without the prior written consent of
such underwriter, for ninety (90) days or such other period of time as such
underwriter shall reasonably request and which is applied to all stockholders
similarly situated.
(1)
0363293.08
080020-007 10/09/96
-5-
2.5 Definition of Shares. As used in this Agreement, the term "Shares"
shall include any additional stock issued to the Stockholder with respect to the
Shares as the result of any recapitalization, stock dividend or stock split, and
all other shares of the common stock of ProMedCo owned by the Stockholder,
whether presently held or hereafter acquired.
ARTICLE 3
REGISTRATION OF PROMEDCO STOCK
3.1 Registrations of ProMedCo Common Stock. On or prior to the 180th
day after the ProMedCo IPO Date, ProMedCo shall make application to register
under the Securities Act of 1933, as amended (the "Act") 20% of the Shares held
by Stockholder, and during the second year after the ProMedCo IPO Date, ProMedCo
shall make application to register under the Act an additional 20% of the Shares
held by Stockholder. In each case, ProMedCo will use its best efforts to cause
each such registration to become and remain effective for a reasonable period of
time not to exceed sixty (60) days or such longer period of time acceptable to
ProMedCo.
3.2 Duty to Furnish Information. Stockholder shall furnish to ProMedCo
and the underwriters such information as ProMedCo and the underwriters may
reasonably request in writing and as shall be required in connection with any
registration, qualification or compliance of any registration statement with
applicable securities laws, and shall otherwise cooperate with ProMedCo and the
underwriters in connection therewith.
3.3 Expenses of Registration. All expenses incident to ProMedCo's
performance of or compliance with this Section, including without limitation all
commissions and any National Association of Securities Dealers, Inc.
registration and filing fees and expenses, fees and expenses of compliance with
securities and blue sky laws (including reasonable fees and disbursements of
counsel for the underwriters in connection with blue sky qualifications of the
Shares), document and certificate preparation and printing expenses, messenger
and delivery expenses, fees and expenses of any transfer agent or registrar,
internal expenses, fees and disbursements of counsel and independent certified
public accountants of ProMedCo, and fees and expenses of any other persons,
including without limitation any special experts retained by ProMedCo
(collectively, the "Registration Expenses") will be borne by ProMedCo except
that the Stockholder shall pay ratably in proportion to the number of Shares to
be registered for the account of the Stockholder any incremental cost incurred
by ProMedCo by inclusion of Stockholder's Shares in such offering, such
incremental cost to be determined by the lead underwriter. Stockholder shall
also pay all underwriting discounts and commissions attributable to the sale of
Stockholder's Shares and the fees and disbursements of any counsel or other
advisors or experts retained by Stockholder.
(1)
0363293.08
080020-007 10/09/96
-6-
3.4 Conditions on Participation in Underwriting. Stockholder may not
participate in any underwritten offering hereunder unless such Stockholder (i)
agrees to sell Shares owned by Stockholder on the basis provided in any
underwriting arrangements approved by the persons entitled hereunder to approve
such arrangements, and (ii) completes and executes all questionnaires, powers of
attorneys, indemnities, underwriting agreements (as a party thereto) and other
documents reasonably required under the terms of such underwriting arrangements.
3.5 Stockholder Holder Put Right. If the ProMedCo IPO Date shall not
have occurred within 180 days after the Closing, Stockholder shall have the
right, to required ProMedCo to purchase up to 20% of the Shares of ProMedCo
Stock held by Stockholder at $14.00 per share, as adjusted to reflect changes in
capitalization resulting stock splits, stock dividends, reverse stock splits or
other changes in capitalization. Such purchase shall occur within 30 days after
ProMedCo has received a notice signed by Stockholder Holder requiring such
purchase. If the ProMedCo IPO Date thereafter occurs, ProMedCo shall have no
obligation to effect the first of the two registrations described in ss. 3.1.
ARTICLE 4
NOTICES
All notices, demands and other communications required or permitted
hereunder shall be made in writing and be deemed communicated on the date when
delivered in person or when delivered, if mailed by certified mail, postage
prepaid, addressed as follows:
Stockholder: ▇▇▇▇ ▇.▇. ▇. ▇. ▇▇▇▇▇▇ ▇▇▇▇
▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇
ProMedCo: ProMedCo, Inc.
▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇
▇▇▇▇▇ ▇▇▇▇
▇▇. ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
Attn: President
or to such other address as either Stockholder or ProMedCo may designate by
notice to the other.
(1)
0363293.08
080020-007 10/09/96
-7-
ARTICLE 5
MISCELLANEOUS
5.1 Entire Agreement. This Agreement constitutes the entire agreement
between the parties hereto pertaining to the subject matter hereof and
supersedes all prior and contemporaneous agreements, understandings,
negotiations and discussions, whether written or oral, of the parties, and there
are no representations, warranties or other agreements between the parties in
connection with the subject matter hereof, except as specifically set forth
herein.
5.2 Governing Law. The validity and construction of this Agreement shall be
governed by the laws of the State of Texas.
5.3 Section Headings. The section headings are for reference only and shall
not limit or control the meaning of any provision of this Agreement.
5.4 Waiver. No delay or omission on the part of any party hereto in
exercising any right hereunder shall operate as a waiver of such right or any
other right under this Agreement.
5.5 Successors and Assigns. This Agreement shall inure to the benefit of
and bind the respective successors and assigns of the parties hereto.
5.6 Amendments. This Agreement may be amended, but only in writing, signed
by the parties hereto.
5.7 Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be an original, but all of which together
shall comprise one and the same instrument.
5.8 Severability. Each section and subsection of this Agreement
constitutes a separate and distinct undertaking, covenant and/or provision
hereof. Whenever possible, each provision of this Agreement shall be interpreted
in such manner as to be effective and valid under applicable law. In the event
that any provision of this Agreement shall finally be determined by a competent
court or tribunal to be unlawful or unenforceable, such provision shall be
deemed severed from this Agreement, but every other provision of this Agreement
shall remain in full force and effect, and in substitution for any such
provision held unlawful or unenforceable, there shall be substituted a provision
of similar import reflecting the original intent of the parties hereto to the
extent permissible under law.
5.9 Termination. Except for the provisions of Section 1.4 of this
Agreement, which the parties hereto agree shall survive the termination of this
Agreement and for so long as the Stockholder shall own any Shares, this
Agreement shall terminate upon the first to occur of (i) a
(1)
0363293.08
080020-007 10/09/96
-8-
successful completion of a Qualified Public Offering by ProMedCo, (ii) upon the
mutual written agreement of the parties hereto, or (iii) the fourth anniversary
of this Agreement.
5.10 Spousal Consent. The spouse of the Stockholder is fully aware of,
understands, and fully consents and agrees to the provisions of this Agreement
and its binding effect upon any community property interest she may now or
hereafter own, and agrees that the termination of her marital relationship with
the Stockholder for any reason shall not have the effect of removing the shares
otherwise subject to this Agreement from the coverage hereof and that her
awareness, understanding, consent, and agreement is evidenced by her signing
this Agreement.
5.11 Arbitration. Any controversy or claim arising out of or relating
to this Agreement or the breach thereof will be settled by binding arbitration
in accordance with the rules of commercial arbitration of the American
Arbitration Association, and judgment upon the award rendered by the
arbitrator(s) may be entered in any court having jurisdiction thereof. Such
arbitration shall occur within the County of ▇▇▇▇, State of Texas, unless the
parties mutually agree to have such proceedings in some other locale. The
arbitrator(s) may in any such proceeding award attorneys' fees and costs to the
prevailing party.
IN WITNESS WHEREOF, the parties hereto have duly executed this
Agreement as of the day and year first above written.
PROMEDCO, INC.
By:
STOCKHOLDER:
SPOUSE OF STOCKHOLDER:
(1)
0363293.08
080020-007 10/09/96